a6727060.s2	The DT 0	symptoms NNS B-noun.communication	exacerbated VBD B-verb.communication	to TO 0	a DT 0	maximum NN B-noun.person	in IN 0	a DT 0	month NN B-noun.person	. . 0	. . 0
a18410508.s6	Because IN 0	the_CNS_damage NN 0	caused VBD B-verb.communication	by_METH JJ B-noun.other	and_MPTP NN I-noun.other	is VBZ B-verb.stative	highly RB B-adv.all	selective JJ B-adj.all	for IN 0	the DT 0	DA NNP 0	neuronal JJ B-adj.all	system NN B-noun.cognition	in IN 0	mouse NN B-noun.animal	models NNS B-noun.artifact	of_neurotoxicity NN I-noun.artifact	, , 0	we PRP 0	hypothesized VBD B-verb.cognition	that IN 0	the DT 0	CX3CR1 NN B-noun.person	plays VBZ B-verb.creation	a DT 0	role NN B-noun.attribute	in_METH JJ I-noun.attribute	- : 0	induced_neurotoxicity NN B-noun.time	and CC 0	microglial JJ B-adj.all	activation NN B-noun.act	. . 0	. . 0
a17439425.s1	1 LS 0	. . 0	. . 0
a16867021.s8	and_thioperamide RB 0	( ( 0	THP NNP 0	) ) 0	( ( 0	15 CD 0	mg FW 0	/ FW 0	kg FW 0	i.p FW 0	. . 0	) ) 0	, , 0	. . 0
a7628595.s2	Seventy NNP B-noun.person	- : 0	five CD 0	human_immunodeficiency_virus_(HIV)-infected JJ 0	patients NNS B-noun.person	with IN 0	CD4 : 0	+ CC 0	cell NN B-noun.person	counts VBZ B-verb.communication	< : 0	500/mm3 JJ B-adj.all	were VBD 0	randomized VBN B-verb.perception	to TO 0	receive VB B-verb.communication	either DT 0	ZDV NNP 0	( ( 0	500 CD 0	mg PRP$ 0	daily JJ B-noun.event	) ) 0	alone RB 0	( ( 0	group NN 0	I PRP 0	, , 0	n PRP 0	= $ 0	38 CD 0	) ) 0	or CC 0	in IN 0	combination NN 0	with IN 0	folinic_acid JJ 0	( ( 0	15 CD 0	mg PRP$ 0	daily JJ B-noun.event	) ) 0	and CC 0	intramascular JJ B-adj.all	vitamin_B12 NN B-noun.phenomenon	( ( 0	1000 CD 0	micrograms NNS B-noun.animal	monthly JJ B-adv.all	) ) 0	( ( 0	group NN 0	II NNP 0	, , 0	n PRP 0	= $ 0	37 CD 0	) ) 0	. . 0	. . 0
a9390208.s11	The DT 0	median JJ B-adj.all	follow NN B-noun.person	- : 0	up IN 0	period NN B-noun.person	was VBD B-verb.stative	14 CD B-adj.all	months NNS B-noun.person	. . 0	. . 0
a2578334.s1	To TO 0	test VB B-verb.social	the DT 0	validity NN B-noun.attribute	of IN 0	the DT 0	hypothesis NN B-noun.cognition	that IN 0	hypomethylation NN 0	of IN 0	DNA NNP B-noun.group	plays VBZ B-verb.social	an DT 0	important JJ B-adj.all	role NN B-noun.attribute	in IN 0	the DT 0	initiation_of_carcinogenic_process NN B-noun.other	, , 0	5-azacytidine JJ 0	( ( 0	5-AzC NN 0	) ) 0	( ( 0	10 CD 0	mg PRP 0	/ : 0	kg LS 0	) ) 0	, , 0	an DT 0	inhibitor NN B-noun.person	of IN 0	DNA NNP 0	methylation NN 0	, , 0	was VBD 0	given VBN B-verb.possession	to TO 0	rats NNS B-noun.location	during IN 0	the DT 0	phase NN B-noun.time	of IN 0	repair NN B-noun.state	synthesis NN I-noun.state	induced VBN B-verb.creation	by IN 0	the DT 0	three CD 0	carcinogens NNS 0	, , 0	benzo[a]-pyrene NNP B-noun.person	( ( 0	200 CD 0	mg NN B-noun.quantity	/ : 0	kg LS 0	) ) 0	, , 0	N NNP 0	- : 0	methyl NN B-noun.attribute	- : 0	N SYM 0	- : 0	nitrosourea NN B-noun.person	( ( 0	60 CD B-adj.all	mg NN B-noun.quantity	/ : 0	kg LS 0	) ) 0	and CC 0	1,2-dimethylhydrazine JJ 0	( ( 0	1,2-DMH JJ 0	) ) 0	( ( 0	100 CD 0	mg NN B-noun.quantity	/ : 0	kg LS 0	) ) 0	. . 0	. . 0
a17020434.s0	Optimising VBG 0	stroke NN B-noun.phenomenon	prevention NN I-noun.phenomenon	in IN 0	non NN B-noun.person	- : 0	valvular JJ B-adj.all	atrial_fibrillation NN B-noun.act	. . 0	. . 0
a14976857.s2	This DT 0	shunt NN B-noun.act	of IN 0	blood NN B-noun.act	via IN 0	a DT 0	patent_foramen_ovale NN B-noun.person	occurred VBD B-verb.cognition	in IN 0	the DT 0	presence NN B-noun.person	of IN 0	a DT 0	normal JJ B-adj.all	pulmonary JJ B-noun.body	artery NN I-noun.body	pressure NN B-noun.person	, , 0	and CC 0	was VBD B-verb.stative	probably RB B-adv.all	precipitated VBN B-verb.creation	by IN 0	a DT 0	propafenone NN B-noun.person	overdose NN B-noun.person	. . 0	. . 0
a11928786.s0	Bupropion NN 0	( ( 0	Zyban NNP B-noun.location	) ) 0	toxicity NN B-noun.quantity	. . 0	. . 0
a347884.s1	A DT 0	total NN B-noun.state	of IN 0	sixty CD 0	patients NNS B-noun.person	were VBD 0	trated VBN B-verb.cognition	with IN 0	bromperidol NN B-noun.person	first RB B-verb.competition	in IN 0	open JJ B-adj.all	conditions NNS B-noun.artifact	( ( 0	20 CD B-adj.all	patients NNS B-noun.artifact	) ) 0	, , 0	then RB B-adv.all	on IN 0	a DT 0	double JJ B-adj.all	blind JJ B-adj.all	basis NN B-noun.cognition	( ( 0	40 CD B-adj.all	patients NNS B-noun.artifact	) ) 0	with IN 0	haloperidol NN B-noun.person	as IN 0	the DT 0	reference NN B-noun.phenomenon	substance NN B-noun.phenomenon	. . 0	. . 0
a8387218.s3	Seventy CD 0	patients NNS B-noun.person	developed VBD B-verb.creation	major JJ B-adj.all	opportunistic_infections NNS B-noun.person	whilst VBP B-verb.communication	on IN 0	therapy NN B-noun.act	, , 0	this DT 0	was VBD B-verb.stative	the DT 0	first JJ B-noun.group	AIDS NNP I-noun.group	diagnosis NN B-noun.communication	in IN 0	17 CD B-adj.all	. . 0	. . 0
a15338796.s16	Support NN B-noun.person	of IN 0	the DT 0	arm NN B-noun.person	decreased VBD B-verb.communication	tremor NN B-noun.feeling	severity NN I-noun.feeling	, , 0	exhaustion NN B-noun.person	increased VBD B-verb.change	tremor NN 0	severity NN 0	significantly RB B-adv.all	. . 0	. . 0
a18439803.s6	Based VBN B-verb.cognition	on IN 0	the DT 0	finding NN B-noun.act	that IN 0	VPU NNP 0	and CC 0	VPA NNP 0	could MD 0	protect VB B-verb.competition	the DT 0	animals NNS B-noun.artifact	against IN 0	pilocarpine NN B-noun.person	- : 0	induced VBN B-verb.creation	seizure NN B-verb.contact	it PRP 0	is VBZ 0	suggested VBN B-verb.communication	that IN 0	the DT 0	reduction NN B-noun.act	of IN 0	inhibitory JJ B-adj.all	amino_acid JJ B-adj.all	neurotransmitters NNS B-noun.person	was VBD B-verb.stative	comparatively RB B-adv.all	minor JJ B-adj.all	and CC 0	offset VBN B-verb.emotion	by IN 0	a DT 0	pronounced JJ B-adj.all	reduction NN B-noun.process	of IN 0	glutamate NN B-noun.person	and CC 0	aspartate NN B-noun.person	. . 0	. . 0
a11961407.s5	Tissues NNS B-noun.person	were VBD 0	analyzed VBN B-verb.cognition	at IN 0	0 CD B-noun.quantity	, , 0	5 CD B-adj.all	, , 0	7 CD 0	, , 0	11 CD B-noun.quantity	, , 0	21 CD 0	, , 0	45 CD 0	, , 0	80 CD B-adj.all	and CC 0	126 CD 0	days NNS B-noun.phenomenon	after IN 0	PAN NNP 0	injection NN 0	so RB 0	as IN 0	to TO 0	include VB B-verb.change	both DT 0	the DT 0	acute JJ B-adj.all	phase NN B-noun.time	of IN 0	proteinuria NN B-noun.person	associated VBN B-verb.cognition	with IN 0	foot NN B-noun.act	process NN I-noun.act	effacement NN B-noun.cognition	( ( 0	days NNS B-noun.communication	5 CD 0	- : 0	11 LS 0	) ) 0	and CC 0	the DT 0	chronic JJ B-adj.pert	phase NN B-noun.time	of IN 0	proteinuria NN B-noun.person	associated VBN B-verb.cognition	with IN 0	glomerulosclerosis NN 0	( ( 0	days NNS B-noun.time	45 CD 0	- : 0	126 CD 0	) ) 0	. . 0	. . 0
a19346865.s6	Findings NNS B-noun.act	of IN 0	initial JJ B-adj.all	and CC 0	follow VB B-verb.possession	- : 0	up IN 0	MRIs NNP B-noun.person	were VBD B-verb.stative	retrospectively RB B-adv.all	evaluated VBN B-verb.communication	by IN 0	2 CD B-adj.all	neuroradiologists NNS B-noun.person	by IN 0	consensus NN 0	, , 0	to TO 0	analyze VB B-verb.cognition	the DT 0	presence NN B-noun.person	of IN 0	abnormal JJ B-adj.all	signal NN B-noun.possession	intensities NNS B-noun.possession	, , 0	their PRP$ 0	locations NNS B-noun.location	, , 0	and CC 0	signal NN B-noun.artifact	changes NNS B-noun.artifact	on IN 0	follow NN B-noun.act	- : 0	up IN 0	images NNS B-noun.person	. . 0	. . 0
a17879945.s1	Individuals NNS B-noun.person	with IN 0	HIV NNP B-noun.group	can MD 0	now RB 0	live VBP B-verb.stative	long JJ B-adj.all	lives NNS B-noun.body	with IN 0	drug NN B-noun.person	therapy NN 0	that WDT 0	often RB B-adv.all	includes VBZ B-verb.stative	protease NN 0	inhibitors NNS 0	such JJ 0	as IN 0	ritonavir NN B-noun.person	. . 0	. . 0
a8595686.s3	Patients NNS B-noun.person	in IN 0	Group NNP 0	C NNP 0	received VBD B-verb.possession	2 CD B-adj.all	ml IN 0	normal JJ B-adj.all	saline NN B-noun.act	, , 0	Group NNP B-noun.person	L NNP I-noun.person	, , 0	2 CD B-adj.all	ml NN B-noun.quantity	, , 0	lidocaine NN B-noun.communication	2 CD B-adj.all	% NN 0	( ( 0	40 CD B-adj.all	mg NN B-noun.quantity	) ) 0	and CC 0	Group NNP B-noun.group	T NNP 0	, , 0	2 CD B-adj.all	ml IN 0	thiopentone JJ 0	2.5 CD 0	% NN 0	( ( 0	50 CD B-adj.all	mg NN B-noun.quantity	) ) 0	. . 0	. . 0
a18703024.s9	This DT 0	animal NN B-noun.animal	model NN B-noun.animal	may MD 0	be VB B-verb.stative	useful JJ B-adj.all	to TO 0	explore VB B-verb.communication	the DT 0	mechanisms NNS B-noun.person	by IN 0	which WDT 0	prenatal JJ B-adj.all	nutritional_deficiency NN B-noun.artifact	enhances NNS I-noun.artifact	risk NN 0	for IN 0	schizophrenia NN B-noun.person	in IN 0	humans NNS B-noun.animal	and CC 0	may MD 0	also RB B-adv.all	have VBP B-verb.possession	implications NNS B-noun.motive	for IN 0	developmental JJ B-adj.all	processes NNS B-noun.possession	leading VBG B-verb.stative	to TO 0	differential JJ B-adj.all	sensitivity NN B-noun.feeling	to TO 0	drugs NNS B-noun.person	of IN 0	abuse NN B-noun.act	. . 0	. . 0
a9812111.s7	Low SYM 0	- : 0	dose NN B-noun.person	haloperidol NN B-noun.person	did VBD 0	not RB B-adv.all	differ VB B-verb.stative	from IN 0	placebo NN B-noun.plant	on IN 0	any DT 0	measure NN B-noun.attribute	of IN 0	efficacy NN B-noun.phenomenon	or CC 0	side JJ B-adj.all	effects NNS B-noun.phenomenon	. . 0	. . 0
a16755009.s1	The DT 0	present JJ B-adj.all	study NN B-noun.artifact	was VBD 0	aimed VBN B-verb.competition	at IN 0	investigating VBG B-verb.stative	the DT 0	effects NNS B-noun.phenomenon	of IN 0	Daucus NNP B-noun.person	carota NN I-noun.plant	seeds NNS B-noun.plant	on IN 0	cognitive JJ B-adj.all	functions NNS B-noun.attribute	, , 0	total JJ B-adj.all	serum NN B-noun.body	cholesterol NN I-noun.body	levels NNS B-noun.attribute	and CC 0	brain NN B-noun.person	cholinesterase NN B-noun.phenomenon	activity NN B-noun.process	in IN 0	mice NNS B-noun.animal	. . 0	. . 0
a6747681.s11	The DT 0	frequency NN B-noun.quantity	of IN 0	visual_loss NNP B-noun.person	decreased VBD B-verb.communication	after IN 0	the DT 0	concentration NN B-noun.event	of IN 0	the DT 0	ethanol NN B-noun.person	diluent NN B-noun.person	was VBD 0	lowered VBN B-verb.change	. . 0	. . 0
a19884587.s2	DESIGN NN B-noun.artifact	, , 0	SETTING NNP B-noun.other	, , 0	AND CC 0	PARTICIPANTS NNS B-noun.group	, , 0	Population NNP B-noun.person	- : 0	based VBN B-verb.cognition	, , 0	multisite JJ 0	, , 0	case NN B-noun.person	- : 0	control NN B-noun.act	study NN B-noun.artifact	of IN 0	women NNS B-noun.person	who WP 0	had VBD 0	pregnancies NNS B-noun.person	affected VBN B-verb.change	by IN 0	1 CD 0	of IN 0	more JJR B-noun.quantity	than IN 0	30 CD B-adj.all	eligible JJ B-adj.all	major JJ B-adj.all	birth_defects NNS B-noun.act	identified VBN B-verb.cognition	via IN 0	birth_defect NN 0	surveillance NN B-adj.all	programs NNS B-noun.cognition	in IN 0	10 CD B-adj.all	states NNS B-noun.location	( ( 0	n UH 0	= $ 0	13 CD B-adj.all	155 CD 0	) ) 0	and CC 0	control VB B-verb.contact	women NNS B-noun.person	randomly RB B-adv.all	selected VBN B-verb.cognition	from IN 0	the DT 0	same JJ B-adj.all	geographical JJ B-adj.all	regions NNS B-noun.motive	( ( 0	n UH 0	= $ 0	4941 CD 0	) ) 0	. . 0	. . 0
a21029050.s8	The DT 0	duration NN 0	of IN 0	apnea NN B-noun.person	was VBD B-verb.stative	5 CD B-adj.all	- : 0	15 CD B-adj.all	min NN B-noun.communication	compared VBN B-verb.possession	with IN 0	3 SYM 0	- : 0	5.3 CD 0	min NN B-noun.quantity	from IN 0	the DT 0	literature NN B-noun.act	. . 0	. . 0
a9672936.s6	The DT 0	routine JJ B-adj.all	use NN B-noun.attribute	of IN 0	pethidine NN 0	via IN 0	PCA NNP 0	even RB 0	for IN 0	a DT 0	brief JJ B-adj.all	postoperative JJ B-adj.all	analgesia NN B-noun.group	should MD 0	be VB 0	reconsidered VBN B-verb.communication	. . 0	. . 0
a1919871.s0	Irreversible JJ B-adj.all	damage NN 0	to TO 0	the DT 0	medullary JJ B-adj.all	interstitium NN B-noun.person	in IN 0	experimental JJ B-adj.all	analgesic JJ B-adj.all	nephropathy NN B-noun.relation	in IN 0	F344 JJ B-adj.all	rats NNS B-noun.animal	. . 0	. . 0
a10091617.s3	This DT 0	unwanted JJ B-adj.all	effect NN B-noun.cognition	on IN 0	postural JJ B-adj.all	blood NN B-noun.group	pressure NN B-noun.person	was VBD 0	not RB 0	the DT 0	result NN B-noun.act	of IN 0	underlying VBG B-verb.stative	autonomic JJ B-adj.all	failure NN B-noun.person	. . 0	. . 0
a8864707.s1	The DT 0	aim NN 0	of IN 0	this DT 0	study NN B-noun.artifact	was VBD 0	to TO 0	evaluate VB B-verb.communication	the DT 0	relationship NN B-noun.state	between IN 0	phenytoin NN B-noun.person	medication NN B-noun.person	and CC 0	cerebellar_atrophy NN B-noun.body	in IN 0	patients NNS B-noun.person	who WP 0	had VBD 0	experienced VBN B-verb.perception	clinical JJ B-adj.all	intoxication NN B-noun.possession	. . 0	. . 0
a11773892.s3	Recently RB B-adv.all	, , 0	however RB 0	, , 0	we PRP 0	have VBP 0	had VBN 0	an DT 0	increase NN B-noun.event	of IN 0	patients NNS B-noun.person	who WP 0	are VBP 0	presenting VBG B-verb.creation	after IN 0	OLTX NNP B-noun.person	with IN 0	end NN B-noun.person	- : 0	stage_renal_disease NN 0	( ( 0	ESRD NNP 0	) ) 0	. . 0	. . 0
a19037603.s7	Shortly RB B-adv.all	after IN 0	treatment NN B-noun.plant	their PRP$ 0	tests NNS B-noun.cognition	normalized VBN B-verb.communication	and CC 0	during IN 0	follow SYM 0	- : 0	up IN 0	period NN B-noun.person	none NN 0	of IN 0	the DT 0	patients NNS B-noun.person	had VBD B-verb.change	abnormal_liver_function JJ B-noun.artifact	tests NNS I-noun.artifact	. . 0	. . 0
a19759529.s9	Importantly RB B-adv.all	, , 0	both DT 0	classical JJ B-noun.attribute	( ( 0	haloperidol NN 0	) ) 0	and CC 0	atypical JJ B-adj.all	( ( 0	olanzapine JJ 0	, , 0	clozapine NN B-noun.person	and CC 0	aripiprazole NN B-noun.cognition	) ) 0	antipsychotics NNS B-noun.location	were VBD B-verb.stative	effective JJ B-adj.all	in IN 0	all PDT 0	these DT 0	models NNS B-noun.artifact	of IN 0	hyperactivity NN B-noun.phenomenon	. . 0	. . 0
a10901305.s16	Ketamine NNP B-noun.person	should MD 0	only RB B-adv.all	be VB 0	used VBN B-verb.consumption	in IN 0	an DT 0	environment NN B-noun.state	such JJ 0	as IN 0	the DT 0	emergency NN B-noun.person	department NN B-noun.person	, , 0	where WRB 0	proper JJ B-adj.all	one CD 0	- : 0	on SYM 0	- : 0	one CD 0	monitoring NN B-verb.perception	is VBZ 0	used VBN B-verb.consumption	and CC 0	board NN B-noun.substance	- : 0	certified JJ B-adj.all	physicians NNS B-noun.person	skilled VBN B-verb.communication	in IN 0	airway NN B-noun.animal	management NN B-noun.group	are VBP 0	directly RB B-adv.all	involved VBN B-verb.stative	in IN 0	the DT 0	care NN B-noun.group	of IN 0	the DT 0	patient NN B-noun.person	. . 0	. . 0
a20080983.s2	METHOD NNP B-noun.attribute	, , 0	Twenty CD 0	cocaine NN 0	- : 0	dependent JJ B-adj.all	participants NNS B-noun.person	were VBD B-verb.stative	randomly RB B-adv.all	assigned VBN B-verb.social	to TO 0	receive VB B-verb.consumption	modafinil NN I-verb.consumption	, , 0	400 CD 0	mg NN B-noun.quantity	( ( 0	N=10 NNP 0	) ) 0	, , 0	or CC 0	placebo NN B-noun.substance	( ( 0	N=10 NNP 0	) ) 0	every DT 0	morning NN B-noun.person	at IN 0	7,30 CD 0	a.m. NN B-noun.time	for IN 0	16 CD B-adj.all	days NNS B-noun.person	in IN 0	an DT 0	inpatient NN B-noun.person	, , 0	double RB 0	- : 0	blind NN B-noun.person	randomized VBD B-verb.communication	trial NN B-noun.person	. . 0	. . 0
a12707296.s3	Eight CD 0	healthy JJ B-adj.all	men NNS B-noun.person	were VBD 0	recruited VBN B-verb.communication	. . 0	. . 0
a18217897.s4	Patients NNS B-noun.person	had VBD 0	received VBN B-verb.possession	a DT 0	median NN B-noun.communication	of IN 0	2 CD B-adj.all	( ( 0	range NN B-noun.person	, , 0	1 CD B-adj.all	- : 0	4 LS 0	) ) 0	prior RB 0	regimens VBZ B-verb.communication	. . 0	. . 0
a3780846.s7	In IN 0	a DT 0	further JJ B-adj.all	series NN B-noun.communication	of IN 0	experiments NNS B-noun.person	, , 0	haloperidol NN B-noun.person	( ( 0	0.2 CD 0	mg FW B-noun.quantity	/ FW 0	kg FW 0	i.p FW 0	. . 0	) ) 0	. . 0
a1835291.s0	Acute NNP B-noun.person	bronchodilating VBG B-verb.motion	effects NNS B-noun.phenomenon	of IN 0	ipratropium_bromide NN B-noun.other	and CC 0	theophylline PRP 0	in IN 0	chronic_obstructive_pulmonary_disease NNP 0	. . 0	. . 0
a150790.s0	A DT 0	pyridoxine NN B-noun.person	- : 0	dependent JJ B-adj.all	behavioral_disorder IN 0	unmasked JJ B-adj.all	by IN 0	isoniazid NN B-noun.person	. . 0	. . 0
a10091617.s9	Stopping VBG B-verb.motion	selegiline NN 0	also RB B-adv.all	significantly RB B-adv.all	reduced_the_supine_systolic_and_diastolic_blood_pressures VBZ B-verb.change	consistent JJ B-adj.all	with IN 0	a DT 0	previously RB B-adv.all	undescribed VBD B-verb.communication	supine JJ B-adj.all	pressor NN B-noun.person	action NN B-noun.person	. . 0	. . 0
a20588063.s10	Nephrin NNP B-noun.person	decreased VBD B-verb.change	further RBR B-adv.all	, , 0	while IN 0	dendrin NN B-noun.person	and CC 0	plekhh2 NN B-noun.person	also RB B-adv.all	decreased VBD B-verb.change	but CC 0	a SYM 0	- : 0	actinin NN B-noun.person	remained VBD B-verb.stative	unchanged JJ B-adj.all	. . 0	. . 0
a19767176.s7	Low SYM 0	- : 0	dose NN 0	PDTC NNP 0	treatment NN B-noun.communication	almost RB B-adv.all	completely RB B-adv.all	protected VBN B-verb.competition	from IN 0	lesions NNS B-noun.communication	in IN 0	the DT 0	piriform NN B-noun.body	cortex NN I-noun.body	. . 0	. . 0
a3437726.s4	and CC 0	then RB B-adv.all	100 CD 0	mg IN 0	b.i.d NNP B-noun.person	. . 0	) ) 0	. . 0
a18020536.s12	Long RB 0	- DT 0	term NN B-noun.time	use NN 0	of IN 0	these DT 0	drugs NNS B-noun.artifact	was VBD 0	associated VBN B-verb.cognition	with IN 0	female JJ B-adj.all	sex NN B-noun.act	and CC 0	use NN 0	of IN 0	a DT 0	higher JJR B-adj.all	number NN B-noun.attribute	of IN 0	drugs NNS B-noun.artifact	with IN 0	effects NNS B-noun.phenomenon	on IN 0	the DT 0	CNS NNP B-noun.group	, , 0	which WDT 0	tended VBD B-verb.stative	to TO 0	be VB 0	related VBN B-verb.cognition	to TO 0	diagnosed VBN B-verb.consumption	dementia NN I-verb.consumption	. . 0	. . 0
a3409645.s2	Assessments NNS B-noun.person	of IN 0	marital JJ B-adj.all	happiness NN B-noun.feeling	and CC 0	depressed_mood NNP B-noun.person	were VBD B-verb.stative	also RB B-adv.all	made VBD 0	using VBG B-verb.consumption	the DT 0	CES NNP B-noun.group	- : 0	D NNP 0	and CC 0	the DT 0	Azrin NNP B-noun.other	Marital NNP I-noun.other	Happiness NNP I-noun.other	Scale NNP I-noun.other	( ( 0	AMHS NNP B-noun.group	) ) 0	. . 0	. . 0
a8955532.s5	These DT 0	findings NNS B-noun.act	suggest VBP B-verb.communication	that IN 0	disruption NN B-noun.act	of IN 0	the DT 0	blood NN B-noun.act	- : 0	brain NN B-noun.food	barrier NN B-noun.artifact	during IN 0	acute JJ B-adj.all	hypertension NN B-noun.person	is VBZ B-verb.stative	not RB B-adv.all	related VBN B-verb.communication	to TO 0	the DT 0	synthesis NN B-noun.cognition	/ : 0	release NN B-noun.process	of IN 0	bradykinin NN B-noun.person	to TO 0	activate VB B-verb.stative	B2 JJ B-adj.all	receptors NNS B-noun.person	. . 0	. . 0
a18410508.s1	Methamphetamine NNP B-noun.person	( ( 0	METH NNP 0	) ) 0	damages VBZ B-verb.stative	dopamine NN 0	( ( 0	DA NNP 0	) ) 0	nerve NN B-noun.animal	endings NNS B-noun.Tops	by IN 0	a DT 0	process NN B-noun.person	that WDT 0	has VBZ 0	been VBN 0	linked VBN B-verb.cognition	to TO 0	microglial JJ B-adj.all	activation NN B-noun.act	but CC 0	the DT 0	signaling NN B-noun.location	pathways NNS B-noun.artifact	that WDT 0	mediate VBP B-verb.cognition	this DT 0	response NN B-noun.communication	have VBP B-verb.stative	not RB I-verb.stative	yet RB 0	been VBN 0	delineated VBN B-verb.change	. . 0	. . 0
a15863244.s12	Prenatal JJ B-adj.all	exposure NN B-noun.cognition	to TO 0	non VB B-verb.communication	- : 0	selective JJ B-adj.all	COX NNP B-noun.group	inhibitors NNS B-noun.attribute	increases VBZ B-verb.change	the DT 0	risk NN 0	of IN 0	VSD NNP B-noun.group	and CC 0	MD NNP 0	when WRB 0	compared VBN B-verb.cognition	to TO 0	historic JJ B-adj.pert	control NN B-noun.act	but CC 0	not RB B-adv.all	with IN 0	selective JJ B-noun.person	COX-2 NN I-noun.person	inhibitors NNS B-noun.person	. . 0	. . 0
a12589964.s10	End SYM 0	- : 0	diastolic NN B-noun.person	( ( 0	ED NNP 0	) ) 0	and CC 0	end NN B-noun.person	- : 0	systolic JJ B-adj.all	( ( 0	ES NNP 0	) ) 0	LV NNP 0	diameters NNS 0	/ IN 0	BW NNP 0	significantly RB B-adv.all	increased VBN B-verb.change	, , 0	whereas IN 0	LV NNP 0	FS NNP 0	was VBD 0	decreased VBN B-verb.change	after IN 0	9 CD B-adj.all	weeks NNS B-noun.time	in IN 0	the DT 0	DOX NNP 0	group NN 0	( ( 0	p<0.001 NNP 0	) ) 0	. . 0	. . 0
a220563.s0	Perhexiline_maleate JJ B-adj.all	and CC 0	peripheral_neuropathy JJ B-noun.person	. . 0	. . 0
a10743446.s5	Infusion NN B-noun.person	started VBD B-verb.creation	15 CD B-adj.all	min NN B-noun.communication	after IN 0	injection NN B-noun.time	of IN 0	capsaicin NN B-noun.communication	. . 0	. . 0
a17400887.s8	In IN 0	behavioral JJ B-adj.all	tests NNS B-noun.cognition	, , 0	animals NNS B-noun.person	treated VBN B-verb.social	with IN 0	terbutaline NN B-noun.artifact	on IN 0	PN NNP 0	2 CD 0	to TO 0	5 CD 0	showed VBD B-verb.communication	consistent JJ B-adj.all	patterns NNS B-noun.person	of IN 0	hyper NN B-noun.person	- : 0	reactivity NN B-noun.motive	to TO 0	novelty NN B-noun.person	and CC 0	aversive JJ B-adj.all	stimuli NNS B-noun.artifact	when WRB 0	assessed VBN B-verb.cognition	in IN 0	a DT 0	novel NN B-noun.artifact	open JJ B-adj.all	field NN B-noun.object	, , 0	as RB 0	well RB 0	as IN 0	in IN 0	the DT 0	acoustic JJ B-adj.all	startle NN B-noun.state	response NN B-noun.communication	test NN B-noun.communication	. . 0	. . 0
a7919560.s1	OBJECTIVE NNP B-noun.group	, , 0	To TO 0	report VB B-verb.communication	a DT 0	case NN B-noun.state	of IN 0	erythema_multiforme NN B-noun.food	and CC 0	hypersensitivity_myocarditis NN 0	caused VBN B-verb.communication	by IN 0	ampicillin NN B-noun.person	. . 0	. . 0
a1009330.s1	Further JJ B-adj.all	studies NNS B-noun.artifact	on IN 0	the DT 0	effects NNS B-noun.phenomenon	of IN 0	certain JJ B-adj.all	irrigating JJ B-adj.all	fluids NNS B-noun.plant	on IN 0	the DT 0	rat NN B-noun.artifact	bladder NN B-noun.person	for IN 0	18 CD B-adj.all	hours NNS B-noun.person	are VBP 0	reported VBN B-verb.communication	. . 0	. . 0
a12589964.s14	Only RB B-adv.all	five CD 0	of IN 0	the DT 0	controls NNS B-noun.artifact	exhibited VBD B-verb.stative	evidence NN B-noun.attribute	of IN 0	very RB B-adv.all	slight JJ B-adj.all	perivascular JJ B-adj.all	fibrosis NN B-noun.food	. . 0	. . 0
a8739323.s7	CY NNP 0	caused VBD B-verb.communication	hemorrhagic_cystitis NNP B-noun.person	in IN 0	40 CD B-adj.all	% NN 0	of IN 0	rats NNS B-noun.animal	, , 0	but CC 0	it PRP 0	did VBD 0	not RB B-adv.all	cause VB B-verb.communication	this DT 0	complication NN B-noun.communication	when WRB 0	combined VBN B-verb.creation	with IN 0	5-FU NN B-noun.food	and CC 0	MTX NNP B-noun.group	. . 0	. . 0
a18768591.s3	The DT 0	present JJ B-adj.all	study NN B-noun.artifact	was VBD 0	performed VBN B-verb.social	to TO 0	elucidate VB B-verb.communication	the DT 0	role NN B-noun.attribute	of IN 0	SGK1 NN B-noun.food	in IN 0	the DT 0	volume_retention NN B-noun.artifact	and CC 0	fibrosis NN 0	during IN 0	nephrotic_syndrome JJ 0	. . 0	. . 0
a3437726.s7	was VBD 0	prescribed VBN B-verb.communication	in IN 0	addition NN 0	. . 0	. . 0
a2515254.s3	Subsequently RB B-adv.all	20 CD B-adj.all	migraine NN B-noun.act	patients NNS B-noun.person	, , 0	who WP 0	developed VBD B-verb.creation	an DT 0	early JJ B-adj.all	onset NN B-noun.event	attack NN B-noun.person	with IN 0	frontotemporal JJ B-adj.all	nitroglycerin NN B-noun.person	, , 0	received VBD B-verb.possession	the DT 0	drug NN B-noun.person	in IN 0	a DT 0	second JJ B-adj.all	induction NN 0	test NN 0	at IN 0	other JJ 0	body NN B-noun.object	areas NNS I-noun.object	. . 0	. . 0
a2334618.s0	Comparison NNP B-noun.person	of IN 0	the DT 0	respiratory JJ B-adj.pert	effects NNS B-noun.phenomenon	of IN 0	i.v NNP B-noun.person	. . 0	infusions NNS B-noun.cognition	of IN 0	morphine NN B-noun.person	and CC 0	regional JJ B-adj.all	analgesia NN B-noun.group	by IN 0	extradural JJ B-adj.all	block NN B-noun.location	. . 0	. . 0
a8682684.s7	The DT 0	reports NNS B-noun.communication	illustrate VBP B-verb.cognition	the DT 0	need NN B-noun.object	for IN 0	clinicians NNS B-noun.person	to TO 0	consider VB B-verb.communication	acetaminophen RB B-adv.all	in IN 0	patients NNS B-noun.person	with IN 0	hypotension NN 0	of IN 0	unknown JJ B-adj.all	origin NN B-noun.location	. . 0	. . 0
a11007689.s5	As IN 0	a DT 0	result NN B-noun.person	, , 0	switching VBG B-verb.motion	to TO 0	tacrolimus NN B-noun.person	has VBZ 0	been VBN 0	reported VBN B-verb.communication	to TO 0	be VB B-verb.stative	a DT 0	viable JJ B-adj.all	therapeutic JJ B-adj.pert	option NN B-noun.person	in IN 0	the DT 0	setting NN B-noun.act	of IN 0	cyclosporine NN B-noun.person	- : 0	induced VBN B-verb.creation	TMA NNP 0	. . 0	. . 0
a2578334.s5	In IN 0	the DT 0	absence NN B-noun.act	of IN 0	the DT 0	carcinogen NN B-noun.artifact	, , 0	5-AzC JJ 0	given VBN B-verb.possession	after IN 0	a DT 0	two CD 0	thirds NNS 0	partial JJ B-adj.all	hepatectomy NN B-noun.person	, , 0	when WRB 0	its PRP$ 0	incorporation NN B-noun.time	should MD 0	be VB B-verb.stative	maximum JJ B-adj.all	, , 0	failed VBD B-verb.social	to TO 0	induce VB B-verb.cognition	any DT 0	gamma NN B-noun.act	- : 0	GT RB 0	positive JJ B-adj.all	foci NN B-noun.state	. . 0	. . 0
a18004067.s2	CASE NNP B-noun.person	REPORT NNP I-noun.person	, , 0	We PRP 0	describe VBP B-verb.stative	2 CD B-adj.all	patients NNS B-noun.person	who WP 0	were VBD B-verb.stative	regular JJ B-adj.all	consumers NNS B-noun.person	of IN 0	alcohol NN B-noun.food	and CC 0	who WP 0	developed VBD B-verb.creation	liver_failure NN B-noun.phenomenon	within IN 0	3 CD B-adj.all	- : 0	5 CD B-adj.all	days NNS B-noun.act	after IN 0	hospitalization NN B-noun.artifact	and CC 0	stopping VBG B-verb.motion	alcohol NN 0	consumption NN 0	while IN 0	being VBG 0	treated VBN B-verb.change	with IN 0	4 CD B-adj.all	g DT 0	paracetamol NN B-noun.cognition	/ : 0	day NN B-noun.person	. . 0	. . 0
a3101906.s8	The DT 0	results NNS B-noun.communication	of IN 0	serum NN B-noun.phenomenon	liver NN B-noun.phenomenon	function NN B-noun.act	tests NNS B-noun.person	suggested VBD B-verb.communication	hepatocellular_injury NNP B-noun.person	in IN 0	10 CD B-adj.all	( ( 0	63 CD 0	% NN 0	) ) 0	, , 0	the DT 0	rest NN B-noun.person	showed VBD B-verb.communication	a DT 0	mixed JJ B-adj.all	pattern NN B-noun.person	. . 0	. . 0
a7977601.s3	RESULTS NNS B-noun.artifact	, , 0	Ophthalmologists NNS B-noun.person	at IN 0	15 CD B-adj.all	institutions NNS B-noun.person	responded VBD B-verb.social	, , 0	reporting VBG B-verb.communication	a DT 0	total NN B-noun.state	of IN 0	3,774 CD 0	indocyanine_green JJ B-adj.all	angiograms NNS B-noun.shape	performed VBN B-verb.communication	on IN 0	2,820 CD 0	patients NNS B-noun.person	between IN 0	June NNP B-noun.location	1984 CD 0	and CC 0	September NNP B-noun.other	1992 CD 0	. . 0	. . 0
a8092427.s8	Anaphylaxis DT 0	was VBD 0	seen VBN B-verb.perception	in IN 0	37 CD 0	patients NNS B-noun.person	( ( 0	69 CD 0	% NN 0	) ) 0	, , 0	the DT 0	other JJ 0	17 CD 0	( ( 0	31 CD 0	% NN 0	) ) 0	having VBG B-verb.contact	urticaria NNS I-verb.contact	and/or CC 0	angioedema NN B-noun.attribute	. . 0	. . 0
a10365197.s0	Cocaine NN B-noun.person	- : 0	induced VBN B-verb.creation	mood_disorder JJR 0	, , 0	prevalence NN B-noun.attribute	rates NNS B-noun.time	and CC 0	psychiatric JJ B-adj.all	symptoms NNS B-noun.body	in IN 0	an DT 0	outpatient NN B-noun.artifact	cocaine NN B-noun.person	- : 0	dependent JJ B-adj.all	sample NN B-noun.cognition	. . 0	. . 0
a10526274.s17	The DT 0	median JJ B-adj.all	age NN B-noun.person	of IN 0	those DT 0	patients NNS B-noun.person	developing VBG B-verb.communication	Grade NNP B-noun.other	3 SYM 0	- : 0	4 CD B-adj.all	neutropenia NN B-noun.person	was VBD B-verb.stative	significantly RB B-adv.all	higher JJR B-adj.all	than IN 0	that DT 0	of IN 0	the DT 0	remaining VBG B-verb.change	patients NNS B-noun.person	( ( 0	75 CD 0	years NNS 0	vs. RB 0	72 CD 0	years NNS B-noun.time	, , 0	P NNP 0	= SYM 0	0.047 CD 0	) ) 0	. . 0	. . 0
a8649546.s3	Ballistic JJ B-adj.all	and CC 0	choreic JJ B-adj.all	dyskinesia NNS B-noun.state	were VBD B-verb.stative	markedly RB B-adv.all	ameliorated VBN B-verb.communication	, , 0	whereas IN 0	dystonia NN B-noun.person	was VBD B-verb.stative	not RB B-adv.all	. . 0	. . 0
a8638206.s2	Reports NNS B-noun.person	of IN 0	persistent JJ B-adj.all	paralysis NN B-noun.communication	after IN 0	the DT 0	discontinuance NN B-noun.act	of IN 0	these DT 0	drugs NNS B-noun.artifact	have VBP 0	most RBS 0	often RB B-adv.all	involved VBN B-verb.stative	aminosteroid IN 0	- : 0	based VBN B-verb.cognition	NMBAs NNP 0	such JJ 0	as IN 0	vecuronium_bromide JJ 0	, , 0	especially RB B-adv.all	when WRB 0	used VBN B-verb.consumption	in IN 0	conjunction NN 0	with IN 0	corticosteroids NNS B-noun.food	. . 0	. . 0
a11206082.s6	Results NNS 0	presented VBN B-verb.possession	here RB 0	show VBP B-verb.communication	that IN 0	the DT 0	differential JJ B-adj.all	sensitivities NNS B-noun.time	of IN 0	BS NNP 0	and CC 0	BR NNP 0	lines NNS B-noun.communication	to TO 0	beta JJ 0	- : 0	CCM NNP B-noun.group	can MD 0	be VB 0	extended VBN B-verb.change	to TO 0	diazepam VB B-verb.social	, , 0	picrotoxin NN B-noun.person	, , 0	and CC 0	pentylenetetrazol NN B-noun.person	, , 0	suggesting VBG B-verb.communication	a DT 0	genetic JJ B-adj.all	selection NN B-noun.act	of IN 0	a DT 0	general JJ B-adj.all	sensitivity NN B-noun.feeling	and CC 0	resistance NN B-noun.act	to TO 0	several JJ B-adj.all	ligands NNS B-noun.relation	of IN 0	the DT 0	GABA(A NN B-noun.artifact	) ) 0	receptor NN B-noun.quantity	. . 0	. . 0
a18544179.s9	Pain NNP B-noun.person	severity NN B-noun.feeling	and CC 0	analgesic JJ B-adj.all	requirements NNS B-noun.object	were VBD B-verb.stative	unaffected JJ B-adj.all	by IN 0	the DT 0	omission NN B-noun.process	of IN 0	fentanyl NN B-noun.food	. . 0	. . 0
a1749407.s4	With IN 0	regard NN B-noun.relation	to TO 0	spasm VB B-verb.communication	, , 0	the DT 0	clinical JJ B-adj.all	findings NNS B-noun.act	are VBP B-verb.stative	largely RB B-adv.all	circumstantial JJ B-adj.all	, , 0	and CC 0	the DT 0	locus NN B-noun.location	of IN 0	cocaine NN B-noun.person	- : 0	induced VBN B-verb.creation	vasoconstriction NN B-noun.artifact	remains VBZ B-verb.change	speculative JJ I-verb.change	. . 0	. . 0
a7628595.s1	A DT 0	prospective JJ B-adj.all	, , 0	randomized VBD B-verb.consumption	study NN B-noun.artifact	was VBD 0	conducted VBN B-verb.communication	to TO 0	evaluate VB B-verb.communication	the DT 0	role NN B-noun.attribute	of IN 0	vitamin_B12 NNP B-noun.person	and CC 0	folinic_acid JJ B-adj.all	supplementation NN I-adj.all	in IN 0	preventing VBG B-verb.creation	zidovudine NN B-noun.substance	( ( 0	ZDV)-induced JJ 0	bone_marrow_suppression NN 0	. . 0	. . 0
a88336.s0	Alpha NNP B-noun.person	and CC 0	beta JJ B-adj.all	coma NN B-noun.group	in IN 0	drug NN 0	intoxication NN 0	uncomplicated JJ 0	by IN 0	cerebral_hypoxia NNP B-noun.person	. . 0	. . 0
a20633755.s2	Here RB 0	, , 0	we PRP 0	present VBP B-verb.creation	a DT 0	similar JJ B-adj.all	incident NN B-noun.shape	in IN 0	a DT 0	severely RB B-adv.all	depressed JJ B-adj.all	patient NN B-noun.person	who WP 0	received VBD B-verb.possession	electroconvulsive JJ B-adj.all	therapy NN B-noun.person	( ( 0	ECT NNP 0	) ) 0	. . 0	. . 0
a7504976.s1	OBJECTIVE NNP B-noun.group	, , 0	This DT 0	study NN B-noun.artifact	was VBD 0	conducted VBN B-verb.communication	to TO 0	assess VB B-verb.cognition	the DT 0	occurrence NN B-noun.state	of IN 0	hepatic_adverse_effects NNS B-noun.person	encountered VBD B-verb.social	with IN 0	antithyroid JJ B-adj.all	drugs NNS B-noun.artifact	. . 0	. . 0
a3425586.s6	Thus RB 0	, , 0	AE NNP B-noun.person	RBCs NNPS I-noun.person	appear VBP B-verb.communication	to TO 0	have VB B-verb.social	an DT 0	increased VBN B-verb.change	sensitivity NN B-noun.feeling	to TO 0	oxidant VB B-verb.change	stress NN B-noun.state	both CC 0	in IN 0	vitro NN B-noun.animal	and CC 0	in IN 0	vivo NN B-noun.animal	, , 0	since IN 0	dapsone NN 0	does VBZ 0	not RB B-adv.all	cause VB B-verb.creation	hemolytic_anemia NN 0	at IN 0	this DT 0	dose NN B-noun.event	in IN 0	hematologically RB B-adv.all	normal JJ B-adj.all	individuals NNS B-noun.person	. . 0	. . 0
a16330293.s18	CONCLUSION NN B-noun.group	, , 0	The DT 0	4-mg JJ B-adj.all	nicotine NN B-noun.artifact	lozenge NN B-noun.artifact	and CC 0	4-mg JJ B-adj.all	nicotine NN B-noun.person	gum NN B-noun.person	had VBD B-verb.stative	comparable JJ B-adj.all	safety NN B-noun.artifact	profiles NNS B-noun.artifact	in IN 0	these DT 0	patients NNS B-noun.person	with IN 0	label NN B-noun.group	- : 0	restricted VBD B-verb.communication	medical JJ B-adj.all	conditions NNS B-noun.cognition	. . 0	. . 0
a7834920.s3	Renal JJ B-adj.all	biopsy NN B-noun.cognition	revealed VBD B-verb.perception	severe JJ 0	glomerulonephritis NN 0	with IN 0	crescents NNS B-noun.person	, , 0	electron NN B-noun.person	dense VBP B-verb.change	fibrillar JJ B-adj.all	deposits NNS B-noun.person	and CC 0	moderate JJ B-adj.all	lymphocytic JJ B-adj.all	interstitial JJ B-adj.all	infiltrate NN B-noun.cognition	. . 0	. . 0
a17639754.s0	Interaction NN B-noun.act	between IN 0	warfarin NN B-noun.location	and CC 0	levofloxacin NN B-noun.state	, , 0	case NN B-noun.communication	series NN B-noun.communication	. . 0	. . 0
a9199746.s2	METHODS NNS B-noun.attribute	, , 0	We PRP 0	present VBP B-verb.creation	a DT 0	case NN B-noun.state	of IN 0	presumed VBN B-verb.cognition	amikacin IN 0	retinal_toxicity NN B-noun.state	following VBG 0	treatment NN B-noun.communication	with IN 0	amikacin NN B-noun.person	and CC 0	vancomycin NN B-noun.person	for IN 0	alpha NN B-noun.act	- : 0	haemolytic JJ B-adj.all	streptococcal_endophthalmitis NN B-noun.artifact	. . 0	. . 0
a8739323.s9	Our PRP$ 0	studies NNS B-noun.group	indicate VBP B-verb.cognition	that DT 0	nephrotoxicity NN B-noun.state	of IN 0	MTX NNP B-noun.group	+ POS 0	5-FU NN B-noun.artifact	+ '' 0	CY NNP 0	administered VBD 0	jointly RB B-adv.all	is VBZ B-verb.stative	lower JJR B-adj.all	than IN 0	in IN 0	monotherapy NN B-noun.animal	. . 0	. . 0
a7234705.s0	Procainamide SYM 0	- : 0	induced VBN B-verb.creation	polymorphous JJ B-adj.all	ventricular_tachycardia NNS B-noun.location	. . 0	. . 0
a7628595.s5	During IN 0	the DT 0	study NN B-noun.artifact	, , 0	vitamin_B12 NNP B-noun.person	and CC 0	folate JJ B-adj.all	levels NNS B-noun.state	were VBD B-verb.stative	significantly RB B-adv.all	higher JJR B-adj.all	in IN 0	group NN 0	II NNP 0	patients NNS B-noun.artifact	, , 0	however RB 0	, , 0	no DT 0	differences NNS B-noun.person	in IN 0	hemoglobin NN 0	, , 0	hematocrit NN 0	, , 0	mean VBP B-verb.stative	corpuscular JJ B-adj.all	volume NN B-noun.artifact	, , 0	and CC 0	white JJ B-noun.attribute	- : 0	cell NN B-noun.person	, , 0	neutrophil NN B-noun.person	and CC 0	platelet NN B-noun.plant	counts NNS B-noun.act	were VBD 0	observed VBN B-verb.perception	between IN 0	groups NNS B-noun.group	at IN 0	3 CD B-adj.all	, , 0	6 CD B-adj.all	, , 0	9 CD B-adj.all	and CC 0	12 CD B-adj.all	months NNS B-noun.person	. . 0	. . 0
a11875660.s2	We PRP 0	examined VBD B-verb.communication	this DT 0	theory NN B-noun.cognition	using VBG B-verb.consumption	the DT 0	exo NN 0	utero NN 0	development NN 0	system NN B-noun.cognition	that WDT 0	allows VBZ B-verb.possession	direct JJ B-noun.possession	and CC 0	sequential JJ B-adj.all	observations NNS B-noun.act	of IN 0	mid- NN B-noun.time	to TO 0	late RB B-adv.all	- : 0	gestation NN B-noun.time	mouse NN B-noun.animal	embryos NNS I-noun.animal	. . 0	. . 0
a20196116.s17	A DT 0	high JJ B-adj.all	proportion NN B-noun.attribute	of IN 0	patients NNS B-noun.person	had VBD 0	consumed VBN B-verb.consumption	ATT NNP 0	empirically RB B-adv.all	, , 0	which WDT 0	could MD 0	have VB 0	been VBN 0	prevented VBN B-verb.creation	. . 0	. . 0
a2924746.s3	A DT 0	rat NN B-noun.artifact	model NN B-noun.person	was VBD 0	developed VBN B-verb.creation	to TO 0	examine VB B-verb.communication	the DT 0	effects NNS B-noun.phenomenon	of IN 0	chronic JJ B-adj.all	CBZ NNP B-noun.group	treatment NN B-noun.communication	on IN 0	folate JJ B-adj.all	concentrations NNS B-noun.food	in IN 0	the DT 0	rat NN B-noun.artifact	. . 0	. . 0
a10683478.s2	Apomorphine NNP B-noun.person	, , 0	a DT 0	nonselective JJ B-adj.all	dopamine_agonist NN B-noun.person	, , 0	was VBD 0	selected VBN B-verb.cognition	due JJ 0	to TO 0	its PRP$ 0	biphasic JJ B-adj.all	behavioral JJ B-adj.pert	effects NNS B-noun.phenomenon	, , 0	its PRP$ 0	ability NN B-noun.motive	to TO 0	induce VB B-verb.consumption	hypothermia NN I-verb.consumption	, , 0	and CC 0	to TO 0	produce VB B-verb.change	distinct JJ B-adj.all	changes NNS B-noun.artifact	to TO 0	dopamine VB B-verb.social	turnover NN B-noun.act	in IN 0	the DT 0	rodent NN B-noun.body	brain NN I-noun.body	. . 0	. . 0
a16428221.s4	We PRP 0	consider VBP B-verb.communication	drug NN B-noun.person	- : 0	induced VBN B-verb.creation	cerebral_vasculitis NN 0	as IN 0	the DT 0	most RBS 0	likely JJ B-adj.all	cause NN B-noun.act	of IN 0	recurrent NN B-noun.object	ischaemic_strokes NNS I-noun.object	in IN 0	the DT 0	absence NN B-noun.act	of IN 0	any DT 0	pathological JJ B-adj.all	findings NNS B-noun.act	during IN 0	the DT 0	diagnostic JJ B-adj.all	work NN B-noun.cognition	- : 0	up RB B-adv.all	. . 0	. . 0
a7420681.s2	Gentamicin_sulfate JJ B-adj.all	and CC 0	tobramycin_sulfate NNP B-noun.person	continue VBP I-noun.person	to TO 0	demonstrate VB B-verb.communication	ototoxicity NN B-noun.feeling	and CC 0	nephrotoxicity NN B-noun.person	in IN 0	both DT 0	animal NN B-noun.animal	and CC 0	clinical JJ B-adj.all	studies NNS B-noun.communication	. . 0	. . 0
a20003049.s4	STUDY NNP B-noun.group	DESIGN NNP B-noun.group	AND CC 0	METHODS NNS B-noun.attribute	, , 0	Plasma NNP B-noun.person	samples NNS B-noun.cognition	from IN 0	before RB 0	and CC 0	after IN 0	CPB NNP B-noun.group	were VBD 0	analyzed VBN B-verb.cognition	postoperatively RB B-adj.all	for IN 0	argatroban JJ B-adj.all	concentration NN B-noun.person	using VBG B-verb.consumption	a DT 0	modified JJ B-adj.all	ecarin NN B-noun.person	clotting NN B-verb.contact	time NN 0	( ( 0	ECT NNP 0	) ) 0	assay NN B-noun.location	. . 0	. . 0
a3409645.s0	Sexual_dysfunction NN B-noun.act	among IN 0	patients NNS B-noun.person	with IN 0	arthritis NN B-noun.food	. . 0	. . 0
a9522143.s4	Two CD 0	groups NNS 0	of IN 0	22 CD B-adj.all	similar JJ B-adj.all	patients NNS B-noun.person	were VBD 0	studied VBN B-verb.cognition	, , 0	one CD 0	group NN B-noun.person	received VBD B-verb.possession	6 CD B-adj.all	mL CD B-noun.quantity	prilocaine NN B-noun.communication	2 CD B-adj.all	% NN 0	, , 0	and CC 0	the DT 0	other JJ 0	received VBD B-verb.possession	3 CD B-adj.all	mL CD B-noun.quantity	bupivacaine NN 0	0.5 CD 0	% NN 0	. . 0	. . 0
a20196116.s16	Because IN 0	the DT 0	mortality NN B-noun.attribute	rate NN B-noun.time	is VBZ B-verb.stative	so RB B-adv.all	high JJ B-adj.all	, , 0	determining VBG B-verb.communication	which WDT 0	factors NNS B-noun.person	are VBP 0	predictors NNS B-noun.person	is VBZ B-verb.stative	less RBR B-adv.all	important JJ B-adj.all	. . 0	. . 0
a19445921.s10	The DT 0	results NNS B-noun.communication	of IN 0	our PRP$ 0	study NN B-noun.artifact	suggest VBP B-verb.communication	that IN 0	salvianolic_acid VBD 0	A DT 0	possessing VBG B-verb.stative	antioxidant JJ B-adj.all	activity NN B-noun.state	has VBZ B-verb.possession	a DT 0	significant JJ B-adj.all	protective JJ B-adj.all	effect NN B-noun.cognition	against IN 0	isoproterenol NN B-noun.person	- : 0	induced VBN B-verb.creation	myocardial_infarction NN 0	. . 0	. . 0
a7582165.s7	We PRP 0	also RB B-adv.all	carried VBD B-verb.stative	out IN 0	oral JJ B-adj.all	and CC 0	parenteral JJ B-noun.body	challenges NNS I-noun.body	with IN 0	other JJ 0	corticosteroids NNS B-noun.person	and CC 0	found VBD B-verb.possession	intolerance NN 0	to TO 0	some DT 0	of IN 0	them PRP 0	. . 0	. . 0
a10406016.s5	The DT 0	hematoma NN B-noun.body	was VBD 0	assessed VBN B-verb.cognition	in IN 0	vivo NN B-noun.animal	by IN 0	magnetic JJ B-adj.all	resonance NN B-noun.act	imaging NN I-noun.act	. . 0	. . 0
a11961407.s7	This DT 0	occurred VBD B-verb.stative	in IN 0	association NN 0	with IN 0	an DT 0	increase NN B-noun.act	in IN 0	urinary JJ B-adj.all	protein NN B-noun.person	content NN B-noun.person	from IN 0	1.8 CD 0	+ : 0	/- $ 0	1 CD B-adj.all	to TO 0	99.0 CD 0	+ : 0	/- $ 0	61 CD 0	mg RB 0	/ JJ 0	day NN 0	( ( 0	p IN 0	< $ 0	0.001 CD 0	) ) 0	. . 0	. . 0
a10406016.s4	Rats NNS B-noun.person	were VBD 0	treated VBN B-verb.change	with IN 0	seven CD 0	day NN 0	intravenous JJ B-adj.all	infusion NN B-noun.cognition	of IN 0	fucoidan NN 0	( ( 0	30 CD B-adj.all	micrograms NNS B-noun.quantity	h-1 VBP 0	) ) 0	or CC 0	vehicle NN B-noun.communication	. . 0	. . 0
a11807648.s5	We PRP 0	wanted VBD B-verb.emotion	to TO 0	study VB B-verb.cognition	whether IN 0	tAMCA NNP B-noun.group	retains VBZ B-verb.possession	its PRP$ 0	convulsive JJ B-adj.all	action NN B-noun.process	if IN 0	incorporated VBN B-verb.change	into IN 0	a DT 0	FS NNP 0	. . 0	. . 0
a3503576.s12	Serial JJ B-adj.all	audiograms NNS B-noun.group	should MD 0	be VB 0	performed VBN B-verb.social	every DT 0	six CD 0	months NNS B-noun.person	in IN 0	those DT 0	without IN 0	problems NNS B-noun.communication	and CC 0	more RBR B-adv.all	frequently RB B-adv.all	in IN 0	young JJ B-adj.all	patients NNS B-noun.person	with IN 0	normal JJ B-adj.all	serum NN B-noun.body	ferritin NN B-adj.all	values NNS B-noun.attribute	and CC 0	in IN 0	those DT 0	with IN 0	auditory_dysfunction NN B-noun.group	. . 0	. . 0
a16167916.s5	Plasma NNP B-noun.person	TAFI NNP I-noun.person	, , 0	tPA NNP B-noun.person	, , 0	and CC 0	PAI-1 JJ 0	antigen NN B-adj.all	levels NNS B-noun.state	were VBD 0	measured VBN B-verb.cognition	at IN 0	baseline NN B-noun.act	and CC 0	after IN 0	3 CD B-adj.all	months NNS B-noun.quantity	of IN 0	treatment NN B-noun.communication	by IN 0	commercially RB B-verb.change	available JJ B-adj.all	ELISA NNP B-noun.group	kits NNS B-noun.artifact	. . 0	. . 0
a18308784.s0	Ginsenoside_Rg1 NN B-noun.artifact	restores VBZ B-verb.stative	the DT 0	impairment_of_learning VBG 0	induced VBN B-verb.creation	by IN 0	chronic JJ B-adj.pert	morphine NN B-noun.phenomenon	administration NN I-noun.phenomenon	in IN 0	rats NNS B-noun.animal	. . 0	. . 0
a16787750.s0	Valproic_acid NN B-noun.attribute	induced VBD B-verb.creation	encephalopathy--19 JJ B-verb.emotion	new JJ B-adj.all	cases NNS B-noun.state	in IN 0	Germany NNP 0	from IN 0	1994 CD 0	to TO 0	2003 CD 0	- : 0	-a JJ 0	side NN 0	effect NN 0	associated VBN B-verb.cognition	to TO 0	VPA NNP B-noun.group	- : 0	therapy NN 0	not RB B-adv.all	only RB B-adv.all	in IN 0	young JJ B-adj.all	children NNS B-noun.person	. . 0	. . 0
a15899738.s5	His PRP$ 0	medical JJ B-adj.all	history NN B-noun.cognition	was VBD B-verb.stative	unremarkable JJ B-adj.all	, , 0	except IN 0	for IN 0	minor JJ B-adj.all	fractures NNS B-noun.person	of IN 0	the DT 0	fingers NNS B-noun.person	and CC 0	foot NN B-noun.body	. . 0	. . 0
a14659530.s0	NO SYM 0	- : 0	induced VBN B-verb.creation	migraine NN B-noun.artifact	attack NN B-noun.artifact	, , 0	strong JJ B-adj.all	increase NN B-noun.communication	in IN 0	plasma NN B-verb.creation	calcitonin_gene SYM 0	- : 0	related_peptide JJ B-noun.other	( ( 0	CGRP NNP 0	) ) 0	concentration NN B-noun.quantity	and CC 0	negative JJ B-adj.all	correlation NN B-noun.person	with IN 0	platelet NN 0	serotonin NN 0	release NN B-noun.state	. . 0	. . 0
a3076126.s6	Clinical JJ B-adj.all	tolerability NN B-noun.attribute	of IN 0	both DT 0	agents NNS B-noun.person	has VBZ 0	been VBN B-verb.stative	good JJ 0	, , 0	with IN 0	fewer JJR B-adj.all	than IN 0	3 CD B-adj.all	% NN 0	of IN 0	patients NNS B-noun.person	withdrawn VBN B-verb.communication	from IN 0	treatment NN B-noun.act	because IN 0	of IN 0	clinical JJ B-adj.all	adverse JJ B-adj.all	experiences NNS B-noun.event	. . 0	. . 0
a9495837.s7	The DT 0	antinociception NN B-noun.communication	produced VBN B-verb.creation	by IN 0	( ( 0	+ PRP$ 0	/-)-PG-9 NN B-noun.person	was VBD 0	prevented VBN B-verb.creation	by IN 0	the DT 0	unselective JJ B-adj.all	muscarinic JJ B-noun.person	antagonist_atropine NNP I-noun.person	, , 0	the DT 0	M1-selective JJ B-noun.other	antagonists_pirenzepine JJ B-adj.all	and_dicyclomine NN B-noun.attribute	and CC 0	the_acetylcholine JJ 0	depletor_hemicholinium-3 NN B-noun.attribute	, , 0	but CC 0	not RB B-adv.all	by IN 0	the DT 0	opioid JJ B-adj.all	antagonist_naloxone NN B-noun.attribute	, , 0	the_gamma PRP 0	- : 0	aminobutyric_acidB IN 0	antagonist_3-aminopropyl SYM 0	- : 0	diethoxy NN B-noun.person	- : 0	methyl NN B-noun.attribute	- : 0	phosphinic_acid JJ B-noun.other	, , 0	the DT 0	H3 ( 0	agonist_R-(alpha)-methylhistamine JJ 0	, , 0	the DT 0	D2 ( 0	antagonist_quinpirole JJ B-adj.all	, , 0	the_5-hydroxytryptamine4 RB 0	antagonist_2-methoxy-4-amino-5-chlorobenzoic_acid_2-(diethylamino)ethyl_ester JJ B-adj.all	hydrochloride NN B-noun.attribute	, , 0	the_5-hydroxytryptamin1A RB 0	antagonist_1-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl]piperazine JJ B-adj.all	hydrobromide NN B-noun.attribute	and CC 0	the DT 0	polyamines NNS B-noun.shape	depletor_reserpine VBP B-verb.stative	. . 0	. . 0
a20196116.s13	The DT 0	mortality NN B-noun.attribute	rate NN B-noun.time	among IN 0	patients NNS B-noun.person	with IN 0	ATT NNP B-noun.group	- : 0	ALF NNP B-noun.person	was VBD B-verb.stative	high JJ B-adj.all	( ( 0	67.1 CD 0	% NN 0	, , 0	n PRP 0	= $ 0	47 CD 0	) ) 0	, , 0	and CC 0	only RB B-adv.all	23 CD B-adj.all	( ( 0	32.9 CD 0	% NN 0	) ) 0	patients NNS B-noun.person	recovered VBD B-verb.communication	with IN 0	medical JJ B-adj.all	treatment NN B-noun.plant	. . 0	. . 0
a18544179.s8	Combining VBG B-verb.change	the DT 0	two CD 0	fentanyl NN 0	groups NNS B-noun.group	revealed VBD B-verb.perception	further RBR B-adv.all	significant JJ B-adj.all	benefits NNS B-noun.person	from IN 0	the DT 0	avoidance NN B-noun.act	of IN 0	opioids NNS B-noun.person	, , 0	reducing VBG B-verb.change	postoperative_nausea_and_vomiting VBG B-verb.stative	and CC 0	nausea NN B-noun.state	prior RB 0	to TO 0	discharge VB B-verb.communication	from IN 0	35 CD B-adj.all	% NN 0	and CC 0	33 CD 0	% NN 0	to TO 0	22 CD B-adj.all	% NN 0	and CC 0	19 CD B-adj.all	% NN 0	( ( 0	P UH 0	= SYM 0	0.049 CD 0	and CC 0	P NNP 0	= SYM 0	0.035 CD 0	) ) 0	, , 0	respectively RB B-adv.all	, , 0	while IN 0	nausea NN B-noun.person	in IN 0	the DT 0	first JJ B-verb.competition	24 CD B-adj.all	h NN 0	was VBD 0	decreased VBN B-verb.change	from IN 0	42 CD 0	% NN 0	to TO 0	27 CD B-adj.all	% NN 0	( ( 0	P UH 0	= SYM 0	0.034 CD 0	) ) 0	. . 0	. . 0
a1009330.s4	Picloxydine NN B-noun.location	irrigations NNS B-noun.person	appeared VBD B-verb.social	to TO 0	have VB B-verb.social	a DT 0	lower JJR B-adj.all	incidence NN B-noun.relation	of IN 0	erosive JJ B-adj.all	cystitis NN B-noun.person	but CC 0	further JJ B-adj.all	studies NNS B-noun.plant	would MD 0	have VB 0	to TO 0	be VB 0	performed VBN B-verb.social	before IN 0	it PRP 0	could MD 0	be VB 0	recommended VBN B-verb.communication	for IN 0	use NN 0	in IN 0	urological JJ B-adj.all	procedures NNS B-noun.person	. . 0	. . 0
a17437408.s12	CONCLUSIONS NNS B-noun.artifact	, , 0	The DT 0	data NNS B-noun.cognition	on IN 0	TR(- NN B-noun.location	) ) 0	rats NNS B-noun.animal	indicate VBP B-verb.communication	that IN 0	Pgp NNP B-noun.person	plays VBZ B-verb.social	an DT 0	important JJ B-adj.all	role NN B-noun.attribute	in IN 0	the DT 0	compensation NN B-noun.act	of IN 0	MRP2 JJ B-adj.all	deficiency NN B-noun.attribute	in IN 0	the DT 0	BBB NNP B-noun.group	. . 0	. . 0
a1378968.s7	HP NNP 0	failed VBD B-verb.social	to TO 0	accentuante VB B-verb.social	progression NN B-noun.act	of IN 0	renal_failure NN B-noun.act	and CC 0	in IN 0	fact NN B-noun.state	tended VBN B-verb.social	to TO 0	increase VB B-verb.change	GFR NNP 0	and CC 0	decrease VB B-verb.change	plasma NN B-noun.plant	creatinine NN B-noun.body	levels NNS B-noun.attribute	in IN 0	lithium NN 0	pretreated VBN B-verb.creation	rats NNS B-noun.animal	. . 0	. . 0
a19729346.s1	This DT 0	study NN B-noun.artifact	measured VBD B-verb.change	the DT 0	objective NN B-noun.cognition	and CC 0	subjective JJ B-adj.all	neurocognitive JJ B-adj.all	effects NNS B-noun.phenomenon	of IN 0	a DT 0	single JJ B-adj.all	10-mg JJ B-adj.all	dose NN B-noun.quantity	of IN 0	immediate JJ B-adj.all	- : 0	release NN B-verb.body	oxycodone NN 0	in IN 0	healthy JJ B-adj.all	, , 0	older JJR B-adj.all	( ( 0	> $ 0	65 CD 0	years NNS B-noun.quantity	) ) 0	, , 0	and CC 0	middle JJ B-noun.body	- : 0	aged VBN B-verb.communication	( ( 0	35 CD 0	to TO 0	55 CD 0	years NNS 0	) ) 0	adults NNS B-noun.animal	who WP 0	were VBD B-verb.stative	not RB I-verb.stative	suffering VBG B-verb.body	from IN 0	chronic NN B-noun.communication	or CC 0	significant JJ B-adj.all	daily JJ B-noun.event	pain NN B-noun.person	. . 0	. . 0
a347884.s2	The DT 0	open JJ B-adj.all	study NN B-noun.artifact	lasted VBD B-verb.contact	for IN 0	four CD 0	weeks NNS B-noun.time	, , 0	the DT 0	drug NN B-noun.person	was VBD 0	administrated VBN B-verb.communication	in IN 0	the DT 0	form NN B-noun.attribute	of IN 0	1 CD B-adj.all	mg NN B-noun.quantity	tablets NNS B-noun.artifact	. . 0	. . 0
a18217897.s8	Of IN 0	concern NN B-noun.feeling	was VBD B-verb.stative	the DT 0	occurrence NN B-noun.state	of IN 0	four CD 0	thromboembolic JJ B-adj.all	events NNS B-noun.event	. . 0	. . 0
a2234245.s4	Visual_toxicity NN B-noun.attribute	was VBD B-verb.stative	of IN 0	retinal JJ B-adj.all	origin NN B-noun.cognition	and CC 0	was VBD 0	characterized VBN B-verb.communication	by IN 0	a DT 0	tritan NN B-noun.communication	- : 0	type NN B-noun.person	dyschromatopsy NN B-noun.artifact	, , 0	sometimes RB B-adv.all	associated VBN B-verb.cognition	with IN 0	a_loss_of_visual_acuity NN B-noun.attribute	and CC 0	pigmentary_retinal_deposits NNS B-noun.location	. . 0	. . 0
a17241784.s8	The DT 0	mechanism NN B-noun.attribute	of IN 0	this DT 0	myopathy NN B-noun.communication	is VBZ B-verb.stative	uncertain JJ B-adj.all	but CC 0	may MD 0	involve VB B-verb.stative	the DT 0	induction NN B-noun.act	by IN 0	statins NNS B-noun.person	of IN 0	an DT 0	endoplasmic JJ B-adj.all	reticulum NN B-noun.artifact	stress NN B-noun.artifact	response NN I-noun.artifact	with IN 0	associated VBN B-verb.cognition	up RP I-verb.cognition	- : 0	regulation NN B-noun.act	of IN 0	MHC NNP B-noun.group	- : 0	I PRP 0	expression VBP B-verb.communication	and CC 0	antigen NN 0	presentation NN 0	by IN 0	muscle NN B-noun.body	fibres NNS I-noun.body	. . 0	. . 0
a8437969.s1	The DT 0	administration NN B-noun.time	of IN 0	intermittent JJ B-adj.all	intravenous JJ B-adj.all	infusions NNS B-noun.cognition	of IN 0	cimetidine NN B-noun.person	is VBZ B-verb.stative	infrequently RB B-adv.all	associated VBN B-verb.cognition	with IN 0	the DT 0	development NN B-noun.process	of IN 0	bradyarrhythmias NNS B-noun.food	. . 0	. . 0
a15899738.s2	Therefore RB 0	, , 0	when WRB 0	the DT 0	arrhythmia NN B-noun.person	is VBZ B-verb.stative	present JJ B-adj.all	in IN 0	this DT 0	population NN B-noun.event	, , 0	reversible JJ B-adj.all	causes NNS B-noun.person	must MD 0	be VB 0	identified VBN B-verb.cognition	and CC 0	resolved VBN B-verb.communication	. . 0	. . 0
a8643971.s19	Results NNS B-noun.person	thus RB 0	far RB 0	suggest VBP B-verb.communication	no DT 0	dose NN B-noun.person	- : 0	response NN B-noun.communication	effect NN B-noun.communication	for IN 0	paclitaxel NN B-noun.artifact	doses NNS B-noun.artifact	above IN 0	200 CD 0	mg NN B-noun.quantity	/ : 0	m2 PRP 0	. . 0	. . 0
a20722491.s7	The DT 0	most RBS 0	commonly RB B-adv.all	reported VBN B-verb.communication	toxic JJ B-adj.all	effects NNS B-noun.phenomenon	of IN 0	capecitabine NN B-noun.act	are VBP B-verb.stative	diarrhea NN B-noun.person	, , 0	nausea NN B-noun.person	, , 0	vomiting NN B-noun.act	, , 0	stomatitis NN B-noun.artifact	and CC 0	hand NN B-noun.act	- : 0	foot_syndrome NN B-noun.group	. . 0	. . 0
a15737522.s4	Fifty JJ B-adj.all	children NNS B-noun.person	who WP 0	were VBD 0	given VBN B-verb.possession	ceftriaxone NN 0	were VBD 0	evaluated VBN B-verb.communication	by IN 0	serial JJ B-adj.all	abdominal JJ B-adj.all	sonograms NNS B-noun.person	. . 0	. . 0
a3970039.s0	Incidence NNP B-noun.person	of IN 0	neoplasms NNS B-noun.Tops	in IN 0	patients NNS B-noun.person	with IN 0	rheumatoid_arthritis NN 0	exposed VBN B-verb.communication	to TO 0	different JJ B-adj.all	treatment NN B-noun.communication	regimens VBZ B-verb.communication	. . 0	. . 0
a9522152.s0	A DT 0	transient JJ B-adj.all	neurological_deficit NN B-noun.artifact	following VBG B-verb.stative	intrathecal JJ B-adj.all	injection NN B-noun.act	of IN 0	1 CD B-adj.all	% NN 0	hyperbaric JJ B-adj.all	bupivacaine NN B-noun.act	for IN 0	unilateral JJ B-adj.all	spinal JJ B-adj.all	anaesthesia NN B-noun.object	. . 0	. . 0
a12653683.s1	In IN 0	experimental JJ B-adj.all	nephrotic_syndrome NN B-noun.group	, , 0	urinary JJ B-adj.all	sodium NN 0	excretion NN 0	is VBZ 0	decreased VBN B-verb.change	during IN 0	the DT 0	early JJ B-adj.all	phase NN B-noun.time	of IN 0	the DT 0	disease NN B-noun.communication	. . 0	. . 0
a12589964.s11	These DT 0	parameters NNS B-noun.person	remained VBD B-verb.stative	unchanged JJ B-adj.all	in IN 0	controls NNS B-noun.artifact	. . 0	. . 0
a20080419.s0	Prevention NNP B-noun.person	of IN 0	seizures NNS B-noun.body	and CC 0	reorganization NN B-noun.act	of IN 0	hippocampal JJ B-adj.pert	functions NNS B-noun.act	by IN 0	transplantation NN B-noun.act	of IN 0	bone NN 0	marrow NN 0	cells NNS B-noun.body	in IN 0	the DT 0	acute JJ B-adj.all	phase NN B-noun.time	of IN 0	experimental JJ B-adj.all	epilepsy NN B-noun.person	. . 0	. . 0
a11334364.s7	Results NNS B-noun.other	indicate VBP B-verb.communication	that IN 0	GSPE NNP 0	preexposure NN 0	prior RB 0	to TO 0	AAP NNP B-noun.person	, , 0	AMI NNP B-noun.group	and CC 0	DOX NNP B-noun.group	, , 0	provided VBD B-verb.communication	near IN 0	complete JJ B-adj.all	protection NN B-noun.person	in IN 0	terms NNS B-noun.communication	of IN 0	serum NN B-noun.body	chemistry NN I-noun.body	changes NNS B-noun.phenomenon	( ( 0	ALT NNP 0	, , 0	BUN NNP 0	and CC 0	CPK NNP 0	) ) 0	, , 0	and CC 0	significantly RB B-adv.all	reduced VBD B-verb.change	DNA NNP 0	fragmentation NN 0	. . 0	. . 0
a19759529.s1	Schizophrenia NNP B-noun.person	has VBZ 0	been VBN 0	initially RB B-adv.all	associated VBN B-verb.cognition	with IN 0	dysfunction NN B-noun.act	in IN 0	dopamine NN 0	neurotransmission NN B-noun.act	. . 0	. . 0
a19767176.s11	However RB 0	, , 0	future JJ B-adj.all	investigations NNS B-noun.act	are VBP B-verb.stative	necessary JJ B-adj.all	to TO 0	exactly RB B-adv.all	analyze VB B-verb.cognition	the DT 0	biochemical JJ B-adj.all	mechanisms NNS B-noun.person	by IN 0	which WDT 0	PDTC NNP B-noun.group	exerted VBD B-verb.social	its PRP$ 0	beneficial JJ B-adj.all	effects NNS B-noun.phenomenon	in IN 0	the DT 0	piriform NN B-noun.body	cortex NN I-noun.body	. . 0	. . 0
a15325671.s8	No DT 0	association NN B-noun.person	was VBD 0	found VBN B-verb.possession	with IN 0	other JJ 0	pretreatment JJ B-adj.all	characteristics NNS B-noun.artifact	. . 0	. . 0
a7802851.s4	Subjects NNS B-noun.person	in IN 0	each DT 0	drug NN 0	group NN 0	also RB B-adv.all	received VBD B-verb.possession	either DT 0	exposure NN B-noun.state	or CC 0	relaxation NN B-noun.act	. . 0	. . 0
a9746003.s5	Absences NNS B-noun.person	were VBD 0	aggravated VBN B-verb.change	in IN 0	both DT 0	cases NNS B-noun.artifact	where WRB 0	vigabatrin NN B-noun.person	was VBD 0	added VBN B-verb.change	on IN 0	to TO 0	concurrent JJ B-adj.all	treatment NN B-noun.communication	. . 0	. . 0
a2484011.s3	These DT 0	were VBD B-verb.stative	the DT 0	albino NN B-noun.person	Sprague NNP I-noun.person	- : 0	Dawley NNP B-noun.person	ICR NNP I-noun.person	and CC 0	BALB NNP B-noun.group	/ ( 0	C NNP 0	, , 0	the DT 0	black JJ B-noun.person	C57BL/6 NN I-noun.person	and CC 0	the DT 0	brown JJ B-noun.group	CDF NNP B-noun.group	- : 0	I PRP 0	mouse VBP B-verb.emotion	strains NNS I-verb.emotion	. . 0	. . 0
a14568327.s6	All DT 0	animals NNS B-noun.food	were VBD 0	similarly RB B-adv.all	symptomatic JJ B-adj.all	at IN 0	the DT 0	start NN B-noun.attribute	of IN 0	levodopa NN B-noun.animal	treatment NN I-noun.animal	and CC 0	had VBD B-verb.change	similar JJ B-adj.all	therapeutic JJ B-adj.pert	responses NNS B-noun.act	to TO 0	the DT 0	drug NN B-noun.artifact	. . 0	. . 0
a8386779.s1	In IN 0	an DT 0	attempt NN B-noun.act	to TO 0	determine VB B-verb.communication	whether IN 0	penile_pain NN B-noun.person	associated VBN B-verb.cognition	with IN 0	intracorporeal JJ B-adj.all	injections NNS B-noun.person	could MD 0	be VB B-verb.stative	due JJ 0	to TO 0	the DT 0	acidity NN B-noun.quantity	of IN 0	the DT 0	medication NN B-noun.artifact	, , 0	we PRP 0	performed VBD B-verb.social	a DT 0	randomized JJ B-adj.all	study NN B-noun.artifact	comparing VBG B-verb.cognition	the DT 0	incidence NN B-noun.event	of IN 0	penile_pain JJ 0	following VBG B-verb.stative	intracorporeal JJ B-adj.all	injections NNS B-noun.person	with IN 0	or CC 0	without IN 0	the DT 0	addition NN B-noun.act	of IN 0	sodium_bicarbonate JJ 0	to TO 0	the DT 0	intracorporeal JJ B-adj.all	medications NNS B-noun.person	. . 0	. . 0
a9869257.s1	The DT 0	effects NNS B-noun.phenomenon	of IN 0	PG-9 NN B-noun.other	( ( 0	3alpha JJ B-noun.group	- : I-noun.group	tropyl_2-(p SYM I-noun.group	- : I-noun.group	bromophenyl)propionate NN I-noun.group	) ) 0	, , 0	the DT 0	acetylcholine NN B-noun.artifact	releaser NN I-noun.artifact	, , 0	on IN 0	memory NN B-noun.artifact	processes NNS I-noun.artifact	and CC 0	nerve NN B-noun.attribute	growth NN I-noun.attribute	factor NN 0	( ( 0	NGF NNP 0	) ) 0	synthesis NN B-noun.cognition	were VBD 0	evaluated VBN B-verb.communication	. . 0	. . 0
a17608141.s1	Immunological JJ B-adj.all	activation NN B-noun.act	has VBZ 0	been VBN 0	proposed VBN B-verb.communication	to TO 0	play VB B-verb.creation	a DT 0	role NN B-noun.attribute	in IN 0	methamphetamine NN B-noun.attribute	- : 0	induced VBN B-verb.creation	dopaminergic_terminal_damage NN B-noun.artifact	. . 0	. . 0
a11773892.s12	Overall JJ B-adj.all	survival NN B-noun.person	from IN 0	the DT 0	time NN B-noun.time	of IN 0	OLTX NNP B-noun.group	was VBD B-verb.stative	not RB B-adv.all	significantly RB B-adv.all	different JJ B-adv.all	among IN 0	groups NNS B-noun.group	, , 0	but CC 0	by IN 0	year NN B-noun.time	13 CD B-adj.all	, , 0	the DT 0	survival NN B-noun.object	of IN 0	the DT 0	patients NNS B-noun.person	who WP 0	had VBD 0	ESRD NNP B-noun.other	was VBD B-verb.stative	only RB B-adv.all	28.2 CD 0	% NN 0	compared VBN B-verb.communication	with IN 0	54.6 CD 0	% NN 0	in IN 0	the DT 0	control NN B-noun.location	group NN B-noun.person	. . 0	. . 0
a10901305.s12	Blood NNP B-noun.person	pressure NN I-noun.person	and CC 0	heart NN B-noun.body	rate NN B-noun.time	remained VBD B-verb.change	stable JJ B-adj.all	. . 0	. . 0
a11263551.s9	Incorrect JJ B-adj.all	diagnosis NN B-noun.relation	of IN 0	the DT 0	syndrome NN B-noun.group	will MD 0	lead VB B-verb.stative	to TO 0	a DT 0	significant JJ B-adj.all	reduction NN B-noun.cognition	of IN 0	life NN B-noun.phenomenon	quality NN B-noun.process	in IN 0	patients NNS B-noun.person	suffering VBG B-verb.body	from IN 0	CIPS NNS B-noun.act	. . 0	. . 0
a18442015.s10	Moreover RB B-adv.all	, , 0	a DT 0	positive JJ B-adj.all	correlation NN B-noun.act	of IN 0	histamine NN 0	to TO 0	gastric_hemorrhage VB B-verb.motion	and CC 0	to TO 0	ulcer NN B-noun.person	was VBD 0	found VBN B-verb.possession	in IN 0	those DT 0	atherosclerotic JJ B-adj.all	rats NNS B-noun.animal	. . 0	. . 0
a7083920.s4	Amiodarone NNP B-noun.person	should MD 0	be VB 0	used VBN B-verb.consumption	with IN 0	caution NN B-noun.artifact	during IN 0	long JJ B-noun.body	- : 0	term NN B-noun.time	oral JJ B-adj.all	therapy NN B-noun.act	in IN 0	patients NNS B-noun.person	with IN 0	or CC 0	without IN 0	clear JJ B-adj.all	intraventricular JJ B-adj.all	conduction NN B-noun.act	defects NNS B-noun.act	. . 0	. . 0
a9855119.s7	The DT 0	serum NN 0	creatinine NN 0	levels NNS B-noun.attribute	of IN 0	patients NNS B-noun.person	in IN 0	the DT 0	mild JJ B-noun.person	- : 0	type NN B-noun.person	chronic NN B-adj.all	FK506 NNP B-noun.other	nephropathy JJ B-adj.all	group NN B-noun.group	, , 0	which WDT 0	included VBD B-verb.stative	7 CD B-adj.all	episode NN B-noun.act	biopsies NNS B-noun.cognition	, , 0	were VBD B-verb.stative	statistically RB B-adv.all	higher JJR B-adj.all	than IN 0	those DT 0	in IN 0	the DT 0	minimum NN B-noun.quantity	- : 0	type NN B-noun.person	chronic NN B-adj.all	FK506-nephropathy JJ B-adj.all	group NN B-noun.group	( ( 0	P NNP 0	< $ 0	0.001 CD 0	) ) 0	. . 0	. . 0
a9727773.s6	Five CD 0	patients NNS B-noun.person	died VBD B-verb.change	before IN 0	the DT 0	interview NN B-noun.location	, , 0	all DT 0	of IN 0	them PRP 0	had VBD 0	taken VBN B-verb.possession	appetite_suppressants NNS B-noun.person	. . 0	. . 0
a3780846.s2	Saline NN B-noun.act	- : 0	pretreated VBN B-verb.creation	controls NNS B-noun.artifact	given VBN B-verb.possession	a DT 0	test NN B-adj.all	dose NN B-noun.event	of IN 0	morphine NN B-noun.phenomenon	( ( 0	20 CD 0	mg FW 0	/ FW 0	kg FW 0	i.p FW 0	. . 0	) ) 0	. . 0
a18083142.s5	The DT 0	Dbh NNP B-noun.person	-/- CD I-noun.person	mice NNS B-noun.person	had VBD B-verb.change	normal JJ B-adj.all	baseline NN B-noun.phenomenon	performance NN B-noun.act	in IN 0	the DT 0	EPM NNP B-noun.group	but CC 0	were VBD B-verb.stative	completely RB B-adv.all	resistant JJ B-adj.all	to TO 0	the DT 0	anxiogenic JJ B-adj.pert	effects NNS B-noun.phenomenon	of IN 0	cocaine NN 0	. . 0	. . 0
a15863244.s15	Prenatal JJ B-adj.all	exposure NN B-noun.cognition	to TO 0	selective VB B-verb.cognition	COX-2 NN B-noun.person	inhibitors NNS I-noun.person	does VBZ 0	not RB B-adv.all	increase VB B-verb.change	the DT 0	risk NN 0	of IN 0	ventricular_septal_and_midline_defects NNS B-noun.location	in IN 0	rat NN 0	when WRB 0	compared VBN B-verb.cognition	to TO 0	non VB B-verb.communication	- : 0	selective JJ B-adj.all	drugs NNS B-noun.artifact	and CC 0	historic JJ B-adj.pert	control NN B-noun.state	. . 0	. . 0
a7881871.s9	This DT 0	study NN B-noun.artifact	supports VBZ B-verb.contact	the DT 0	role NN B-noun.attribute	of IN 0	lipid JJ B-adj.all	peroxidation NN B-noun.person	in IN 0	mediating VBG B-verb.change	the DT 0	proteinuric_injury NN B-noun.other	in IN 0	PAN NNP 0	nephropathy NN 0	. . 0	. . 0
a2559236.s9	Enalapril NNP B-noun.person	treatment NN I-noun.person	blunted VBN B-verb.cognition	but CC 0	did VBD 0	not RB B-adv.all	prevent VB B-verb.creation	reduction NN B-noun.process	in IN 0	GFR NNP 0	in IN 0	group NN 0	4 CD 0	( ( 0	0.86 CD 0	+ : 0	/- $ 0	0.15 CD 0	ml RB B-noun.quantity	/ JJ 0	min NN 0	at IN 0	4 CD B-adj.all	months NNS B-noun.person	, , 0	0.69 CD 0	+ : 0	/- $ 0	0.13 CD 0	ml NN B-noun.quantity	/ : 0	min NN 0	at IN 0	6 CD B-adj.all	months NNS B-noun.person	, , 0	both DT 0	P NNP 0	less JJR 0	than IN 0	0.05 CD 0	vs. NN B-noun.quantity	group NN B-noun.communication	3 CD 0	) ) 0	. . 0	. . 0
a12716030.s1	The DT 0	aggravated VBN B-verb.social	risk NN I-verb.social	on IN 0	intracerebral_hemorrhage NN 0	( ( 0	ICH NNP 0	) ) 0	with IN 0	drugs NNS B-noun.artifact	used VBN B-verb.consumption	for IN 0	stroke NN B-noun.person	patients NNS B-noun.person	should MD 0	be VB 0	estimated VBN B-verb.cognition	carefully RB B-adv.all	. . 0	. . 0
a16330293.s13	Stratification NN 0	of IN 0	patients NNS B-noun.person	by IN 0	sex NN B-noun.person	, , 0	age NN B-noun.person	, , 0	extent NN B-noun.person	of IN 0	concurrent JJ B-adj.all	smoking NN B-noun.act	, , 0	extent NN B-noun.person	of IN 0	product NN B-noun.substance	use NN I-noun.substance	, , 0	and CC 0	severity NN B-noun.attribute	of IN 0	adverse JJ B-adj.all	events NNS B-noun.person	revealed VBD B-verb.perception	no DT 0	clinically RB B-adv.all	significant JJ B-adj.all	differences NNS B-noun.cognition	between IN 0	the DT 0	lozenge NN B-noun.artifact	and CC 0	gum NN B-noun.person	. . 0	. . 0
a3101906.s12	Hepatitis NNP B-noun.person	was VBD B-verb.stative	usually RB B-adv.all	reversible JJ B-adj.all	when WRB 0	treatment NN B-noun.person	was VBD 0	stopped VBN B-verb.stative	, , 0	with IN 0	the DT 0	results NNS B-noun.communication	of IN 0	liver NN B-noun.food	function NN B-noun.act	tests NNS B-noun.person	returning VBG B-verb.communication	to TO 0	normal JJ B-adj.all	after IN 0	an DT 0	average NN B-noun.act	of IN 0	3.1 CD 0	months NNS B-noun.quantity	. . 0	. . 0
a2224762.s14	The DT 0	recommended VBN B-verb.communication	starting VBG B-verb.change	dose NN B-noun.act	for IN 0	Phase NNP B-noun.time	II NNP 0	trials NNS B-noun.communication	is VBZ B-verb.stative	60 CD B-adj.all	mg NN B-noun.quantity	/ '' 0	m2 IN 0	IV NNP 0	bolus CC 0	every DT 0	3 CD B-adj.all	weeks NNS B-noun.time	. . 0	. . 0
a2505783.s4	When WRB 0	instilled VBN B-verb.communication	directly RB B-adv.all	into IN 0	the DT 0	bladder NN B-noun.person	, , 0	CAA NNP B-noun.group	exerts VBZ B-verb.social	urotoxic JJ B-adj.all	effects NNS B-noun.phenomenon	, , 0	it PRP 0	is VBZ B-verb.stative	, , 0	however RB 0	, , 0	susceptible JJ 0	to TO 0	detoxification NN B-noun.act	with IN 0	mesna NN B-noun.food	. . 0	. . 0
a227508.s3	Naloxone NNP B-noun.person	alone RB I-noun.person	did VBD 0	not RB B-adv.all	affect VB B-verb.change	either DT 0	blood NN B-noun.location	pressure NN B-noun.state	or CC 0	heart NN B-noun.body	rate NN B-noun.time	. . 0	. . 0
a1592014.s6	BE VB B-verb.stative	- : 0	Induced VBN B-verb.creation	seizures NNS B-noun.person	occurred VBD B-verb.cognition	more RBR B-adv.all	frequently RB B-adv.all	and CC 0	had VBD 0	significantly RB B-adv.all	longer JJR B-adj.all	latencies NNS B-noun.person	than IN 0	those DT 0	induced VBN B-verb.creation	by IN 0	equimolar JJ B-adj.all	amounts NNS B-noun.quantity	of IN 0	cocaine NN 0	. . 0	. . 0
a15649445.s9	Importantly RB B-adv.all	, , 0	a DT 0	decrease NN B-noun.event	in IN 0	glutamate JJ B-adj.all	uptake NN B-noun.person	correlates VBZ B-verb.creation	negatively RB I-verb.creation	with IN 0	an DT 0	increase NN B-noun.act	in IN 0	the DT 0	incidence NN B-noun.event	of IN 0	orofacial_diskinesia NNP B-noun.location	. . 0	. . 0
a6747681.s3	Twelve CD 0	patients NNS B-noun.person	with IN 0	Grade NNP B-noun.person	III NNP I-noun.person	or CC 0	IV NNP 0	astrocytomas NNS 0	were VBD 0	treated VBN B-verb.change	after IN 0	partial JJ B-adj.all	resection NN B-noun.act	of IN 0	the DT 0	tumor NN B-noun.feeling	without IN 0	prior JJ B-adj.all	radiation NN B-noun.act	therapy NN 0	. . 0	. . 0
a18439803.s5	In IN 0	addition NN 0	, , 0	a DT 0	statistically RB B-adv.all	significant JJ B-adj.all	reduction NN B-noun.person	was VBD B-verb.stative	also RB B-adv.all	observed VBN B-verb.perception	on IN 0	the DT 0	level NN B-noun.state	of IN 0	GABA NNP B-noun.other	and CC 0	glycine NN B-noun.person	but CC 0	less JJR 0	than IN 0	a DT 0	drastic JJ B-adj.all	reduction NN B-noun.act	of IN 0	glutamate NN B-noun.person	and CC 0	aspartate JJ B-adj.all	level NN B-noun.state	. . 0	. . 0
a16330293.s3	OBJECTIVE NNP B-noun.group	, , 0	The DT 0	objective NN B-noun.cognition	of IN 0	this DT 0	study NN B-noun.artifact	was VBD 0	to TO 0	compare VB B-verb.stative	the DT 0	safety NN B-noun.artifact	profiles NNS B-noun.artifact	of IN 0	the DT 0	4-mg JJ B-adj.all	nicotine NN B-noun.artifact	lozenge NN B-noun.artifact	and CC 0	4-mg JJ B-adj.all	nicotine NN B-noun.person	gum NN B-noun.person	in IN 0	smokers NNS B-noun.person	with IN 0	selected VBN B-verb.cognition	label NN B-noun.act	- : 0	restricted JJ B-adj.all	diseases NNS B-noun.person	. . 0	. . 0
a2950248.s0	Dipyridamole SYM 0	- : 0	induced VBN B-verb.creation	myocardial_ischemia NNP B-noun.person	. . 0	. . 0
a15515654.s12	Regular JJ B-adj.all	audiologic JJ B-adj.all	evaluation NN B-noun.act	is VBZ B-verb.stative	imperative JJ B-adj.all	in IN 0	all DT 0	thalassemic JJ B-adj.all	patients NNS B-noun.person	so RB B-adv.all	that IN 0	early JJ B-adj.all	changes NNS B-noun.relation	may MD 0	be VB 0	recognized VBN B-verb.cognition	and CC 0	treatment NN B-noun.plant	may MD 0	be VB B-verb.stative	judiciously RB B-adv.all	adjusted VBN B-verb.change	in IN 0	order NN 0	to TO 0	prevent VB B-verb.emotion	or CC 0	reverse VB B-verb.communication	hearing_impairment NN I-verb.communication	. . 0	. . 0
a18020536.s16	A DT 0	higher JJR B-adj.all	residual JJ B-adj.all	serum NN B-noun.body	concentration NN B-noun.event	of IN 0	temazepam NN B-noun.artifact	correlated VBN B-verb.stative	with IN 0	a DT 0	lower JJR B-adj.all	MMSE NNP B-noun.group	sum NN 0	score NN 0	after IN 0	adjustment NN B-noun.person	for IN 0	confounding VBG B-verb.communication	variables NNS B-noun.cognition	. . 0	. . 0
a11807648.s9	The DT 0	degree NN B-noun.communication	of IN 0	these DT 0	seizures NNS B-noun.artifact	increased VBN B-verb.change	with IN 0	increasing VBG B-verb.change	concentration NN B-noun.event	of IN 0	tAMCA NNP B-noun.location	. . 0	. . 0
a10579464.s1	NRA0160 NN B-noun.artifact	, , 0	5_-_[2-_(_4-_(_3_-_fluorobenzylidene)_piperidin-1-yl)_ethyl]_-_4_-(4-fluorophenyl)_thiazole-2-carboxamide JJ 0	, , 0	has VBZ B-verb.possession	a DT 0	high JJ B-adj.all	affinity NN B-noun.attribute	for IN 0	human NN B-noun.person	cloned VBD B-verb.contact	dopamine JJ B-adj.all	D4.2 NN B-noun.artifact	, , 0	D4.4 NNP B-noun.person	and CC 0	D4.7 JJ B-adj.all	receptors NNS B-noun.person	, , 0	with IN 0	Ki NNP 0	values NNS B-noun.attribute	of IN 0	0.5 CD 0	, , 0	0.9 CD 0	and CC 0	2.7 CD 0	nM CD B-noun.quantity	, , 0	respectively RB B-adv.all	. . 0	. . 0
a16858720.s7	Of IN 0	the DT 0	59 CD B-adj.all	cases NNS B-noun.quantity	, , 0	26 CD 0	( ( 0	44 CD 0	% NN 0	) ) 0	had VBD B-verb.stative	a DT 0	fatal JJ B-adj.all	outcome NN 0	, , 0	compared VBN B-verb.cognition	to TO 0	136 CD 0	( ( 0	25 CD B-adj.all	% NN 0	) ) 0	among IN 0	the DT 0	non NN B-noun.person	- : 0	warfarin NN B-noun.act	patients NNS B-noun.person	( ( 0	p IN 0	< $ 0	0.01 CD 0	) ) 0	. . 0	. . 0
a11773892.s15	The DT 0	development NN B-noun.process	of IN 0	ESRD NNP B-noun.other	decreases VBZ B-verb.communication	survival NN B-noun.animal	, , 0	particularly RB B-adv.all	in IN 0	those DT 0	patients NNS B-noun.person	treated VBD B-verb.social	with IN 0	dialysis NN B-noun.person	only RB B-adv.all	. . 0	. . 0
a9855119.s1	BACKGROUND NN 0	, , 0	We PRP 0	clinically RB B-adv.all	and CC 0	pathologically RB B-adv.all	analyzed JJ B-verb.cognition	renal JJ B-adj.all	allografts NNS B-noun.person	from IN 0	1 CD B-adj.all	9 CD 0	renal JJ B-adj.all	transplant NN B-noun.person	patients NNS B-noun.person	treated VBD B-verb.social	with IN 0	tacrolimus NN B-noun.person	( ( 0	FK506 NNP 0	) ) 0	for IN 0	more JJR B-noun.quantity	than IN 0	1 CD B-adj.all	year NN B-noun.time	. . 0	. . 0
a11431197.s5	The DT 0	biopsy NN B-noun.artifact	specimen NNS B-noun.person	showed VBD B-verb.communication	pathognomonic JJ B-adj.pert	features NNS B-noun.body	, , 0	including VBG B-verb.change	eosinophilic JJ B-adj.all	infiltration NN B-noun.cognition	of IN 0	the DT 0	interstitial JJ B-adj.all	compartment NN B-noun.person	. . 0	. . 0
a10365197.s2	243 CD 0	cocaine NN 0	- : 0	dependent JJ B-adj.all	outpatients NNS B-noun.person	with IN 0	cocaine NN B-noun.person	- : 0	induced VBN B-verb.creation	mood_disorder JJR 0	( ( 0	CIMD NNP B-noun.group	) ) 0	, , 0	other JJ B-adj.all	mood_disorders NNS B-noun.person	, , 0	or CC 0	no DT 0	mood_disorder NNP B-noun.person	were VBD 0	compared VBN B-verb.change	on IN 0	measures NNS B-noun.attribute	of IN 0	psychiatric JJ B-adj.all	symptoms NNS B-noun.body	. . 0	. . 0
a12574103.s1	Dexamethasone NN B-noun.person	is VBZ B-verb.stative	frequently RB B-adv.all	administered VBN B-verb.perception	to TO 0	the DT 0	developing VBG B-verb.communication	fetus NN I-verb.communication	to TO 0	accelerate VB B-verb.change	pulmonary JJ B-adj.all	development NN B-noun.process	. . 0	. . 0
a16167916.s9	A DT 0	significant JJ B-adj.all	correlation NN B-noun.person	was VBD 0	found VBN B-verb.possession	between IN 0	baseline NN B-noun.person	TAFI NNP I-noun.person	antigen NN B-noun.animal	concentrations NNS I-noun.animal	and CC 0	the DT 0	duration NN 0	of IN 0	amenorrhea NN B-noun.animal	( ( 0	P NNP 0	< $ 0	0.05 CD 0	, , 0	r NN 0	= SYM 0	0.33 CD 0	) ) 0	. . 0	. . 0
a14596845.s5	Beginning VBG B-verb.change	on IN 0	day NN 0	22 CD 0	, , 0	all DT 0	rats NNS B-noun.location	were VBD 0	maintained VBN B-verb.consumption	on IN 0	ad NN 0	libitum NN 0	chow NN 0	. . 0	. . 0
a12084448.s0	Ifosfamide RB 0	encephalopathy JJ 0	presenting VBG B-verb.stative	with IN 0	asterixis NN B-noun.food	. . 0	. . 0
a11773892.s6	Our PRP$ 0	prospectively RB B-adv.all	collected VBN B-verb.possession	database NN B-noun.person	was VBD B-verb.stative	the DT 0	source NN B-noun.person	of IN 0	information NN B-noun.cognition	. . 0	. . 0
a12063090.s5	Simultaneous JJ B-adj.all	administration NN B-noun.act	of IN 0	morphine NN B-noun.person	with IN 0	metamizol NN B-noun.person	resulted VBD B-verb.social	in IN 0	a DT 0	markedly RB B-adv.all	antinociceptive JJ B-adj.all	potentiation NN B-noun.person	and CC 0	an DT 0	increasing VBG B-verb.change	of IN 0	the DT 0	duration NN 0	of IN 0	action NN B-noun.act	after IN 0	a DT 0	single JJ B-adj.all	( ( 0	298+/-7 FW B-noun.other	vs. FW I-noun.other	139+/-36 CD I-noun.other	units NNS B-noun.relation	area NN B-noun.cognition	( ( 0	ua NN 0	) ) 0	, , 0	P<0.001 NNP 0	) ) 0	and CC 0	repeated VBN B-verb.communication	administration NN B-noun.person	( ( 0	280+/-17 FW B-noun.other	vs. FW I-noun.other	131+/-22 JJ I-noun.other	ua NN B-noun.quantity	, , 0	P<0.001 NNP 0	) ) 0	. . 0	. . 0
a20003049.s7	Because IN 0	DTIs NNP 0	do VBP 0	not RB B-adv.all	have VB 0	reversal NN B-noun.act	agents NNS B-noun.person	, , 0	surgical JJ B-adj.all	teams NNS B-noun.body	and CC 0	transfusion NN B-noun.act	services NNS B-noun.group	should MD 0	remain VB B-verb.change	aware JJ B-adj.all	of IN 0	the DT 0	possibility NN B-noun.state	of IN 0	massive JJ B-adj.all	transfusion NN B-noun.act	events NNS B-noun.artifact	during IN 0	anticoagulation NN 0	with IN 0	these DT 0	agents NNS B-noun.person	. . 0	. . 0
a12653683.s0	Epithelial NNP B-noun.person	sodium NN 0	channel NN 0	( ( 0	ENaC NNP B-noun.other	) ) 0	subunit NN B-noun.location	mRNA NNP I-noun.location	and CC 0	protein NN B-noun.communication	expression NN B-noun.communication	in IN 0	rats NNS B-noun.animal	with IN 0	puromycin_aminonucleoside JJ B-noun.group	- : 0	induced VBD B-verb.creation	nephrotic_syndrome JJ 0	. . 0	. . 0
a2234245.s7	This DT 0	toxicity NN B-noun.attribute	appeared VBD B-verb.change	in IN 0	patients NNS B-noun.person	receiving VBG B-verb.communication	the DT 0	higher JJR B-adj.all	doses NNS B-noun.person	of IN 0	desferrioxamine NN B-noun.state	or CC 0	coincided VBN B-verb.change	with IN 0	the DT 0	normalization NN B-noun.person	of IN 0	ferritin NN B-noun.state	or CC 0	aluminium NN B-noun.body	serum NN B-noun.body	levels NNS B-noun.attribute	. . 0	. . 0
a17639754.s5	Physicians NNS B-noun.person	should MD 0	be VB B-verb.stative	aware JJ B-adj.all	of IN 0	this DT 0	potential JJ B-adj.all	interaction NN B-noun.act	and CC 0	use VB B-verb.consumption	caution NN B-noun.communication	when WRB 0	prescribing VBG B-verb.creation	levofloxacin NN B-noun.attribute	to TO 0	patients NNS B-noun.person	taking VBG B-verb.social	warfarin NN B-noun.act	. . 0	. . 0
a8643971.s16	Alopecia NNP B-noun.person	, , 0	paresthesias NNS B-noun.person	, , 0	and CC 0	arthralgias NNS B-noun.communication	/ : 0	myalgias NNS B-noun.substance	have VBP 0	occurred VBN B-verb.cognition	frequently RB B-adv.all	, , 0	but CC 0	with IN 0	one CD 0	exception NN 0	( ( 0	a DT 0	grade NN B-noun.communication	3 CD B-adj.all	myalgia NN B-noun.quantity	) ) 0	they PRP 0	have VBP 0	been VBN B-verb.stative	grade JJ 0	1 CD 0	or CC 0	2 CD B-adj.all	. . 0	. . 0
a16904497.s3	The DT 0	following JJ B-adj.all	case NN B-noun.communication	is VBZ B-verb.stative	a DT 0	report NN B-noun.person	of IN 0	cauda_equina_syndrome VBN 0	possibly RB B-adv.all	caused VBN B-verb.communication	by IN 0	epidural JJ B-adj.all	injection NN B-noun.act	of IN 0	triamcinolone NN B-noun.person	and CC 0	bupivacaine NN B-noun.person	. . 0	. . 0
a18703024.s5	No DT 0	changes NNS B-noun.relation	in IN 0	haloperidol NN B-noun.person	- : 0	induced VBN B-verb.creation	catalepsy NN B-noun.artifact	or CC 0	MK-801-induced JJ B-adj.all	locomotion NN B-noun.artifact	were VBD 0	seen VBN B-verb.perception	following VBG 0	PD NNP 0	. . 0	. . 0
a15009014.s2	Both DT 0	the DT 0	trigeminal JJ B-adj.all	and CC 0	the DT 0	cranial JJ B-adj.all	parasympathetic JJ B-adj.all	systems NNS B-noun.relation	may MD 0	be VB 0	involved VBN B-verb.stative	in IN 0	mediating VBG B-verb.change	these DT 0	dysfunctions NNS B-noun.artifact	. . 0	. . 0
a18162529.s2	Although IN 0	central JJ B-noun.body	prolactin NN I-noun.body	actions NNS B-noun.process	are VBP 0	thought VBN B-verb.cognition	to TO 0	contribute VB B-verb.social	to TO 0	this DT 0	, , 0	the DT 0	mechanisms NNS B-noun.person	are VBP 0	poorly RB B-adv.all	understood VBN B-verb.cognition	. . 0	. . 0
a9587734.s5	The DT 0	serum NN B-noun.body	level NN B-noun.attribute	of IN 0	potassium NN B-noun.person	was VBD 0	observed VBN B-verb.perception	to TO 0	be VB B-verb.stative	8.4 CD 0	mequiv NN B-noun.quantity	L-1 NN 0	. . 0	. . 0
a7504976.s4	Two CD 0	patients NNS B-noun.person	had VBD 0	a DT 0	cholestatic_hepatitis NN 0	induced VBN B-verb.creation	by IN 0	carbimazole NN B-noun.communication	( ( 0	N__omercazole JJ 0	) ) 0	. . 0	. . 0
a2266990.s5	Mazindol NNP B-noun.person	did VBD 0	not RB B-adv.all	benefit VB B-verb.body	strength NN I-verb.body	at IN 0	any DT 0	point NN B-noun.state	in IN 0	the DT 0	study NN B-noun.artifact	. . 0	. . 0
a20880751.s3	Although IN 0	preclinical JJ B-adj.all	and CC 0	clinical JJ B-adj.all	findings NNS B-noun.act	suggest VBP B-verb.communication	pulsatile JJ B-noun.phenomenon	stimulation NN I-noun.phenomenon	of IN 0	striatal JJ B-adj.all	postsynaptic JJ B-adj.all	receptors NNS B-noun.person	as IN 0	a DT 0	key JJ 0	mechanism NN 0	underlying VBG B-verb.stative	levodopa NN B-noun.attribute	- : 0	induced VBN B-verb.creation	dyskinesias NNS B-noun.artifact	, , 0	their PRP$ 0	pathogenesis NN B-noun.location	is VBZ B-verb.stative	still RB B-adv.all	unclear JJ B-adj.all	. . 0	. . 0
a9862868.s4	Immunolocalization NNP B-noun.person	of IN 0	7H6 NNP B-noun.person	appears VBZ B-verb.communication	to TO 0	closely RB B-adj.all	correlate VB I-adj.all	with IN 0	paracellular JJ B-adj.all	permeability NN B-noun.person	. . 0	. . 0
a3800626.s2	However RB 0	, , 0	compression_neuropathy JJ 0	due JJ 0	to TO 0	fibrotic JJ B-adj.all	muscle NN B-noun.body	affected VBN B-verb.change	by IN 0	pentazocine NNS B-noun.person	- : 0	induced VBN B-verb.creation	myopathy NN 0	has VBZ 0	not RB B-adv.all	previously RB B-adv.all	been VBN 0	reported VBN B-verb.communication	. . 0	. . 0
a2484011.s2	in IN 0	6 CD B-adj.all	increments NNS B-noun.quantity	of IN 0	100 CD 0	mg PRP 0	/ ( 0	kg IN 0	each DT 0	over IN 0	30 CD B-adj.all	hr NN B-noun.time	, , 0	on IN 0	mouse NN B-noun.animal	motility NN I-noun.animal	and CC 0	whole JJ B-adj.all	brain NN B-noun.food	content NN B-noun.attribute	of IN 0	selected VBN B-verb.cognition	biogenic JJ B-adj.all	amines NNS B-noun.artifact	and CC 0	major JJ B-adj.all	metabolites NNS B-noun.person	was VBD 0	studied VBN B-verb.cognition	in IN 0	4 CD B-adj.all	strains NNS B-noun.quantity	of IN 0	mice NNS B-noun.animal	. . 0	. . 0
a19037603.s1	The DT 0	objective NN B-noun.cognition	of IN 0	this DT 0	study NN B-noun.artifact	was VBD 0	to TO 0	report VB B-verb.communication	our PRP$ 0	experience NN B-noun.cognition	concerning VBG B-verb.communication	the DT 0	effectiveness NN B-noun.cognition	of IN 0	the DT 0	prophylactic JJ B-adj.all	administration NN B-noun.time	of IN 0	lamivudine NN B-noun.act	in IN 0	hepatitis_B_virus_surface_antigen NNP 0	( ( 0	HBs_Ag NN 0	) ) 0	positive JJ B-adj.all	patients NNS B-noun.person	with IN 0	rheumatologic_disease NN B-noun.state	. . 0	. . 0
a8739323.s5	After IN 0	the DT 0	administration NN B-noun.time	of IN 0	NG NNP 0	, , 0	5-FU NN B-noun.person	and CC 0	CY NNP 0	neither CC 0	a DT 0	statistically RB B-adv.all	significant JJ B-adj.all	increase NN B-noun.event	in IN 0	creatinine NN 0	concentration NN B-noun.event	nor CC 0	an DT 0	increase NN B-noun.act	in IN 0	creatinine NN 0	clearance NN B-noun.person	was VBD 0	observed VBN B-verb.perception	compared VBN B-verb.cognition	to TO 0	the DT 0	group NN 0	receiving VBG B-verb.communication	no DT 0	cytostatics NNS B-noun.person	. . 0	. . 0
a2484011.s11	The DT 0	results NNS B-noun.communication	suggest VBP B-verb.communication	a DT 0	strain NN B-noun.person	- : 0	dependent JJ B-adj.all	effect NN B-noun.cognition	of IN 0	amantadine NN B-noun.person	on IN 0	motility NN B-noun.motive	and CC 0	indicate VBP B-verb.communication	a DT 0	differential JJ B-adj.all	response NN B-noun.communication	to TO 0	the DT 0	acute NN B-noun.person	and CC 0	multiple JJ B-adj.all	dose NN B-noun.event	regimens VBZ 0	used VBN B-verb.consumption	. . 0	. . 0
a9746003.s3	Vigabatrin NNP B-noun.person	was VBD B-verb.stative	also RB B-adv.all	used VBN B-verb.consumption	in IN 0	the DT 0	treatment NN B-noun.communication	of IN 0	two CD 0	children NNS B-noun.person	. . 0	. . 0
a16740173.s21	For IN 0	the DT 0	first JJ B-adj.all	time NN B-noun.time	, , 0	an DT 0	analytical JJ B-noun.group	method NN B-noun.attribute	for IN 0	the DT 0	determination NN B-noun.cognition	of IN 0	carbachol NN B-noun.food	in IN 0	plasma NN B-noun.substance	and CC 0	urine NN B-noun.person	has VBZ 0	been VBN 0	developed VBN B-verb.creation	. . 0	. . 0
a9495837.s14	In IN 0	the DT 0	antinociceptive JJ B-adj.all	and CC 0	antiamnesic JJ B-adj.all	dose NN B-noun.state	range NN I-noun.state	, , 0	( ( 0	+ PRP$ 0	/-)-PG-9 NNP B-noun.person	did VBD 0	not RB B-adv.all	impair JJ B-adj.all	mouse NN B-noun.act	performance NN B-noun.act	evaluated VBN B-verb.change	by IN 0	the DT 0	rota NN B-noun.group	- : 0	rod NN 0	test NN 0	and CC 0	Animex NNP B-noun.person	apparatus NN B-noun.artifact	. . 0	. . 0
a12369736.s2	Male NNP B-noun.person	Wistar NNP I-noun.person	rats NNS I-noun.person	were VBD 0	implanted VBN B-verb.change	bilaterally RB B-adv.all	with IN 0	cannulae NN B-noun.food	into IN 0	the DT 0	accumbens NNS B-noun.artifact	shell VBP 0	or CC 0	core NN B-noun.quantity	, , 0	and CC 0	then RB B-adv.all	were VBD B-verb.stative	locally RB B-adv.all	injected VBN B-verb.change	with IN 0	GR_55562 NNP B-noun.person	( ( 0	an DT 0	antagonist NN B-noun.person	of IN 0	5-HT1B JJ B-noun.group	receptors NNS I-noun.group	) ) 0	or CC 0	CP_93129 NN B-noun.substance	( ( 0	an DT 0	agonist NN B-noun.person	of IN 0	5-HT1B JJ B-noun.group	receptors NNS I-noun.group	) ) 0	. . 0	. . 0
a8919272.s4	Lesions NNS B-noun.person	of IN 0	the DT 0	capillary NN B-noun.communication	included VBD B-verb.stative	necrosis NN 0	of IN 0	endothelial JJ B-adj.all	cells NNS B-noun.body	. . 0	. . 0
a14568327.s5	In IN 0	contrast NN 0	, , 0	monkeys NNS B-noun.person	with IN 0	long JJ B-noun.body	- : 0	term NN B-noun.time	MPTP NNP 0	exposure NN B-noun.communication	, , 0	slow JJ B-adj.all	symptom NN B-noun.communication	progression NN B-noun.communication	and/or CC 0	long JJ B-adj.all	symptom NN B-noun.body	duration NN 0	prior RB 0	to TO 0	initiation NN B-noun.act	of IN 0	levodopa NN B-noun.person	therapy NN B-noun.person	were VBD B-verb.stative	more RBR B-adv.all	resistant JJ B-adj.all	to TO 0	developing VBG B-verb.communication	LIDs NNP B-noun.person	( ( 0	e.g. UH 0	, , 0	dyskinesia NN B-noun.person	developed VBD B-verb.creation	no DT 0	sooner RBR 0	than IN 0	146 CD 0	days NNS B-noun.person	of IN 0	chronic JJ B-adj.all	levodopa NN B-noun.attribute	administration NN I-noun.attribute	) ) 0	. . 0	. . 0
a17241784.s4	All DT 0	had VBD B-verb.change	myofibre JJ B-adj.all	necrosis NN B-noun.person	but CC 0	only RB B-adv.all	3 CD 0	had VBD 0	an DT 0	inflammatory JJ B-adj.all	infiltrate NN B-noun.person	. . 0	. . 0
a9284778.s10	Trifluoroacetyl SYM 0	- : 0	adducted VBD B-verb.communication	proteins NNS B-noun.person	were VBD 0	detected VBN B-verb.perception	in IN 0	surviving VBG B-verb.competition	hepatocytes NNS I-verb.competition	. . 0	. . 0
a8864707.s0	Magnetic JJ B-adj.all	resonance NN B-noun.phenomenon	volumetry NN B-noun.attribute	of IN 0	the DT 0	cerebellum NN B-noun.artifact	in IN 0	epileptic JJ B-adj.all	patients NNS B-noun.person	after IN 0	phenytoin NN B-noun.body	overdosages NNS I-noun.body	. . 0	. . 0
a1428568.s4	During IN 0	the DT 0	six CD 0	- : 0	month NN B-noun.person	follow VB B-verb.stative	up RP 0	, , 0	depression NN B-noun.person	was VBD 0	quantified VBN B-verb.change	through IN 0	the DT 0	Beck NNP B-noun.person	and CC 0	Zung NNP B-noun.person	- : 0	Conde JJ B-noun.other	scales NNS B-noun.event	every DT 0	two CD 0	months NNS B-noun.person	. . 0	. . 0
a2396046.s5	The DT 0	results NNS B-noun.communication	evinced VBD B-verb.communication	no DT 0	enhancement NN B-noun.person	of IN 0	the DT 0	hepatocarcinogenicity NN B-noun.attribute	of IN 0	the DT 0	choline NN B-noun.act	- : 0	devoid JJ B-adj.all	diet NN B-noun.person	by IN 0	phenobarbital NN B-noun.artifact	. . 0	. . 0
a3615541.s2	Among IN 0	these DT 0	behavioral JJ B-adj.pert	effects NNS B-noun.phenomenon	are VBP B-verb.stative	decreases NNS B-noun.person	in IN 0	food NN B-noun.location	intake NN B-noun.person	and CC 0	decreases VBZ B-verb.change	in IN 0	amphetamine JJ B-adj.all	- : 0	induced VBN B-verb.creation	locomotor NN B-noun.process	activity NN B-noun.process	. . 0	. . 0
a18410508.s0	Methamphetamine SYM 0	- : 0	induced VBN B-verb.communication	neurotoxicity NN B-noun.person	and CC 0	microglial JJ B-adj.all	activation NN B-noun.process	are VBP 0	not RB B-adv.all	mediated VBN B-verb.cognition	by IN 0	fractalkine NN B-noun.person	receptor NN B-noun.artifact	signaling NN B-noun.act	. . 0	. . 0
a18186898.s6	Three CD 0	yr NN 0	after IN 0	transplantation NN B-noun.act	she PRP 0	developed VBD B-verb.creation	renal_Fanconi_syndrome NN I-verb.creation	with IN 0	severe JJ B-adj.all	metabolic_acidosis NN B-noun.food	, , 0	hypophosphatemia NN B-noun.person	, , 0	glycosuria NN B-noun.person	, , 0	and CC 0	aminoaciduria NNS B-noun.person	. . 0	. . 0
a8864707.s7	In IN 0	addition NN 0	3D CD 0	gradient NN B-noun.quantity	echo VBP B-verb.perception	data NNS B-noun.cognition	sets NNS B-noun.artifact	from IN 0	10 CD B-adj.all	healthy JJ B-adj.all	male NN B-noun.person	and CC 0	10 CD B-adj.all	healthy JJ B-adj.all	female NN B-noun.person	age NN B-noun.person	- : 0	matched VBN B-verb.contact	volunteers NNS B-noun.person	were VBD 0	used VBN B-verb.consumption	to TO 0	compare VB B-verb.change	cerebellar JJ B-adj.all	volumes NNS B-noun.artifact	. . 0	. . 0
a9284778.s5	Both DT 0	compounds NNS B-noun.person	are VBP 0	metabolised VBN B-verb.stative	in IN 0	the DT 0	same JJ B-adj.all	way NN 0	as IN 0	1-bromo-1-chloro-2,2,2-trifluoroethane NNP 0	( ( 0	halothane NN 0	) ) 0	to TO 0	form VB B-verb.creation	reactive JJ 0	trifluoroacetyl NN 0	halide NN 0	intermediates NNS B-noun.event	, , 0	which WDT 0	have VBP 0	been VBN 0	implicated VBN B-verb.communication	in IN 0	the DT 0	hepatotoxicity NN B-noun.attribute	of IN 0	halothane NN B-noun.person	. . 0	. . 0
a2054792.s0	Effect NN 0	of IN 0	adriamycin NN B-noun.person	combined VBN B-verb.change	with IN 0	whole JJ B-adj.all	body NN 0	hyperthermia NN 0	on IN 0	tumor NN B-noun.artifact	and CC 0	normal JJ B-noun.body	tissues NNS I-noun.body	. . 0	. . 0
a9931093.s3	To TO 0	clarify VB B-verb.cognition	the DT 0	mechanisms NNS B-noun.person	of IN 0	FK_506-induced JJ B-adj.all	hypertension NN B-noun.person	, , 0	we PRP 0	studied VBD B-verb.cognition	the DT 0	chronic JJ B-adj.pert	effects NNS B-noun.phenomenon	of IN 0	FK_506 NNP B-noun.person	on IN 0	the DT 0	synthesis NN B-noun.cognition	of IN 0	endothelin-1 JJ B-noun.cognition	( ( 0	ET-1 NN 0	) ) 0	, , 0	the DT 0	expression NN B-noun.communication	of IN 0	mRNA NNP B-noun.person	of IN 0	ET-1 NN B-noun.other	and CC 0	endothelin VB B-verb.stative	- : 0	converting VBG B-verb.communication	enzyme-1 JJ I-verb.communication	( ( 0	ECE-1 NN 0	) ) 0	, , 0	the DT 0	endothelial JJ B-adj.all	nitric_oxide JJ B-noun.other	synthase NN B-noun.cognition	( ( 0	eNOS NNS B-noun.attribute	) ) 0	activity NN B-noun.quantity	, , 0	and CC 0	the DT 0	expression NN B-noun.communication	of IN 0	mRNA NNP B-noun.person	of IN I-noun.person	eNOS NNS I-noun.person	and CC 0	C NNP 0	- : 0	type NN B-noun.person	natriuretic JJ B-adj.all	peptide NN B-noun.cognition	( ( 0	CNP NNP 0	) ) 0	in IN 0	rat NN 0	blood NN B-noun.body	vessels NNS I-noun.body	. . 0	. . 0
a2234245.s1	During IN 0	an DT 0	18-month JJ 0	period NN B-noun.person	of IN 0	study NN B-noun.communication	41 CD 0	hemodialyzed VBD B-verb.communication	patients NNS B-noun.person	receiving VBG B-verb.communication	desferrioxamine NN B-noun.person	( ( 0	10 CD B-adj.all	- : 0	40 CD B-adj.all	mg NN B-noun.quantity	/ ) 0	kg RB 0	BW/3 JJ B-adj.all	times NNS B-noun.event	weekly JJ B-adj.all	) ) 0	for IN 0	the DT 0	first JJ B-adj.all	time NN B-noun.time	were VBD 0	monitored VBN B-verb.perception	for IN 0	detection NN B-noun.act	of IN 0	audiovisual_toxicity NN B-noun.group	. . 0	. . 0
a12653683.s3	The DT 0	rate NN B-noun.time	- : 0	limiting VBG B-verb.social	constituent NN B-noun.act	of IN 0	collecting VBG B-verb.possession	duct NN B-noun.phenomenon	sodium NN B-noun.artifact	transport NN I-noun.artifact	is VBZ B-verb.stative	the DT 0	epithelial NN B-noun.body	sodium NN 0	channel NN 0	( ( 0	ENaC NNP B-noun.other	) ) 0	. . 0	. . 0
a12536034.s5	The DT 0	underlying VBG 0	epileptogenecity NN B-noun.attribute	of IN 0	the DT 0	patients NNS B-noun.person	or CC 0	the DT 0	synergistic JJ B-adj.all	effects NNS B-noun.phenomenon	of IN 0	the DT 0	accompanying VBG B-noun.artifact	drugs NNS I-noun.artifact	is VBZ 0	required VBN B-verb.stative	to TO 0	trigger VB B-verb.social	the DT 0	de FW 0	novo RB 0	absence_seizure JJ 0	. . 0	. . 0
a20084309.s0	Safety NN B-noun.person	of IN 0	transesophageal NN B-noun.process	echocardiography NN I-noun.process	in IN 0	adults NNS B-noun.animal	, , 0	study NN B-noun.artifact	in IN 0	a DT 0	multidisciplinary JJ B-adj.all	hospital NN B-noun.artifact	. . 0	. . 0
a11773892.s7	Patients NNS B-noun.person	were VBD 0	divided VBN B-verb.social	into IN 0	three CD 0	groups NNS 0	, , 0	Controls NNP B-noun.group	, , 0	no DT 0	CRF NNP 0	or CC 0	ESRD NNP B-noun.other	, , 0	n=748 NNP B-noun.person	, , 0	CRF NNP 0	, , 0	sustained VBD B-verb.contact	serum NN B-noun.person	creatinine NN B-noun.person	> $ 0	2.5 CD 0	mg FW B-noun.quantity	/ FW 0	dl FW 0	, , 0	n=41 NNP B-noun.person	, , 0	and CC 0	ESRD NNP B-noun.other	, , 0	n=45 NNP B-noun.person	. . 0	. . 0
a2559236.s8	Untreated JJ B-adj.all	group NN B-noun.communication	3 CD B-adj.all	rats NNS B-noun.person	exhibited VBD B-verb.consumption	a DT 0	progressive JJ B-adj.all	reduction NN B-noun.process	in IN 0	GFR NNP 0	( ( 0	0.35 CD 0	+ : 0	/- $ 0	0.08 CD 0	ml PRP 0	/ `` 0	min NN 0	at IN 0	4 CD B-adj.all	months NNS B-noun.person	, , 0	0.27 CD 0	+ : 0	/- $ 0	0.07 CD 0	ml PRP 0	/ `` 0	min NN 0	at IN 0	6 CD B-adj.all	months NNS B-noun.quantity	) ) 0	. . 0	. . 0
a1378968.s2	Newborn NNP B-noun.person	female NNP B-noun.person	Wistar NNP I-noun.person	rats NNS I-noun.person	were VBD 0	fed VBN B-verb.consumption	a DT 0	lithium NN B-noun.person	- : 0	containing VBG B-verb.communication	diet NN B-noun.substance	( ( 0	50 CD B-adj.all	mmol NN B-noun.quantity	/ : 0	kg LS 0	) ) 0	for IN 0	8 CD B-adj.all	weeks NNS B-noun.time	and CC 0	then RB B-adv.all	randomized VBD B-verb.cognition	to TO 0	normal JJ B-adj.all	diet NN B-noun.person	, , 0	HP NNP 0	diet NN 0	( ( 0	40 CD B-adj.all	vs. NN B-noun.communication	19 CD B-adj.all	% NN 0	) ) 0	, , 0	NX NNP 0	or CC 0	HP+NX NN B-noun.group	for IN 0	another DT 0	8 CD B-adj.all	weeks NNS B-noun.time	. . 0	. . 0
a17615423.s6	Nine CD 0	days NNS 0	later RB 0	the DT 0	patient NN B-noun.person	's POS 0	creatine NN 0	kinase NN 0	had VBD 0	dropped VBN B-verb.motion	to TO 0	1695 CD 0	U NNP 0	/ NNP 0	L NNP 0	and CC 0	creatinine NN B-noun.person	was VBD B-verb.stative	3.3 CD 0	mg PRP 0	/ $ 0	dL. PDT 0	The DT 0	patient NN B-noun.person	was VBD 0	discharged VBN B-verb.contact	and CC 0	continued VBD B-verb.stative	outpatient JJ B-adj.all	dialysis NN B-noun.person	for IN 0	1 CD B-adj.all	month NN B-noun.quantity	until IN 0	his PRP$ 0	renal JJ B-adj.all	function NN B-noun.act	recovered VBD B-verb.perception	. . 0	. . 0
a11334364.s10	Additionally RB B-adv.all	, , 0	histopathological JJ B-adj.all	alterations NNS B-noun.person	mirrored VBD B-verb.contact	both DT 0	serum NN B-noun.body	chemistry NN B-noun.body	changes NNS I-noun.body	and CC 0	the DT 0	pattern NN B-noun.act	of IN 0	DNA NNP 0	fragmentation NN 0	. . 0	. . 0
a1664218.s1	CI-921 NN 0	( ( 0	NSC_343499 UH 0	, , 0	9-[[2-methoxy-4-[(methylsulphonyl)amino]phenyl]amino]_-N,5-dimethyl-_4-acridinecarboxamide JJ 0	) ) 0	is VBZ B-verb.stative	a DT 0	topoisomerase NN 0	II NNP 0	poison NN 0	with IN 0	high JJ B-adj.all	experimental JJ B-adj.all	antitumour JJ B-adj.all	activity NN B-noun.state	. . 0	. . 0
a20196116.s9	The DT 0	median JJ B-adj.all	duration NN B-noun.act	of IN 0	ATT NNP 0	before IN 0	ALF NNP B-noun.person	was VBD B-verb.stative	30 CD B-adj.all	( ( 0	7 CD 0	- : 0	350 CD 0	) ) 0	days NNS B-noun.phenomenon	. . 0	. . 0
a8595686.s11	We PRP 0	conclude VBP B-verb.cognition	that IN 0	lidocaine NN B-noun.person	reduces VBZ B-verb.change	the DT 0	incidence NN B-noun.communication	and CC 0	severity NN B-noun.attribute	of IN 0	propofol NN B-noun.possession	injection NN B-noun.act	pain NN B-noun.cognition	in IN 0	ambulatory JJ B-adj.all	patients NNS B-noun.person	whereas IN 0	thiopentone NN 0	only RB B-adv.all	reduces VBZ B-verb.change	its PRP$ 0	severity NN B-noun.attribute	. . 0	. . 0
a1428568.s0	Changes NNS B-noun.relation	in IN 0	depressive JJ B-adj.all	status NN B-noun.communication	associated VBN B-verb.cognition	with IN 0	topical JJ B-adj.all	beta NN B-noun.act	- : 0	blockers NNS B-noun.person	. . 0	. . 0
a20667451.s9	The DT 0	administration NN B-noun.time	of IN 0	phenobarbitone NN B-noun.person	and CC 0	carbamazepine NN B-noun.act	for IN 0	21days NNS B-noun.person	caused VBD B-verb.communication	a DT 0	significant JJ B-adj.all	impairment_of_learning_and_memory JJ B-noun.attribute	as RB 0	well RB 0	as IN 0	an DT 0	increased VBN B-verb.change	oxidative JJ B-adj.all	stress NN B-noun.state	. . 0	. . 0
a8387218.s2	Patient JJ B-adj.all	response NN B-noun.communication	was VBD 0	assessed VBN B-verb.cognition	using VBG B-verb.consumption	changes NNS B-noun.food	in IN 0	CD4 CD 0	+ DT 0	lymphocyte NN B-noun.artifact	subset NN B-noun.artifact	count NN B-noun.act	, , 0	HIV NNP 0	p24 CD 0	antigen NN 0	, , 0	weight NN B-noun.artifact	, , 0	and CC 0	quality NN B-noun.attribute	of IN 0	life NN B-noun.time	. . 0	. . 0
a3403780.s3	Continuous JJ B-adj.all	arteriovenous JJ B-adj.all	haemofiltration NN B-noun.act	proved VBD B-verb.stative	a DT 0	valuable JJ B-adj.all	means NNS B-noun.person	of IN 0	maintaining VBG B-verb.possession	fluid NN B-noun.substance	and CC 0	electrolyte JJ B-adj.all	balance NN B-noun.possession	. . 0	. . 0
a16330293.s0	Safety NN B-noun.person	profile NN B-noun.quantity	of IN 0	a DT 0	nicotine JJ B-adj.all	lozenge NN B-noun.feeling	compared VBN B-verb.possession	with IN 0	that DT 0	of IN 0	nicotine NN B-noun.person	gum NN B-noun.person	in IN 0	adult NN B-noun.act	smokers NNS I-noun.act	with IN 0	underlying VBG B-verb.stative	medical JJ B-adj.all	conditions NNS B-noun.cognition	, , 0	a DT 0	12-week JJ 0	, , 0	randomized VBD B-verb.cognition	, , 0	open JJ B-noun.person	- : 0	label NN B-noun.substance	study NN B-noun.artifact	. . 0	. . 0
a2445283.s1	Tolerance NNP B-noun.person	and CC 0	antiviral JJ B-adj.all	effect NN B-noun.cognition	of IN 0	ribavirin NN B-noun.person	was VBD 0	studied VBN B-verb.cognition	in IN 0	6 CD B-adj.all	patients NNS B-noun.person	with IN 0	Argentine_hemorrhagic_fever NN B-noun.person	( ( 0	AHF NNP 0	) ) 0	of IN 0	more JJR B-noun.quantity	than IN 0	8 CD B-adj.all	days NNS B-noun.time	of IN 0	evolution NN B-noun.time	. . 0	. . 0
a3719553.s4	Discontinuance NN B-noun.person	of IN 0	effective JJ B-noun.phenomenon	chemotherapy NN I-noun.phenomenon	in IN 0	this DT 0	patient NN B-noun.artifact	during IN 0	partial JJ B-adj.all	remission NN B-noun.act	resulted VBD B-verb.stative	in IN 0	fatal JJ B-adj.all	disease NN B-noun.act	progression NN B-noun.act	. . 0	. . 0
a18417364.s0	Nicotine SYM 0	- : 0	induced VBN B-verb.creation	nystagmus NN 0	correlates VBZ B-verb.stative	with IN 0	midpontine JJ B-adj.all	activation NN B-noun.act	. . 0	. . 0
a10901305.s7	RESULTS NNS B-noun.artifact	, , 0	The DT 0	average JJ B-adj.all	time NN B-noun.time	from IN 0	intravenous JJ B-adj.all	administration NN B-noun.time	of IN 0	ketamine NN B-noun.person	to TO 0	manipulation NN B-noun.act	of IN 0	the DT 0	fracture NN B-noun.act	or CC 0	dislocation NN B-noun.act	was VBD B-verb.stative	one CD 0	minute NN B-noun.quantity	and CC 0	thirty NN B-noun.person	- : 0	six CD 0	seconds NNS B-noun.person	( ( 0	range NN B-noun.person	, , 0	twenty CD 0	seconds NNS B-noun.quantity	to TO 0	five CD B-adj.all	minutes NNS B-noun.time	) ) 0	, , 0	and CC 0	the DT 0	average JJ B-adj.all	time NN B-noun.time	from IN 0	intramuscular JJ B-adj.all	administration NN B-noun.person	to TO 0	manipulation NN B-noun.act	was VBD B-verb.stative	four CD B-adj.all	minutes NNS B-noun.time	and CC 0	forty NN B-noun.attribute	- : 0	two CD 0	seconds NNS B-noun.person	( ( 0	range NN B-noun.person	, , 0	sixty JJ B-adj.all	seconds NNS B-noun.person	to TO 0	fifteen JJ B-adj.all	minutes NNS B-noun.time	) ) 0	. . 0	. . 0
a11587867.s2	The DT 0	girl NN B-noun.person	died VBD B-verb.change	seven CD B-adj.all	days NNS B-noun.person	, , 0	the DT 0	man NN 0	four CD 0	weeks NNS B-noun.time	after IN 0	intrathecal JJ B-adj.all	injection NN B-noun.act	of IN 0	vincristine NN B-noun.location	. . 0	. . 0
a18752389.s2	However RB 0	, , 0	hepatotoxic JJ B-adj.all	events NNS B-noun.plant	have VBP 0	not RB 0	been VBN 0	widely RB B-adv.all	published VBN B-verb.creation	with IN 0	ezetimibe NN B-noun.person	or CC 0	the DT 0	combination NN B-noun.person	agent NN B-noun.person	simvastatin NN B-noun.person	- : 0	ezetimibe NN B-noun.person	. . 0	. . 0
a17931375.s7	Dimensions NNS B-noun.person	of IN 0	the DT 0	bruising VBG B-verb.contact	on IN 0	the DT 0	heparin NN B-noun.person	applied VBD B-verb.stative	areas NNS B-noun.location	were VBD 0	measured VBN B-verb.cognition	using VBG B-verb.consumption	transparent JJ B-adj.all	millimetric JJ 0	measuring VBG B-verb.stative	paper NN 0	. . 0	. . 0
a3780846.s10	However RB 0	, , 0	the DT 0	level NN B-noun.state	in IN 0	the DT 0	AS NNP 0	/ ( 0	KS NNP 0	group NN 0	remained VBD B-verb.stative	considerably RB B-adv.all	lower JJR B-adj.all	than IN 0	in IN 0	the DT 0	A NNP 0	group NN 0	. . 0	. . 0
a11135224.s0	Paclitaxel NNP B-noun.person	, , 0	cisplatin NN B-noun.person	, , 0	and CC 0	gemcitabine JJ B-adj.all	combination NN B-noun.person	chemotherapy NN B-noun.phenomenon	within IN 0	a DT 0	multidisciplinary JJ B-adj.all	therapeutic JJ B-adj.pert	approach NN B-noun.person	in IN 0	metastatic JJ B-adj.all	nonsmall_cell_lung_carcinoma NN B-noun.group	. . 0	. . 0
a20067456.s12	CONCLUSIONS NNS B-noun.artifact	, , 0	Bupropion NNP B-noun.person	is VBZ B-verb.stative	an DT 0	effective JJ B-adj.all	treatment NN B-noun.communication	for IN 0	male NN 0	SD NNP 0	induced VBN B-verb.creation	by IN 0	SSRIs NNP B-noun.person	. . 0	. . 0
a21029050.s10	Neuromuscular JJ B-adj.all	monitoring NN B-verb.perception	was VBD 0	used VBN B-verb.consumption	in IN 0	two CD 0	patients NNS B-noun.person	. . 0	. . 0
a1378968.s1	Rats NNS B-noun.person	with IN 0	lithium NN B-noun.person	- : 0	induced VBN B-verb.creation	nephropathy JJ B-adj.all	were VBD 0	subjected VBN B-verb.perception	to TO 0	high JJ B-adj.all	protein NN B-noun.person	( ( 0	HP NNP 0	) ) 0	feeding NN B-noun.act	, , 0	uninephrectomy NN B-noun.person	( ( 0	NX NNP 0	) ) 0	or CC 0	a DT 0	combination NN B-noun.event	of IN 0	these DT 0	, , 0	in IN 0	an DT 0	attempt NN B-noun.act	to TO 0	induce VB B-verb.cognition	glomerular JJ B-adj.all	hyperfiltration NN B-noun.act	and CC 0	further JJ B-adj.all	progression NN B-noun.act	of IN 0	renal_failure NN B-noun.act	. . 0	. . 0
a20520283.s7	Across IN 0	all DT 0	groups NNS B-noun.group	, , 0	no DT 0	more JJR B-noun.quantity	than IN 0	5 CD B-adj.all	% NN 0	of IN 0	patients NNS B-noun.person	had VBD 0	clinically RB B-verb.contact	significant JJ B-adj.all	weight NN B-noun.artifact	change NN B-noun.artifact	. . 0	. . 0
a20080983.s8	The DT 0	effect NN B-noun.cognition	of IN 0	modafinil NN B-noun.artifact	interacted VBN B-verb.contact	with IN 0	the DT 0	abstinence NN B-noun.artifact	week NN I-noun.artifact	and CC 0	was VBD 0	associated VBN B-verb.cognition	with IN 0	longer RBR B-adv.all	total JJ B-adj.all	sleep JJ B-adj.all	time NN B-noun.time	and CC 0	shorter JJR B-adj.all	REM NNP B-noun.group	sleep JJ B-adj.all	latency NN B-noun.person	in IN 0	the DT 0	third JJ B-adj.all	week NN B-noun.event	of IN 0	abstinence NN B-noun.act	. . 0	. . 0
a18752389.s12	We PRP 0	postulate VBP B-verb.cognition	that IN 0	the DT 0	mechanism NN B-noun.attribute	of IN 0	the DT 0	simvastatinezetimibe NN B-noun.person	- : 0	induced VBN B-verb.creation	hepatotoxicity NN B-noun.attribute	is VBZ B-verb.stative	the DT 0	increased VBN B-verb.change	simvastatin JJ B-adj.all	exposure NN B-noun.cognition	by IN 0	ezetimibe NN B-noun.person	inhibition NN B-noun.person	of IN 0	UGT NNP 0	enzymes VBZ B-verb.stative	. . 0	. . 0
a809711.s5	SigmaST NN 0	, , 0	the DT 0	sum NN 0	of IN 0	ST NNP 0	- : 0	segment NN B-noun.person	elevations NNS B-noun.person	in IN 0	16 CD B-adj.all	precordial JJ B-adj.all	leads NNS B-noun.cognition	, , 0	decreased VBD B-verb.communication	( ( 0	P NNP 0	less JJR 0	than IN 0	0.02 CD 0	) ) 0	with IN 0	intravenous JJ B-adj.all	nitroglycerin NN B-noun.person	. . 0	. . 0
a8319760.s0	Dup_753 NN 0	prevents VBZ B-verb.stative	the DT 0	development NN B-noun.process	of IN 0	puromycin_aminonucleoside JJ B-noun.other	- : 0	induced VBN B-verb.communication	nephrosis NN B-noun.person	. . 0	. . 0
a15859940.s7	Three CD 0	of IN 0	these DT 0	cases NNS B-noun.state	were VBD B-verb.stative	from IN 0	the DT 0	25 CD B-adj.all	transplantations NNS B-noun.communication	performed VBN B-verb.competition	at IN 0	King NNP B-noun.other	Fahad NNP I-noun.other	National NNP I-noun.other	Guard NNP I-noun.other	Hospital NNP I-noun.other	, , 0	while IN 0	the DT 0	other JJ 0	2 CD B-adj.all	transplantations NNS B-noun.communication	had VBD 0	been VBN 0	performed VBN B-verb.communication	abroad RB I-verb.communication	and CC 0	were VBD 0	referred VBN B-verb.perception	to TO 0	us PRP 0	for IN 0	follow NN B-noun.act	- : 0	up RB B-adv.all	. . 0	. . 0
a19037603.s3	Liver NN 0	function NN B-noun.act	tests NNS B-noun.cognition	, , 0	hepatitis NN 0	B NNP 0	virus NN B-noun.animal	( ( 0	HBV NNP 0	) ) 0	serologic JJ B-adj.all	markers NNS B-noun.person	, , 0	and CC 0	HBV NNP 0	DNA NNP 0	levels NNS B-noun.attribute	of IN 0	the DT 0	patients NNS B-noun.artifact	during IN 0	follow SYM 0	- : 0	up RB 0	were VBD 0	obtained VBN B-verb.possession	from IN 0	hospital NN B-noun.animal	file NN B-noun.possession	records NNS B-noun.communication	. . 0	. . 0
a2870085.s8	In IN 0	contrast NN 0	with IN 0	other JJ 0	beta JJ B-adj.all	blockers NNS B-noun.person	, , 0	flestolol NN B-noun.person	- : 0	induced VBN B-verb.creation	effects NNS B-noun.phenomenon	reverse VBP B-verb.communication	rapidly RB B-adv.all	( ( 0	within IN 0	30 CD B-adj.all	minutes NNS B-noun.time	) ) 0	following VBG B-verb.stative	discontinuation NN B-noun.act	because IN 0	of IN 0	its PRP$ 0	short JJ B-noun.body	half NN I-noun.body	- : 0	life NN B-noun.time	. . 0	. . 0
a322550.s3	Ten CD 0	cm IN 0	H2O NNP B-noun.person	CPAP NNP I-noun.person	before IN 0	nitroprusside JJ 0	infusion NN 0	produced VBD B-verb.creation	a DT 0	further JJ B-adj.all	decrease_in_arterial_blood_pressure NN B-noun.act	and CC 0	significantly RB B-adv.all	increased VBD B-verb.change	heart NN B-noun.body	rate NN B-noun.time	and CC 0	decreased_cardiac_output NN B-noun.act	and CC 0	QS NNP 0	/ NNP 0	QT NNP 0	. . 0	. . 0
a17437408.s11	Experiments NNS B-noun.person	with IN 0	systemic JJ B-adj.all	administration NN B-noun.time	of IN 0	the DT 0	Pgp NNP B-noun.other	substrate JJ B-adj.all	phenobarbital NN B-noun.artifact	and CC 0	the DT 0	selective JJ B-noun.person	Pgp NNP I-noun.person	inhibitor NN I-noun.person	tariquidar NN B-noun.person	in IN 0	TR(- NN 0	) ) 0	rats NNS B-noun.location	substantiated VBD B-verb.communication	that IN 0	Pgp NNP B-noun.person	is VBZ B-verb.stative	functional JJ B-adj.all	and CC 0	compensates NNS B-noun.person	for IN 0	the DT 0	lack NN B-noun.person	of IN 0	MRP2 NNP B-noun.person	in IN 0	the DT 0	BBB NNP B-noun.group	. . 0	. . 0
a15275829.s8	mRNA JJ B-adj.all	levels NNS B-noun.state	for IN 0	the DT 0	alpha5 NNP B-noun.other	and CC 0	the DT 0	beta4 JJ B-adj.all	subunits NNS B-noun.person	were VBD B-verb.stative	unchanged JJ B-adj.all	in IN 0	alpha3 NNP B-noun.other	+ : 0	/- CC 0	brains NNS B-noun.possession	. . 0	. . 0
a16330293.s8	The DT 0	majority NN B-noun.quantity	were VBD B-verb.stative	women NNS B-noun.person	( ( 0	52.7 CD 0	% NN 0	) ) 0	. . 0	. . 0
a17020434.s6	Idraparinux NNP B-noun.person	, , 0	a DT 0	Factor NNP B-noun.person	Xa NNP I-noun.person	inhibitor NN I-noun.person	, , 0	is VBZ 0	being VBG 0	evaluated VBN B-verb.communication	in IN 0	patients NNS B-noun.person	with IN 0	atrial_fibrillation NN B-noun.act	. . 0	. . 0
a10901305.s8	The DT 0	average JJ B-adj.all	score NN B-noun.person	according VBG 0	to TO 0	the DT 0	Children NNP B-noun.person	's POS 0	Hospital NNP B-noun.other	of IN I-noun.other	Eastern NNP I-noun.other	Ontario NNP I-noun.other	Pain NNP I-noun.other	Scale NNP I-noun.other	was VBD B-verb.stative	6.4 CD 0	points NNS B-noun.quantity	( ( 0	range NN B-noun.person	, , 0	5 CD 0	to TO 0	10 CD B-adj.all	points NNS B-noun.cognition	) ) 0	, , 0	reflecting VBG B-verb.perception	minimal JJ I-verb.perception	or CC 0	no DT 0	pain NN B-noun.cognition	during IN 0	fracture NN B-noun.phenomenon	reduction NN B-noun.process	. . 0	. . 0
a17612891.s2	There EX 0	is VBZ B-verb.stative	an DT 0	urgent JJ B-adj.all	need NN B-noun.motive	to TO 0	raise VB B-verb.emotion	awareness NN I-verb.emotion	about IN 0	this DT 0	potentially RB B-adj.all	fatal JJ B-adj.all	complication NN B-noun.act	of IN 0	clozapine NN B-noun.phenomenon	use NN B-noun.process	. . 0	. . 0
a17931375.s11	It PRP 0	was VBD 0	determined VBN B-verb.communication	that IN 0	the DT 0	size NN B-noun.attribute	of IN 0	the DT 0	bruising NN B-noun.artifact	was VBD B-verb.stative	smaller JJR B-adj.all	in IN 0	the DT 0	30-second JJ 0	injection NN B-noun.act	. . 0	. . 0
a15338796.s15	Postural JJ B-adj.all	tremor NN B-noun.feeling	showed VBD B-verb.communication	no DT 0	significant JJ B-adj.all	difference NN B-noun.cognition	between IN 0	the DT 0	first JJ B-adj.all	and CC 0	third JJ B-adj.all	session NN B-noun.act	( ( 0	P UH 0	= SYM 0	0.07 CD 0	) ) 0	. . 0	. . 0
a10901305.s11	Patency NN B-noun.person	of IN 0	the DT 0	airway NN B-noun.artifact	and CC 0	independent JJ B-adj.all	respiration NN B-noun.act	were VBD 0	maintained VBN B-verb.stative	in IN 0	all DT 0	of IN 0	the DT 0	patients NNS B-noun.person	. . 0	. . 0
a227508.s5	These DT 0	findings NNS B-noun.act	indicate VBP B-verb.cognition	that IN 0	in IN 0	spontaneously RB B-adv.all	hypertensive JJ B-adj.all	rats NNS B-noun.animal	the DT 0	effects NNS B-noun.phenomenon	of IN 0	central JJ B-noun.body	alpha NN I-noun.body	- : 0	adrenoceptor NN 0	stimulation NN 0	involve VB B-verb.stative	activation NN B-noun.process	of IN 0	opiate JJ B-adj.all	receptors NNS B-noun.person	. . 0	. . 0
a12757899.s0	Estradiol NN B-noun.act	reduces VBZ B-verb.change	seizure NN B-noun.act	- : 0	induced VBN B-verb.creation	hippocampal_injury NN 0	in IN 0	ovariectomized JJ B-adj.all	female NN B-noun.person	but CC 0	not RB B-adv.all	in IN 0	male NN B-noun.animal	rats NNS I-noun.animal	. . 0	. . 0
a8372922.s4	Under IN 0	anesthesia NN B-noun.object	, , 0	the DT 0	superior JJ B-adj.all	temporal JJ B-adj.all	gyrus NN B-noun.person	of IN 0	adult NN B-noun.person	macaque NN B-noun.person	monkeys NNS B-noun.person	was VBD 0	exposed VBN B-verb.perception	, , 0	and CC 0	the DT 0	tonotopic JJ B-adj.all	organization NN B-noun.cognition	of IN 0	A1 NN 0	was VBD 0	mapped VBN B-verb.contact	using VBG B-verb.consumption	conventional JJ B-adj.all	microelectrode NN B-noun.person	recording VBG B-verb.communication	techniques NNS B-noun.cognition	. . 0	. . 0
a2224762.s3	A DT 0	total NN B-noun.state	of IN 0	167 CD 0	courses NNS B-noun.act	at IN 0	doses NNS B-noun.act	of IN 0	15 CD 0	to TO 0	70 CD B-adj.all	mg NN B-noun.quantity	/ : 0	m2 PRP 0	were VBD B-verb.stative	evaluable JJ B-adj.all	. . 0	. . 0
a7628595.s3	Finally RB B-adv.all	, , 0	15 CD B-adj.all	patients NNS B-noun.person	were VBD 0	excluded VBN B-verb.stative	from IN 0	the DT 0	study NN B-noun.artifact	( ( 0	noncompliance RB 0	14 CD 0	, , 0	death NN 0	1 CD 0	) ) 0	, , 0	thus RB 0	, , 0	60 CD B-adj.all	patients NNS B-noun.person	( ( 0	31 CD 0	in IN 0	group NN 0	I PRP 0	and CC 0	29 CD B-noun.quantity	in IN 0	group NN 0	II NNP 0	) ) 0	were VBD B-verb.stative	eligible JJ B-adj.all	for IN 0	analysis NN B-noun.act	. . 0	. . 0
a21029050.s0	Butyrylcholinesterase NNP 0	gene NN 0	mutations NNS B-noun.act	in IN 0	patients NNS B-noun.person	with IN 0	prolonged JJ B-adj.all	apnea NN B-noun.person	after IN 0	succinylcholine NN B-noun.person	for IN 0	electroconvulsive JJ B-adj.all	therapy NN B-noun.person	. . 0	. . 0
a8590259.s4	Decreases_in_systolic_blood_pressure NN B-noun.state	were VBD B-verb.stative	statistically RB B-adv.all	, , 0	but CC 0	not RB B-adv.all	clinically RB B-adv.all	, , 0	significant JJ B-adj.all	. . 0	. . 0
a20196116.s12	Compared VBN B-verb.cognition	with IN 0	hepatitis NNP 0	E NNP 0	virus NN 0	( ( 0	HEV NNP 0	) ) 0	and CC 0	non NN B-noun.person	- : 0	A DT 0	non NN B-noun.person	- : 0	E SYM 0	- : 0	induced VBN B-verb.creation	ALF NNP 0	, , 0	ATT NNP B-noun.group	- : 0	ALF NN B-noun.group	patients NNS B-noun.person	had VBD 0	nearly RB B-verb.change	similar JJ B-adj.all	presentations NNS B-noun.artifact	except IN 0	for IN 0	older JJR B-adj.all	age NN B-noun.person	and CC 0	less JJR B-adj.all	elevation NN B-noun.act	of IN 0	liver NN B-noun.animal	enzymes NNS I-noun.animal	. . 0	. . 0
a1428568.s3	Eight CD 0	glaucomatous JJ B-adj.all	patients NNS B-noun.person	chronically RB B-adv.all	treated VBN B-verb.change	with IN 0	timolol NN 0	0.5%/12h NN 0	, , 0	suffering VBG B-verb.body	from IN 0	depression NN B-noun.person	diagnosed VBD B-verb.communication	through IN 0	DMS NNS B-noun.group	- : 0	III SYM 0	- : 0	R NN 0	criteria NNS 0	, , 0	were VBD 0	included VBN B-verb.stative	in IN 0	the DT 0	study NN B-noun.artifact	. . 0	. . 0
a7930386.s1	The DT 0	present JJ B-adj.all	study NN B-noun.artifact	was VBD 0	undertaken VBN B-verb.cognition	to TO 0	examine VB B-verb.communication	the DT 0	role NN B-noun.attribute	of IN 0	sleep_disturbance NN B-noun.food	, , 0	induced VBN B-verb.creation	by IN 0	clomipramine JJ B-adj.all	administration NN B-noun.person	, , 0	on IN 0	the DT 0	secretory JJ B-adj.all	rate NN B-noun.time	of IN 0	prolactin NN B-noun.substance	( ( 0	PRL NNP 0	) ) 0	in IN 0	addition NN 0	to TO 0	the DT 0	direct JJ B-adj.all	drug NN 0	effect NN 0	. . 0	. . 0
a10406016.s1	Inflammatory JJ B-adj.all	cells NNS B-noun.body	are VBP 0	postulated VBN B-verb.communication	to TO 0	mediate VB B-verb.social	some DT 0	of IN 0	the DT 0	brain_damage NN B-noun.artifact	following VBG B-verb.stative	ischemic_stroke NNP I-verb.stative	. . 0	. . 0
a12589964.s13	In IN 0	7 CD 0	of IN 0	the DT 0	18 CD B-adj.all	rats NNS B-noun.time	, , 0	degeneration NN B-noun.communication	and CC 0	myocyte NN B-noun.person	vacuolisation NN B-noun.person	were VBD 0	found VBN B-verb.possession	. . 0	. . 0
a16330293.s9	Patients NNS B-noun.person	' POS 0	mean JJ B-adj.all	age NN B-noun.person	was VBD B-verb.stative	53.9 CD 0	years NNS B-noun.quantity	, , 0	their PRP$ 0	mean JJ B-adj.all	weight NN B-noun.artifact	was VBD B-verb.stative	193.9 CD 0	pounds NNS B-noun.quantity	, , 0	and CC 0	they PRP 0	smoked VBD B-verb.consumption	a DT 0	mean NN B-noun.attribute	of IN 0	25.2 CD 0	cigarettes NNS B-noun.artifact	per IN 0	day NN B-noun.animal	at IN 0	baseline NN B-noun.location	. . 0	. . 0
a12063090.s6	Antinociceptive JJ B-adj.all	effect NN B-noun.cognition	of IN 0	morphine NN B-noun.person	was VBD 0	reduced VBN B-verb.change	in IN 0	chronically RB B-adv.all	treated VBN B-verb.change	rats NNS B-noun.animal	( ( 0	39+/-10 FW 0	vs. FW 0	18+/-5 NNP B-noun.other	au LS 0	) ) 0	while IN 0	the DT 0	combination NN B-noun.person	- : 0	induced VBN B-verb.creation	antinociception NN B-noun.attribute	was VBD 0	remained VBN B-verb.change	similar JJ B-adj.all	as IN 0	an DT 0	acute JJ B-adj.all	treatment NN B-noun.communication	( ( 0	298+/-7 FW 0	vs. FW 0	280+/-17 JJ 0	au NN 0	) ) 0	. . 0	. . 0
a9862868.s6	Alterations NNS B-noun.person	in IN 0	hepatocyte NN 0	TJs NNP B-noun.person	were VBD 0	assessed VBN B-verb.communication	by IN 0	double JJ B-adj.all	- : 0	immunolabeling VBG B-verb.cognition	for IN 0	7H6 NNP B-noun.person	and CC 0	ZO-1 NN B-noun.person	using VBG B-verb.consumption	a DT 0	confocal JJ B-adj.all	laser NN B-noun.act	scanning VBG B-verb.perception	microscope NN I-verb.perception	. . 0	. . 0
a3076126.s5	Modest JJ B-adj.all	increases NNS B-noun.event	in IN 0	HDL NNP 0	- : 0	cholesterol NN B-noun.act	levels NNS B-noun.attribute	of IN 0	about IN 0	10 CD B-adj.all	% NN 0	are VBP B-verb.stative	also RB B-adv.all	reported VBD B-verb.communication	. . 0	. . 0
a9351491.s0	Extrapyramidal JJ B-adj.all	side NN 0	effects NNS B-noun.phenomenon	with IN 0	risperidone NN 0	and CC 0	haloperidol NN B-noun.person	at IN 0	comparable JJ B-adj.all	D2 NN B-noun.artifact	receptor NN I-noun.artifact	occupancy NN B-noun.event	levels NNS B-noun.attribute	. . 0	. . 0
a17919553.s13	CONCLUSION NN B-noun.group	, , 0	Here RB 0	we PRP 0	report VBP B-verb.communication	a DT 0	case NN B-noun.state	of IN 0	acute JJ B-adj.all	hepatitis NN B-noun.person	probably RB B-adv.all	associated VBN B-verb.cognition	with IN 0	the DT 0	administration NN B-noun.time	of IN 0	telithromycin NN B-noun.food	. . 0	. . 0
a17600377.s5	Cells NNS B-noun.body	were VBD 0	pretreated VBN B-verb.creation	with IN 0	maltolyl_p JJ B-noun.person	- : 0	coumarate NN B-noun.person	, , 0	before RB 0	exposed VBN B-verb.perception	to TO 0	amyloid_beta_peptide(1 VB B-verb.social	- : 0	42 CD 0	) ) 0	, , 0	glutamate NN B-noun.person	or CC 0	H2O2 NN B-noun.artifact	. . 0	. . 0
a15572383.s1	BACKGROUND NN 0	, , 0	In IN 0	man NN 0	, , 0	differences NNS B-noun.person	in IN 0	angiotensin NN 0	- : 0	converting VBG B-verb.communication	enzyme NN B-noun.person	( ( 0	ACE NNP 0	) ) 0	levels NNS B-noun.state	, , 0	related VBN B-verb.communication	to TO 0	ACE NNP B-noun.person	( ( 0	I PRP 0	/ VBP 0	D NNP 0	) ) 0	genotype NN B-noun.quantity	, , 0	are VBP 0	associated VBN B-verb.cognition	with IN 0	renal JJ B-adj.all	prognosis NN B-noun.person	. . 0	. . 0
a11135224.s9	7 SYM 0	- : 0	85.4 CD 0	% NN 0	) ) 0	. . 0	. . 0
a4027862.s4	Further JJ B-adj.all	studies NNS B-noun.group	of IN 0	specifically RB B-adv.all	elderly JJ B-adj.all	patients NNS B-noun.person	are VBP 0	now RB 0	required VBN B-verb.stative	to TO 0	establish VB B-verb.cognition	safer JJR B-adj.all	and CC 0	more RBR B-adv.all	appropriate JJ B-adj.all	guidelines NNS B-noun.communication	for IN 0	drug NN B-noun.person	therapy NN 0	. . 0	. . 0
a11135224.s7	An DT 0	objective JJ B-adj.all	response NN B-noun.communication	was VBD 0	observed VBN B-verb.perception	in IN 0	73.5 CD 0	% NN 0	of IN 0	the DT 0	patients NNS B-noun.person	( ( 0	95 CD 0	% NN 0	confidence NN B-noun.act	interval NN I-noun.act	[ '' 0	CI NNP 0	] # 0	, , 0	55.6 CD 0	- : 0	87.1 CD 0	% NN 0	) ) 0	, , 0	including VBG B-verb.stative	4 CD B-adj.all	complete JJ B-adj.all	responses NNS B-noun.communication	( ( 0	11.7 CD 0	% NN 0	) ) 0	. . 0	. . 0
a10406016.s7	Fucoidan SYM 0	- : 0	treated VBN B-verb.communication	rats NNS B-noun.person	exhibited VBD B-verb.communication	evidence NN B-noun.communication	of IN 0	impaired_blood_clotting VBG B-verb.possession	and CC 0	hemodilution NN B-noun.person	, , 0	had VBD B-verb.change	larger JJR B-adj.all	hematomas NNS B-noun.location	, , 0	and CC 0	tended VBD B-verb.social	to TO 0	have VB B-verb.change	less JJR B-adj.all	inflammation NN B-noun.cognition	in IN 0	the DT 0	vicinity NN B-noun.attribute	of IN 0	the DT 0	hematoma NN B-noun.location	after IN 0	three CD B-adj.all	days NNS B-noun.time	. . 0	. . 0
a20667451.s4	Therefore RB 0	, , 0	the DT 0	present JJ B-adj.all	study NN B-noun.artifact	was VBD 0	carried VBN B-verb.change	out IN 0	to TO 0	investigate VB B-verb.communication	the DT 0	effect NN B-noun.cognition	of IN 0	chronic JJ B-adj.all	curcumin NN B-noun.person	administration NN B-noun.person	on IN 0	phenobarbitone- NN B-noun.artifact	and CC 0	carbamazepine NN B-noun.person	- : 0	induced VBN B-verb.creation	cognitive_impairment NN B-noun.artifact	and CC 0	oxidative JJ B-adj.all	stress NN B-noun.state	in IN 0	rats NNS B-noun.animal	. . 0	. . 0
a12684739.s4	METHODS NNS B-noun.attribute	, , 0	Using VBG B-verb.consumption	in IN 0	vivo JJ B-adj.all	microdialysis NN B-noun.food	, , 0	we PRP 0	compared VBD B-verb.cognition	acute JJ B-adj.all	exposure NN B-noun.cognition	( ( 0	450 CD 0	mg NNS B-noun.quantity	/ : 0	kg LS 0	) ) 0	to TO 0	an DT 0	identical JJ B-adj.all	sub NN B-noun.person	- : 0	chronic JJ B-adj.all	exposure NN B-noun.cognition	( ( 0	150 CD 0	mg FW 0	/ FW 0	kg FW 0	per FW 0	day NN 0	for IN 0	3 CD B-adj.all	days NNS B-noun.artifact	) ) 0	, , 0	followed VBN B-verb.stative	by IN 0	1- CD 0	or CC 0	3-day JJ B-adj.all	washout NN B-noun.act	. . 0	. . 0
a18619688.s3	METHODS NNS B-noun.attribute	, , 0	3-methyladenine JJ 0	( ( 0	3MA NNP 0	) ) 0	, , 0	a DT 0	specific JJ B-adj.all	inhibitor NN B-noun.person	on IN 0	autophagy NN B-noun.person	was VBD 0	used VBN B-verb.consumption	in IN 0	a DT 0	heart_failure JJ B-adj.all	model NN B-noun.person	of IN 0	rats NNS B-noun.phenomenon	induced VBN B-verb.creation	by IN 0	adriamycin NN B-noun.person	. . 0	. . 0
a9766615.s5	The DT 0	newer JJR B-adj.all	atypical JJ B-adj.all	agents NNS B-noun.person	have VBP B-verb.stative	a DT 0	lower JJR B-adj.all	risk NN B-noun.person	of IN 0	EPS NNP B-noun.group	, , 0	but CC 0	are VBP 0	associated VBN B-verb.cognition	in IN 0	varying VBG B-verb.change	degrees NNS B-noun.communication	with IN 0	sedation NN B-noun.feeling	, , 0	cardiovascular JJ B-adj.all	effects NNS B-noun.phenomenon	, , 0	anticholinergic JJ B-adj.pert	effects NNS B-noun.phenomenon	, , 0	weight_gain NNP B-noun.person	, , 0	sexual_dysfunction NN 0	, , 0	hepatic JJ B-adj.all	effects NNS B-noun.phenomenon	, , 0	lowered VBN B-verb.change	seizure NN B-noun.artifact	threshold NN B-noun.artifact	( ( 0	primarily RB B-adv.all	clozapine NN 0	) ) 0	, , 0	and CC 0	agranulocytosis NN B-noun.cognition	( ( 0	clozapine NN B-adv.all	only RB I-adv.all	) ) 0	. . 0	. . 0
a17600377.s1	To TO 0	develop VB B-verb.change	a DT 0	novel NN B-noun.communication	and CC 0	effective JJ B-adj.all	drug NN B-noun.attribute	that WDT 0	could MD 0	enhance VB B-verb.change	cognitive JJ B-adj.all	function NN B-noun.act	and CC 0	neuroprotection NN B-noun.act	, , 0	we PRP 0	newly RB B-adv.all	synthesized VBN B-verb.consumption	maltolyl_p JJ I-verb.consumption	- : 0	coumarate NN B-noun.person	by IN 0	the DT 0	esterification NN B-noun.act	of IN 0	maltol NN B-noun.person	and CC 0	p SYM 0	- : 0	coumaric_acid NN B-noun.group	. . 0	. . 0
a19211690.s0	Testosterone NN B-noun.person	- : 0	dependent JJ B-adj.all	hypertension NN B-noun.person	and CC 0	upregulation NN B-noun.act	of IN 0	intrarenal JJ B-adj.all	angiotensinogen NN B-noun.person	in IN 0	Dahl NNP B-noun.person	salt VBD B-verb.communication	- : 0	sensitive JJ B-adj.all	rats NNS B-noun.animal	. . 0	. . 0
a3371379.s2	Use NNP B-noun.person	of IN 0	verapamil NN B-noun.food	in IN 0	combination NN 0	with IN 0	carbamazepine NN B-noun.group	should MD 0	either RB 0	be VB 0	avoided VBN B-verb.social	or CC 0	prescribed VBN B-verb.communication	only RB B-adv.all	with IN 0	appropriate JJ B-adj.all	adjustment NN B-noun.act	of IN 0	the DT 0	carbamazepine NN 0	dose NN 0	( ( 0	usually RB B-adv.all	reduction NN B-noun.process	of IN 0	the DT 0	carbamazepine NN 0	dose NN 0	by IN 0	one CD 0	half NN B-noun.quantity	) ) 0	. . 0	. . 0
a2950248.s3	Epicardial NNP B-noun.person	coronary JJ B-adj.all	collateral NN B-noun.body	vessels NNS B-noun.body	were VBD 0	demonstrated VBN B-verb.perception	in IN 0	all DT 0	four CD B-adj.all	patients NNS B-noun.artifact	, , 0	a DT 0	coronary JJ B-adj.all	" CD 0	steal NN B-noun.quantity	" : 0	phenomenon NN B-noun.animal	may MD 0	be VB B-verb.stative	the DT 0	mechanism NN B-noun.attribute	of IN 0	the DT 0	dipyridamole NN B-noun.person	- : 0	induced VBN B-verb.creation	ischemia NN B-noun.person	observed VBD B-verb.perception	. . 0	. . 0
a9088814.s4	Controlled VBN B-verb.social	hypotension NN B-noun.act	in IN 0	groups NNS B-noun.group	A DT 0	and CC 0	C NNP 0	was VBD 0	induced VBN B-verb.creation	with IN 0	PGE1 NN 0	to TO 0	maintain VB B-verb.possession	mean JJ B-adj.all	arterial JJ B-adj.pert	blood NN B-noun.group	pressure NN B-noun.person	at IN 0	55 CD 0	mmHg NNP 0	for IN 0	180 CD 0	min NN 0	. . 0	. . 0
a6518066.s2	In IN 0	one CD 0	infant NN B-noun.cognition	, , 0	Ebstein's_anomaly RB 0	of IN 0	the DT 0	tricuspid JJ B-adj.all	valve NN B-noun.artifact	was VBD 0	identified VBN B-verb.cognition	. . 0	. . 0
a11706060.s9	Findings NNS B-noun.act	were VBD 0	confirmed VBN B-verb.change	ultrastructurally RB B-adv.all	. . 0	. . 0
a20098969.s2	BACKGROUND NN 0	, , 0	Methamphetamine NNP B-noun.person	is VBZ B-verb.stative	a DT 0	very RB B-adv.all	addictive JJ B-adj.all	, , 0	powerful JJ B-adj.all	stimulant NN B-noun.plant	that WDT 0	increases VBZ B-verb.stative	wakefulness NN B-noun.attribute	and CC 0	physical JJ B-adj.all	activity NN B-noun.state	and CC 0	can MD 0	produce VB B-verb.cognition	other JJ 0	effects NNS B-noun.phenomenon	such JJ 0	as IN 0	cardiac_dysrhythmias NNS 0	, , 0	hypertension NN 0	, , 0	hallucinations NNS B-noun.person	, , 0	and CC 0	violent_behavior JJ B-noun.other	. . 0	. . 0
a18752389.s5	A DT 0	routine JJ B-adj.all	laboratory NN B-noun.artifact	work NN B-noun.artifact	- : 0	up RB B-adv.all	10 CD B-adj.all	weeks NNS B-noun.time	after IN 0	conversion NN B-noun.person	revealed VBD B-verb.perception	elevated JJ B-adj.all	serum NN B-noun.artifact	aminotransferase NN I-noun.artifact	levels NNS B-noun.state	. . 0	. . 0
a3409645.s6	Marital JJ B-adj.all	unhappiness NN B-noun.feeling	, , 0	as IN 0	indicated VBN B-verb.communication	by IN 0	AMHS NNP B-noun.group	scores NNS B-noun.cognition	, , 0	was VBD B-verb.stative	not RB B-adv.all	associated VBN B-verb.cognition	with IN 0	arthritis NN B-noun.artifact	but CC 0	was VBD 0	associated VBN B-verb.cognition	with IN 0	sexual_dysfunction NN B-noun.feeling	, , 0	sexual JJ 0	dissatisfaction NN B-noun.act	and CC 0	being VBG B-verb.stative	female JJ B-adj.all	. . 0	. . 0
a11928786.s11	The DT 0	potential JJ B-adj.all	toxic JJ B-adj.all	effects NNS B-noun.phenomenon	should MD 0	be VB 0	considered VBN B-verb.cognition	when WRB 0	prescribing VBG B-verb.communication	it PRP 0	as IN 0	a DT 0	smoking NN B-noun.artifact	cessation NN I-noun.artifact	aid NN B-noun.possession	. . 0	. . 0
a11773892.s11	Multivariate JJ B-adj.all	stepwise NN B-noun.communication	logistic JJ B-adj.all	regression NN B-noun.act	analysis NN 0	using VBG B-verb.consumption	preoperative JJ B-adj.all	and CC 0	postoperative JJ B-adj.all	variables NNS B-noun.cognition	identified VBN B-verb.cognition	that IN 0	an DT 0	increase NN B-noun.event	of IN 0	serum NN 0	creatinine NN 0	compared VBN B-verb.possession	with IN 0	average NN B-noun.food	at IN 0	1 CD B-adj.all	year NN B-noun.time	, , 0	3 CD B-adj.all	months NNS B-noun.person	, , 0	and CC 0	4 CD B-adj.all	weeks NNS B-noun.time	postoperatively RB I-noun.time	were VBD B-verb.stative	independent JJ B-adj.all	risk NN B-noun.person	factors NNS B-noun.person	for IN 0	the DT 0	development NN B-noun.process	of IN 0	CRF NNP B-noun.group	or CC 0	ESRD NNP B-noun.other	with IN 0	odds JJ B-adj.all	ratios NNS B-noun.time	of IN 0	2.6 CD 0	, , 0	2.2 CD 0	, , 0	and CC 0	1.6 CD 0	, , 0	respectively RB B-adv.all	. . 0	. . 0
a18020536.s15	Use NNP B-noun.person	of IN 0	BZDs NNP B-noun.group	/ NNP I-noun.group	RDs NNP I-noun.group	tended VBD B-verb.social	to TO 0	be VB 0	associated VBN B-verb.cognition	with IN 0	a DT 0	reduced VBN B-verb.change	ability NN 0	to TO 0	walk VB B-verb.emotion	and CC 0	shorter JJR B-adj.all	night NN B-noun.person	- : 0	time NN B-noun.time	sleep NN 0	during IN 0	the DT 0	week NN B-noun.time	prior RB 0	to TO 0	admission NN B-noun.person	. . 0	. . 0
a12639165.s6	Hepatitis NNP B-noun.person	may MD 0	develop VB B-verb.stative	weeks NNS B-noun.time	after IN 0	discontinuation NN B-noun.act	of IN 0	the DT 0	drug NN B-noun.artifact	and CC 0	may MD 0	run VB B-verb.stative	a DT 0	prolonged JJ B-adj.all	course NN B-noun.location	, , 0	but CC 0	complete JJ B-adj.all	remission NN B-noun.person	was VBD 0	observed VBN B-verb.perception	in IN 0	all DT 0	reported VBD B-verb.communication	cases NNS B-noun.person	. . 0	. . 0
a1833784.s3	In IN 0	addition NN 0	, , 0	the DT 0	role NN B-noun.attribute	of IN 0	dopamine NN B-noun.person	receptors NNS B-noun.person	in IN 0	mediating VBG B-verb.communication	nicotine NN B-noun.person	- : 0	induced VBN B-verb.creation	locomotor NN 0	stimulation NN B-noun.artifact	was VBD 0	investigated VBN B-verb.creation	by IN 0	examining VBG B-verb.communication	the DT 0	effects NNS B-noun.phenomenon	of IN 0	selective JJ B-adj.all	D1 NN 0	and CC 0	D2 : 0	dopamine NN B-noun.person	receptor NN B-noun.person	antagonists NNS B-noun.person	on IN 0	activity NN B-noun.process	induced VBN B-verb.creation	by IN 0	nicotine NN B-noun.person	. . 0	. . 0
a3437726.s13	Moreover RB B-adv.all	, , 0	the DT 0	coadministration NN B-noun.person	of IN 0	these DT 0	frequently RB B-adv.all	used VBN B-verb.consumption	drugs NNS B-noun.artifact	is VBZ 0	expected VBN B-verb.cognition	to TO 0	be VB B-verb.stative	especially RB B-adv.all	harmful JJ B-adj.all	in IN 0	this DT 0	subgroup NN B-noun.group	of IN 0	patients NNS B-noun.person	. . 0	. . 0
a15899738.s10	Exogenous JJ B-adj.all	creatine NN B-noun.person	is VBZ 0	used VBN B-verb.consumption	by IN 0	athletes NNS B-noun.person	to TO 0	theoretically RB B-adv.all	improve VB B-verb.social	exercise NN B-noun.act	performance NN B-noun.act	. . 0	. . 0
a2375138.s0	Possible JJ B-adj.all	intramuscular JJ B-adj.all	midazolam NN B-noun.person	- : 0	associated VBN B-verb.cognition	cardiorespiratory_arrest NNP B-noun.person	and CC 0	death NN B-noun.person	. . 0	. . 0
a10193204.s0	Effects NNS B-noun.phenomenon	of IN 0	tetrandrine NN B-noun.attribute	and CC 0	fangchinoline NN B-noun.person	on IN 0	experimental JJ B-adj.all	thrombosis NN B-noun.cognition	in IN 0	mice NNS B-noun.animal	and CC 0	human JJ B-adj.all	platelet_aggregation NN B-noun.person	. . 0	. . 0
a10706004.s1	In IN 0	the DT 0	cardiovascular JJ B-adj.all	system NN B-noun.body	, , 0	NO NNP 0	is VBZ 0	involved VBN B-verb.stative	in IN 0	the DT 0	regulation NN B-noun.act	of IN 0	a DT 0	variety NN B-noun.cognition	of IN 0	functions NNS B-noun.act	. . 0	. . 0
a19957053.s1	BACKGROUND NN 0	, , 0	Vasopressor NNP B-noun.person	agents NNS I-noun.person	are VBP 0	used VBN B-verb.consumption	to TO 0	correct VB B-verb.stative	anesthesia NNS I-verb.stative	- : 0	induced VBN B-verb.creation	hypotension NN 0	. . 0	. . 0
a2224762.s11	Adriamycinol NNP B-noun.person	, , 0	doxorubicin NN B-noun.person	, , 0	adriamycinone NN B-noun.person	, , 0	and CC 0	tetrahydropyranyladriamycinol NN B-noun.person	were VBD B-verb.stative	the DT 0	metabolites NNS B-noun.object	detected VBN B-verb.perception	in IN 0	plasma NN B-noun.substance	and CC 0	the DT 0	amount NN B-noun.possession	of IN 0	doxorubicin NN B-noun.person	was VBD B-verb.stative	less JJR B-noun.quantity	than IN 0	or CC 0	equal JJ B-adj.all	to TO 0	10 CD B-adj.all	% NN 0	of IN 0	the DT 0	total JJ B-adj.all	metabolites NNS B-noun.location	. . 0	. . 0
a9100294.s4	Pregnant JJ B-noun.person	rats NNS I-noun.person	were VBD 0	administered VBN B-verb.possession	one CD 0	of IN 0	these DT 0	calcium NN 0	channel NN 0	blockers NNS 0	during IN 0	the DT 0	period NN B-noun.time	of IN 0	cardiac JJ B-adj.all	morphogenesis NN B-noun.motive	and CC 0	the DT 0	offspring NN B-noun.person	examined VBD B-verb.communication	on IN 0	day NN 0	20 CD 0	of IN 0	gestation NN B-noun.act	for IN 0	cardiovascular_malformations NNS B-noun.group	. . 0	. . 0
a20098969.s3	Dental JJ B-adj.all	patients NNS B-noun.person	abusing VBG B-verb.social	methamphetamine NN B-noun.person	can MD 0	present VB B-verb.creation	with IN 0	poor JJ B-adj.all	oral JJ B-adj.all	hygiene NN B-noun.person	, , 0	xerostomia NN B-noun.person	, , 0	rampant JJ B-adj.all	caries NNS B-noun.communication	( ( 0	" FW B-adv.all	meth_mouth FW I-adv.all	" LS 0	) ) 0	, , 0	and CC 0	excessive JJ B-adj.all	tooth_wear NN B-noun.act	. . 0	. . 0
a16867021.s21	THP NNP 0	exhibited VBD B-verb.stative	an DT 0	antipsychotic JJ B-adj.all	- : 0	like IN 0	profile NN B-noun.person	by IN 0	potentiating_haloperidol JJ B-noun.person	- : 0	induced_catalepsy JJ B-noun.time	, , 0	reducing_amphetamine JJ B-noun.group	- : 0	induced_hyperactivity NN B-noun.time	and CC 0	reducing_apomorphine VB B-verb.social	- : 0	induced VBN B-verb.creation	climbing VBG B-verb.motion	in IN 0	mice NNS B-noun.animal	. . 0	. . 0
a18619688.s6	We PRP 0	also RB B-adv.all	assessed VBN B-verb.competition	cell NN B-noun.artifact	viability NN I-noun.artifact	, , 0	mitochondrial JJ B-adj.all	membrane NN B-noun.state	potential JJ B-noun.phenomenon	changes NNS I-noun.phenomenon	and CC 0	counted VBN B-verb.stative	autophagic JJ B-adj.all	vacuoles NNS B-noun.artifact	in IN 0	cultured VBN B-verb.communication	cardiomyocytes NNS B-noun.person	. . 0	. . 0
a3437726.s5	had VBD 0	been VBN 0	initiated VBN B-verb.creation	. . 0	. . 0
a20667451.s11	Curcumin NNP B-noun.person	co SYM 0	- : 0	administration NN B-noun.person	did VBD 0	not RB B-adv.all	cause VB B-verb.creation	any DT 0	significant JJ B-adj.all	alteration NN B-noun.cognition	in IN 0	the DT 0	serum NN B-noun.body	concentrations NNS B-noun.attribute	of IN 0	both DT 0	phenobarbitone NN 0	as RB 0	well RB 0	as IN 0	carbamazepine NN 0	. . 0	. . 0
a6538499.s1	The DT 0	effect NN B-noun.cognition	of IN 0	a DT 0	widely RB B-adv.all	used VBN B-verb.consumption	organic JJ B-adj.all	solvent NN B-noun.person	, , 0	polyethylene_glycol_400 NN 0	( ( 0	PEG_400 NN 0	) ) 0	, , 0	on IN 0	the DT 0	toxic JJ B-adj.all	action NN B-noun.state	of IN 0	an DT 0	acute NN B-noun.communication	or CC 0	chronic JJ B-adj.all	treatment NN B-noun.plant	with IN 0	adriamycin NN B-noun.person	( ( 0	ADR NNP 0	) ) 0	was VBD 0	evaluated VBN B-verb.change	in IN 0	mice NNS B-noun.animal	. . 0	. . 0
a12589964.s3	METHODS NNS B-noun.attribute	, , 0	Thirty NNP B-noun.person	- : 0	five CD 0	Wistar NNP B-noun.person	rats NNS I-noun.person	were VBD 0	given VBN B-verb.possession	1.5 CD 0	mg PRP B-noun.quantity	/ ( 0	kg IN 0	DOX NNP B-noun.group	, , 0	i.v NNP B-noun.person	. . 0	, , 0	. . 0
a10901305.s2	The DT 0	purpose NN B-noun.attribute	of IN 0	the DT 0	present JJ B-adj.all	study NN B-noun.artifact	was VBD 0	to TO 0	examine VB B-verb.communication	the DT 0	safety NN B-noun.artifact	and CC 0	efficacy NN B-noun.person	of IN 0	ketamine NN B-noun.person	for IN 0	sedation NN B-noun.act	in IN 0	the DT 0	treatment NN B-noun.communication	of IN 0	children NNS B-noun.person	's POS 0	fractures NNS B-noun.body	in IN 0	the DT 0	emergency NN B-noun.person	department NN B-noun.person	. . 0	. . 0
a20003049.s6	CONCLUSIONS NNS B-noun.artifact	, , 0	Correlation NNP B-noun.person	of IN 0	plasma NN B-noun.substance	argatroban JJ B-adj.pert	concentration NN B-noun.cognition	versus IN 0	the DT 0	patient NN B-noun.person	's POS 0	coagulation NN B-noun.artifact	variables NNS B-noun.artifact	and CC 0	clinical JJ B-adj.all	course NN B-noun.communication	suggest VBP B-verb.communication	that IN 0	prolonged VBD B-verb.creation	elevated JJ B-adj.all	levels NNS B-noun.attribute	of IN 0	plasma NN B-noun.substance	argatroban NN I-noun.substance	may MD 0	have VB 0	contributed VBN B-verb.communication	to TO 0	the DT 0	patient NN B-noun.person	's POS 0	extended JJ B-adj.all	coagulopathy NN B-noun.person	. . 0	. . 0
a2802551.s0	Sodium NN B-noun.person	status NN B-noun.state	influences VBZ B-verb.stative	chronic JJ B-adj.all	amphotericin NN B-noun.group	B NNP 0	nephrotoxicity NN B-noun.state	in IN 0	rats NNS B-noun.animal	. . 0	. . 0
a12063090.s10	The DT 0	combination NN B-noun.person	inhibited VBD B-verb.change	intestinal JJ B-adj.all	transit NN B-noun.event	similar JJ B-adj.all	to TO 0	that DT 0	produced VBD B-verb.creation	by_morphine JJ 0	regardless RB 0	of IN 0	the DT 0	time NN B-noun.time	of IN 0	treatment NN B-noun.communication	, , 0	suggesting VBG B-verb.communication	that_metamizol NN B-noun.person	did VBD 0	not RB B-adv.all	potentiate_morphine JJ B-noun.person	- : 0	induced_constipation NN B-noun.time	. . 0	. . 0
a3615541.s0	Regional JJ B-adj.all	localization NN B-noun.act	of IN 0	the DT 0	antagonism NN B-noun.attribute	of IN 0	amphetamine JJ B-noun.person	- : 0	induced VBN B-verb.creation	hyperactivity NN 0	by IN 0	intracerebral JJ B-adj.all	calcitonin NN B-noun.act	injections NNS I-noun.act	. . 0	. . 0
a11773892.s9	RESULTS NNS B-noun.artifact	, , 0	At IN 0	13 CD B-adj.all	years NNS B-noun.time	after IN 0	OLTX NNP B-noun.group	, , 0	the DT 0	incidence NN B-noun.event	of IN 0	severe JJ B-adj.all	renal_dysfunction NN B-noun.act	was VBD B-verb.stative	18.1 CD 0	% NN 0	( ( 0	CRF NNP 0	8.6 CD 0	% NN 0	and CC 0	ESRD NNP B-noun.group	9.5 CD 0	% NN 0	) ) 0	. . 0	. . 0
a18464113.s11	Twelve CD 0	( ( 0	24 CD B-adj.all	% NN 0	) ) 0	of IN 0	them PRP 0	were VBD 0	evaluated VBN B-verb.change	as RB 0	severe JJ 0	hepatitis NN 0	. . 0	. . 0
a6286738.s4	Signs NNS B-noun.communication	of IN 0	vitamin_D3 JJ B-adj.all	toxicity NN B-noun.attribute	were VBD B-verb.stative	not RB B-adv.all	observed VBN B-verb.perception	in IN 0	nonlactating VBG B-verb.communication	nonpregnant JJ B-adj.all	cows NNS B-noun.person	, , 0	however RB 0	, , 0	pregnant JJ B-adj.all	cows NNS B-noun.person	commonly RB B-adv.all	developed VBN B-verb.creation	severe JJ B-adj.all	signs NNS B-noun.communication	of IN 0	vitamin_D3 JJ B-adj.all	toxicity NN B-noun.attribute	and CC 0	10 CD B-adj.all	of IN 0	17 CD B-adj.all	cows NNS B-noun.person	died VBD B-verb.change	. . 0	. . 0
a21029050.s11	CONCLUSION NN B-noun.group	, , 0	eleven CD 0	of IN 0	13 CD B-adj.all	patients NNS B-noun.person	with IN 0	a DT 0	prolonged JJ B-adj.all	duration NN 0	of IN 0	action NN B-noun.process	of IN 0	succinylcholine NN B-noun.person	had VBD 0	mutations NNS B-noun.person	in IN 0	BCHE NNP 0	, , 0	indicating VBG B-verb.communication	that IN 0	this DT 0	is VBZ B-verb.stative	the DT 0	possible JJ B-adj.all	reason NN B-noun.person	for IN 0	a DT 0	prolonged JJ B-adj.all	period NN B-noun.person	of IN 0	apnea NN B-noun.person	. . 0	. . 0
a8558192.s8	One CD 0	of IN 0	16 CD B-adj.all	patients NNS B-noun.person	( ( 0	6 CD B-adj.all	% NN 0	) ) 0	with IN 0	prior JJ B-adj.all	chemotherapy NN B-noun.communication	had VBD B-verb.stative	a DT 0	complete JJ B-adj.all	response NN B-noun.communication	( ( 0	CR NNP 0	) ) 0	of IN 0	31 CD 0	weeks NNS B-noun.time	' POS 0	duration NN 0	( ( 0	95 CD 0	% NN 0	CI NNP 0	, , 0	0 CD B-noun.quantity	% NN 0	to TO 0	30 CD B-adj.all	% NN 0	) ) 0	. . 0	. . 0
a7582165.s6	A DT 0	single JJ B-adj.all	- : 0	blind JJ B-adj.all	parenteral JJ B-adj.all	challenge NN B-noun.feeling	with IN 0	Triniol NNP B-noun.person	was VBD B-verb.stative	positive JJ B-adj.all	in IN 0	both DT 0	patients NNS B-noun.person	after IN 0	the DT 0	administration NN B-noun.time	of IN 0	1 CD B-adj.all	ml NN B-noun.quantity	of IN 0	the DT 0	drug NN B-noun.artifact	, , 0	and CC 0	negative JJ B-adj.all	with IN 0	its PRP$ 0	excipients NNS B-noun.act	. . 0	. . 0
a2802551.s1	The DT 0	nephrotoxic JJ B-adj.all	potential NN B-noun.state	of IN 0	amphotericin NN 0	B NNP 0	( ( 0	5 CD 0	mg FW 0	/ FW 0	kg FW 0	per FW 0	day NN 0	intraperitoneally RB 0	for IN 0	3 CD B-adj.all	weeks NNS B-noun.time	) ) 0	has VBZ 0	been VBN 0	investigated VBN B-verb.communication	in IN 0	salt NN B-noun.act	- : 0	depleted VBN B-verb.communication	, , 0	normal JJ B-adj.all	- : 0	salt NN B-noun.food	, , 0	and CC 0	salt NN B-noun.act	- : 0	loaded VBN B-verb.contact	rats NNS B-noun.animal	. . 0	. . 0
a10526274.s3	In IN 0	the DT 0	current JJ B-adj.all	study NN B-noun.artifact	the DT 0	efficacy NN B-noun.person	and CC 0	toxicity NN B-noun.attribute	of IN 0	the DT 0	combination NN B-noun.event	of IN 0	GEM NNP B-noun.group	and CC 0	VNB NNP B-noun.group	in IN 0	elderly JJ B-adj.all	patients NNS B-noun.person	with IN 0	advanced JJ B-adj.all	NSCLC NNP B-noun.group	or CC 0	those DT 0	with IN 0	some DT 0	contraindication NN 0	to TO 0	receiving VBG B-verb.perception	cisplatin NN B-noun.food	were VBD 0	assessed VBN B-verb.communication	. . 0	. . 0
a12757899.s6	17beta JJ 0	- : 0	Estradiol NN B-noun.person	did VBD 0	not RB B-adv.all	alter VB B-verb.change	the DT 0	onset NN B-noun.event	of IN 0	first JJ B-adj.all	clonus NN B-noun.cognition	in IN 0	ovariectomized VBN B-verb.communication	rats NNS B-noun.person	but CC 0	accelerated VBD B-verb.change	it PRP 0	in IN 0	males NNS B-noun.animal	. . 0	. . 0
a19889778.s9	These DT 0	findings NNS B-noun.act	reveal VBP B-verb.change	the DT 0	differential JJ B-adj.all	impact NN B-noun.state	of IN 0	immune JJ B-adj.all	escape NN B-noun.act	variants NNS B-noun.artifact	on IN 0	the DT 0	replication NN B-noun.act	and CC 0	drug NN B-noun.person	susceptibility NN 0	of IN 0	complex JJ B-adj.all	HBV NNP B-noun.person	mutants NNS I-noun.person	, , 0	supporting VBG B-verb.contact	the DT 0	need NN B-noun.object	of IN 0	close JJ B-adj.all	surveillance NN B-noun.person	and CC 0	treatment NN B-noun.communication	adjustment NN B-noun.communication	in IN 0	response NN B-noun.communication	to TO 0	the DT 0	selection NN B-noun.act	of IN 0	distinct JJ B-adj.all	mutational JJ B-adj.all	patterns NNS B-noun.artifact	. . 0	. . 0
a19211690.s7	Ovariectomy NN B-noun.person	of IN 0	female JJ B-noun.person	DS NNP I-noun.person	had VBD 0	no DT 0	effect NN B-noun.cognition	on IN 0	intrarenal JJ B-adj.all	angiotensinogen NN 0	expression NN B-noun.communication	on IN 0	either DT 0	diet NN B-noun.location	. . 0	. . 0
a20067456.s8	Total JJ B-adj.all	ASEX NNP B-noun.act	scores NNS B-noun.cognition	were VBD B-verb.stative	significantly RB B-adv.all	lower JJR B-adj.all	, , 0	i.e. FW B-adv.all	better RBR I-adv.all	, , 0	among IN 0	men NNS B-noun.person	who WP 0	received VBD B-verb.possession	bupropion NN B-noun.communication	than IN 0	placebo NN 0	, , 0	at IN 0	15.5 CD 0	( ( 0	4.3 CD 0	) ) 0	vs $ 0	21.5 CD 0	( ( 0	4.7 CD 0	) ) 0	( ( 0	P= $ 0	0.002 CD 0	) ) 0	. . 0	. . 0
a6640832.s9	Of IN 0	the DT 0	82 CD 0	evaluable JJ B-adj.all	patients NNS B-noun.person	, , 0	50 CD B-adj.all	did VBD 0	not RB B-adv.all	show VB B-verb.change	any DT 0	recurrence NN B-noun.act	after IN 0	1 CD B-adj.all	year NN B-noun.time	( ( 0	61 CD 0	% NN 0	) ) 0	, , 0	while IN 0	32 CD 0	presented VBN B-verb.possession	with IN 0	one CD 0	or CC 0	more JJR B-noun.quantity	recurrences NNS B-noun.act	( ( 0	39 CD 0	% NN 0	) ) 0	. . 0	. . 0
a17532790.s2	To TO 0	this DT 0	day NN B-noun.person	, , 0	transcriptome VB B-verb.motion	analysis NN 0	has VBZ 0	been VBN 0	performed VBN B-verb.social	in IN 0	a DT 0	rat NN B-noun.artifact	model NN B-noun.person	of IN 0	LID NNP B-noun.group	[ POS 0	Neurobiol NNP B-noun.person	. . 0	. . 0
a11752354.s5	The DT 0	adjusted JJ B-adj.all	odds NNS B-noun.person	ratio NN B-noun.person	was VBD B-verb.stative	2.5 CD 0	( ( 0	95 CD 0	percent NN B-noun.quantity	confidence NN B-noun.relation	interval NN I-noun.relation	, , 0	1.5 CD 0	to TO 0	4.1 CD 0	) ) 0	among IN 0	women NNS B-noun.person	who WP 0	used VBD B-verb.consumption	second JJ B-adj.all	- : 0	generation NN B-noun.time	oral_contraceptives NNS B-noun.event	and CC 0	1.3 CD 0	( ( 0	95 CD 0	percent NN B-noun.quantity	confidence NN B-noun.relation	interval NN I-noun.relation	, , 0	0.7 CD 0	to TO 0	2.5 CD 0	) ) 0	among IN 0	those DT 0	who WP 0	used VBD B-verb.consumption	third JJ I-verb.consumption	- : 0	generation NN B-noun.time	oral_contraceptives NNS B-noun.event	. . 0	. . 0
a6534871.s1	The DT 0	effects NNS B-noun.phenomenon	of IN 0	exercise NN B-noun.act	on IN 0	the DT 0	severity NN B-noun.attribute	of IN 0	isoproterenol NN B-noun.feeling	- : 0	induced VBN B-verb.creation	myocardial_infarction CD 0	were VBD 0	studied VBN B-verb.cognition	in IN 0	female JJ B-adj.all	albino NN B-noun.person	rats NNS I-noun.person	of IN 0	20,40,60 CD 0	and CC 0	80 CD B-adj.all	weeks NNS B-noun.time	of IN 0	age NN B-noun.time	. . 0	. . 0
a17600377.s0	A DT 0	novel JJ B-adj.all	compound NN B-noun.act	, , 0	maltolyl_p JJ B-noun.person	- : 0	coumarate NN B-noun.person	, , 0	attenuates VBZ B-verb.stative	cognitive_deficits NNS B-noun.person	and CC 0	shows NNS B-verb.weather	neuroprotective JJ B-adj.all	effects NNS B-noun.phenomenon	in IN 0	vitro NN B-noun.animal	and CC 0	in IN 0	vivo JJ B-adj.all	dementia NN B-noun.group	models NNS B-noun.person	. . 0	. . 0
a3101906.s11	Allergic JJ B-adj.all	manifestations NNS B-noun.state	such JJ 0	as IN 0	rash NN B-noun.person	and CC 0	eosinophilia NNS B-noun.person	were VBD B-verb.stative	rare JJ B-adj.all	. . 0	. . 0
a354896.s2	The DT 0	patient NN B-noun.person	had VBD B-verb.body	no DT 0	apparent JJ B-adj.all	associated JJ B-adj.all	conditions NNS B-noun.artifact	which WDT 0	might MD 0	have VB 0	predisposed VBN B-verb.communication	him PRP 0	to TO 0	the DT 0	development NN B-noun.process	of IN 0	bradyarrhythmias NNS B-noun.shape	, , 0	and CC 0	, , 0	thus RB 0	, , 0	this DT 0	probably RB B-adv.all	represented VBD B-verb.stative	a DT 0	true JJ B-adj.all	idiosyncrasy NN B-noun.person	to TO 0	lidocaine VB B-verb.social	. . 0	. . 0
a18631865.s0	mToR NN B-noun.artifact	inhibitors NNS B-noun.person	- : 0	induced VBN B-verb.creation	proteinuria NN B-noun.person	, , 0	mechanisms NNS B-noun.person	, , 0	significance NN B-noun.communication	, , 0	and CC 0	management NN B-noun.person	. . 0	. . 0
a7504976.s8	Only RB B-adv.all	2 CD B-adj.all	patients NNS B-noun.person	of IN 0	our PRP$ 0	retrospective JJ B-adj.all	study NN B-noun.artifact	experienced VBD B-verb.communication	a DT 0	mild JJ B-noun.person	or CC 0	severe JJ B-adj.all	neutropenia NN B-noun.person	. . 0	. . 0
a7977601.s2	METHODS NNS B-noun.attribute	, , 0	We PRP 0	sent VBD B-verb.motion	a DT 0	questionnaire NN B-noun.communication	concerning VBG B-verb.stative	complications NNS B-noun.person	of IN 0	indocyanine_green JJ 0	to TO 0	32 CD 0	institutions NNS B-noun.quantity	in IN 0	Japan NNP B-noun.location	, , 0	which WDT 0	were VBD 0	selected VBN B-verb.cognition	on IN 0	the DT 0	basis NN B-noun.cognition	of IN 0	the DT 0	client NN B-noun.communication	list NN B-noun.communication	from IN 0	the DT 0	Topcon NNP B-noun.person	Company NNP I-noun.person	, , 0	which WDT 0	manufactures VBZ B-verb.stative	the DT 0	indocyanine_green JJ B-adj.all	fundus NN B-noun.attribute	camera NN I-noun.attribute	. . 0	. . 0
a10683478.s1	These DT 0	studies NNS B-noun.act	were VBD 0	conducted VBN B-verb.communication	to TO 0	examine VB B-verb.communication	the DT 0	differential JJ B-adj.all	response NN B-noun.communication	to TO 0	a DT 0	drug NN B-noun.artifact	challenge NN B-noun.artifact	under IN 0	varied VBN B-verb.change	experimental JJ B-adj.all	test NN B-adj.all	conditions NNS B-noun.cognition	routinely RB B-adv.all	employed VBN B-verb.consumption	to TO 0	study VB B-verb.cognition	drug NN B-noun.person	- : 0	induced VBN B-verb.creation	behavioral JJ B-adj.all	and CC 0	neurophysiological JJ B-adj.all	responses NNS B-noun.act	in IN 0	rodents NNS B-noun.animal	. . 0	. . 0
a16867021.s3	Catalepsy NNP B-noun.person	was VBD 0	induced VBN B-verb.creation	by IN 0	haloperidol NN B-noun.person	( ( 0	2 CD 0	mg FW 0	/ FW 0	kg FW 0	p.o FW 0	. . 0	) ) 0	, , 0	. . 0
a14765563.s0	Risks NNS 0	of IN 0	the DT 0	consumption NN B-noun.act	of IN 0	beverages NNS B-noun.artifact	containing VBG B-verb.stative	quinine NN B-noun.location	. . 0	. . 0
a12707296.s6	Thirty CD 0	milliliters NNS B-noun.quantity	of IN 0	blood NN B-noun.location	was VBD 0	obtained VBN B-verb.social	for IN 0	isolation NN B-noun.act	of IN 0	peripheral JJ B-adj.pert	blood NN B-noun.body	mononuclear NN B-noun.body	cells NNS B-noun.body	after IN 0	each DT 0	treatment NN B-noun.plant	period NN B-noun.person	. . 0	. . 0
a7582165.s1	Two CD 0	patients NNS B-noun.person	treated VBD B-verb.social	with IN 0	parenteral JJ B-adj.all	paramethasone NN 0	( ( 0	Triniol NNP B-noun.person	) ) 0	and CC 0	dexamethasone NN B-noun.person	( ( 0	Sedionbel NNP 0	) ) 0	are VBP 0	described VBN B-verb.communication	. . 0	. . 0
a16005948.s6	Significant JJ B-adj.all	blockade NN B-noun.attribute	of IN 0	cocaine NN B-noun.phenomenon	toxicity NN B-noun.attribute	was VBD 0	observed VBN B-verb.perception	with IN 0	the DT 0	higher JJR B-adj.all	dose NN B-noun.person	of IN 0	GNC92H2 NNP B-noun.person	( ( 0	190 CD 0	mg NN B-noun.quantity	/ : 0	kg LS 0	) ) 0	, , 0	where WRB 0	premorbid JJ B-adj.all	behaviors NNS B-noun.person	were VBD 0	reduced VBN B-verb.change	up RP 0	to TO 0	40 CD B-adj.all	% NN 0	, , 0	seizures VBZ B-verb.contact	up RP 0	to TO 0	77 CD 0	% NN 0	and CC 0	death NN B-noun.state	by IN 0	72 CD 0	% NN 0	. . 0	. . 0
a1009330.s3	A DT 0	high JJ B-adj.all	percentage NN B-noun.attribute	of IN 0	kanamycin NN B-noun.person	- : 0	colistin NN B-noun.person	and CC 0	povidone NN B-noun.person	- : 0	iodine NN B-noun.substance	irrigations NNS B-noun.artifact	were VBD 0	associated VBN B-verb.cognition	with IN 0	erosive JJ B-adj.all	cystitis NN B-noun.state	and CC 0	suggested VBD B-verb.communication	a DT 0	possible JJ B-adj.all	complication NN B-noun.person	with IN 0	human JJ B-adj.all	usage NN B-noun.attribute	. . 0	. . 0
a19767176.s4	Treatment NN B-noun.person	with IN 0	150 CD 0	mg PRP 0	/ ( 0	kg IN 0	PDTC NNP 0	before IN 0	and CC 0	following VBG B-verb.stative	status_epilepticus JJ 0	significantly RB B-adv.all	increased VBD B-verb.change	the DT 0	mortality NN B-noun.attribute	rate NN B-noun.time	to TO 0	100 CD 0	% NN 0	. . 0	. . 0
a7088431.s2	One CD 0	patient NN B-noun.person	, , 0	aged VBN B-verb.consumption	23 CD B-adj.all	, , 0	had VBD 0	been VBN 0	followed VBN B-verb.social	for IN 0	2 CD B-adj.all	years NNS B-noun.act	before IN 0	carcinoma NN B-noun.group	was VBD 0	diagnosed VBN B-verb.communication	, , 0	the DT 0	second JJ B-adj.all	patient NN B-noun.person	, , 0	aged VBN B-verb.contact	22 CD B-adj.all	, , 0	had VBD 0	been VBN 0	seen VBN B-verb.perception	on IN 0	a DT 0	regular JJ B-adj.all	basis NN B-noun.cognition	for IN 0	5 CD B-adj.all	years NNS B-noun.time	, , 0	8 CD B-adj.all	months NNS B-noun.person	. . 0	. . 0
a1378968.s9	NX+HP NN B-noun.person	caused VBD B-verb.communication	a DT 0	further JJ B-adj.all	rise NN B-noun.attribute	in IN 0	blood NN B-adj.all	pressure NN B-noun.act	in IN 0	Li SYM 0	- : 0	pretreated VBN B-verb.creation	rats NNS B-noun.animal	. . 0	. . 0
a3719553.s1	An DT 0	allergic_reaction NN B-noun.group	consisting VBG B-verb.stative	of IN I-verb.stative	angioneurotic_edema NNP B-noun.person	secondary JJ I-noun.person	to TO 0	continuous JJ B-adj.all	infusion NN B-noun.cognition	5-fluorouracil NN 0	occurred VBD B-verb.stative	in IN 0	a DT 0	patient NN B-noun.person	with IN 0	recurrent NN B-noun.artifact	carcinoma_of_the_oral_cavity NN I-noun.artifact	, , 0	cirrhosis NN B-noun.cognition	, , 0	and CC 0	cisplatin NN B-noun.person	- : 0	induced VBN B-verb.creation	impaired_renal_function NN B-noun.feeling	. . 0	. . 0
a17261653.s3	METHODS NNS B-noun.attribute	AND CC 0	RESULTS NNS B-noun.artifact	, , 0	To TO 0	test VB B-verb.social	whether IN 0	clonidine NN B-noun.artifact	elicits NNS B-noun.artifact	pharmacological JJ B-adj.all	effects NNS B-noun.phenomenon	independent JJ B-adj.all	of IN 0	alpha2-adrenoceptors NNS B-noun.person	, , 0	we PRP 0	have VBP 0	generated VBN B-verb.communication	mice NNS I-verb.communication	with IN 0	a DT 0	targeted JJ B-adj.all	deletion NN B-noun.group	of IN 0	all DT 0	3 CD B-adj.all	alpha2-adrenoceptor NN B-noun.quantity	subtypes NNS B-noun.person	( ( 0	alpha2ABC-/- NNP 0	) ) 0	. . 0	. . 0
a18619688.s5	We PRP 0	then RB B-adv.all	examined VBD B-verb.communication	the DT 0	morphology NN B-noun.attribute	, , 0	expression NN B-noun.communication	of IN 0	beclin IN 0	1 CD B-adj.all	gene NN B-noun.person	, , 0	mitochondrial JJ B-adj.all	permeability NN B-noun.possession	transition NN B-noun.act	( ( 0	MPT NNP 0	) ) 0	, , 0	and CC 0	Na+--K+ NNP B-noun.person	ATPase NNP I-noun.person	activity NN B-noun.process	in IN 0	vivo NN B-noun.animal	. . 0	. . 0
a10193204.s3	In IN 0	the DT 0	in FW 0	vivo FW 0	study NN B-noun.artifact	, , 0	the DT 0	administration NN B-noun.time	( ( 0	50 CD 0	mg FW 0	/ FW 0	kg FW 0	, , 0	i.p NNP B-noun.person	. . 0	) ) 0	. . 0
a2870085.s5	Flestolol NNP B-noun.person	blood NN I-noun.person	concentrations NNS B-noun.person	increased VBD B-verb.change	linearly RB B-adv.all	with IN 0	increasing VBG B-verb.change	dose NN B-noun.quantity	and CC 0	good JJ 0	correlation NN 0	exists VBZ B-verb.stative	between IN 0	blood NN B-noun.location	concentrations NNS B-noun.person	of IN 0	flestolol NN B-noun.person	and CC 0	beta JJ B-noun.body	- : 0	adrenergic JJ B-adj.all	blockade NN B-noun.attribute	. . 0	. . 0
a18162529.s1	Hyperprolactinemia NNP B-noun.person	can MD 0	reduce VB B-verb.change	fertility NN B-noun.state	and CC 0	libido NN B-noun.person	. . 0	. . 0
a20080983.s4	The DT 0	Multiple NNP B-noun.other	Sleep NNP I-noun.other	Latency NNP I-noun.other	Test NNP I-noun.other	was VBD 0	performed VBN B-verb.social	at IN 0	11,30 CD 0	a.m. NN B-noun.time	, , 0	2,00 CD 0	p.m. NN B-noun.time	, , 0	and CC 0	4,30 CD 0	p.m. NN B-noun.time	on IN 0	days NNS B-noun.time	2 CD 0	, , 0	8 CD B-adj.all	, , 0	and CC 0	15 CD B-adj.all	. . 0	. . 0
a7977601.s6	The DT 0	dosage NN B-noun.quantity	of IN 0	indocyanine_green CD 0	used VBN B-verb.consumption	for IN 0	angiography NN 0	varied VBN B-verb.stative	from IN 0	25 CD B-adj.all	to TO 0	75 CD 0	mg NN B-noun.quantity	, , 0	depending VBG B-verb.communication	upon IN 0	the DT 0	institution NN B-noun.act	. . 0	. . 0
a9855119.s8	CONCLUSIONS NNS B-noun.artifact	, , 0	This DT 0	study NN B-noun.communication	demonstrates VBZ B-verb.communication	that IN 0	chronic JJ B-adj.all	FK506 NNP B-noun.other	nephropathy JJ B-noun.artifact	consists VBZ B-verb.stative	primarily RB I-verb.stative	of IN 0	arteriolopathy JJ B-adj.all	manifesting NN B-noun.act	as IN 0	insudative JJ 0	hyalinosis NN 0	of IN 0	the DT 0	arteriolar JJ B-adj.all	wall NN 0	, , 0	and CC 0	suggests VBZ B-verb.communication	that IN 0	mild JJ B-noun.person	- : 0	type NN B-noun.person	chronic NN B-adj.all	FK506 NNP B-noun.other	nephropathy JJ B-adj.all	is VBZ B-verb.stative	a DT 0	condition NN B-noun.act	which WDT 0	may MD 0	lead VB B-verb.cognition	to TO 0	deterioration NN B-noun.act	of IN 0	renal JJ B-adj.all	allograft NN B-noun.act	function NN B-noun.act	. . 0	. . 0
a7881871.s0	Time NNP B-noun.person	course NN I-noun.person	of IN 0	lipid JJ B-adj.all	peroxidation NN B-noun.person	in IN 0	puromycin_aminonucleoside JJ B-noun.other	- : 0	induced VBN B-verb.creation	nephropathy JJ B-adj.all	. . 0	. . 0
a18768591.s0	Serum- NN B-noun.body	and CC 0	glucocorticoid JJ B-adj.all	- : 0	inducible JJ B-adj.all	kinase NN B-noun.cognition	1 CD B-adj.all	in IN 0	doxorubicin NN B-noun.act	- : 0	induced VBD B-verb.creation	nephrotic_syndrome JJ 0	. . 0	. . 0
a10406016.s0	Effect NN 0	of IN 0	fucoidan JJ 0	treatment NN B-noun.person	on IN 0	collagenase NN B-noun.person	- : 0	induced VBN B-verb.creation	intracerebral_hemorrhage NN B-noun.artifact	in IN 0	rats NNS B-noun.animal	. . 0	. . 0
a18791946.s7	No DT 0	signs NNS B-noun.communication	of IN 0	bone_marrow_depression NN 0	were VBD 0	found VBN B-verb.possession	. . 0	. . 0
a10901305.s14	No DT 0	long JJ B-noun.body	- : 0	term NN B-noun.time	sequelae NN 0	were VBD 0	noted VBN B-verb.perception	, , 0	and CC 0	no DT 0	patients NNS B-noun.person	had VBD 0	hallucinations NNS B-noun.artifact	or CC 0	nightmares NNS B-noun.person	. . 0	. . 0
a88336.s5	All DT 0	four CD B-noun.group	recovered VBD B-verb.possession	completely RB B-adv.all	without IN 0	neurological_sequelae JJ 0	following VBG B-verb.stative	the DT 0	withdrawal NN B-noun.act	of IN 0	the DT 0	offending VBG B-verb.possession	agents NNS B-noun.person	. . 0	. . 0
a8955532.s0	Role NNP B-noun.person	of IN 0	activation NN B-noun.act	of IN 0	bradykinin NN B-noun.food	B2 JJ B-adj.all	receptors NNS B-noun.person	in IN 0	disruption NN B-noun.act	of IN 0	the DT 0	blood NN B-noun.act	- : 0	brain NN B-noun.food	barrier NN B-noun.artifact	during IN 0	acute JJ B-adj.all	hypertension NN B-noun.person	. . 0	. . 0
a18809400.s4	Our PRP$ 0	results NNS B-noun.communication	demonstrate VBP B-verb.communication	that IN 0	both DT 0	cisplatin NN B-noun.person	and CC 0	paclitaxel NN B-noun.artifact	cause NN I-noun.artifact	early JJ B-adj.all	mitochondrial_impairment NN B-noun.other	with IN 0	loss NN B-noun.process	of IN 0	membrane NN B-noun.state	potential NN I-noun.state	and CC 0	induction NN B-noun.act	of IN 0	autophagic JJ B-adj.all	vacuoles NNS B-noun.artifact	in IN 0	neurons NNS B-noun.animal	. . 0	. . 0
a2266990.s6	Side JJ 0	effects NNS B-noun.phenomenon	attributable JJ B-adj.all	to TO 0	mazindol NN B-noun.person	included VBD B-verb.stative	decreased_appetite JJ 0	( ( 0	36 CD 0	% NN 0	) ) 0	, , 0	dry_mouth NNP 0	( ( 0	10 CD B-adj.all	% NN 0	) ) 0	, , 0	behavioral JJ B-adj.all	change NN B-noun.relation	( ( 0	22 CD B-adj.all	% NN 0	) ) 0	, , 0	and CC 0	gastrointestinal_symptoms NNS B-noun.location	( ( 0	18 CD B-adj.all	% NN 0	) ) 0	, , 0	mazindol NN B-noun.person	dosage NN I-noun.person	was VBD 0	reduced VBN B-verb.change	in IN 0	43 CD B-adj.all	% NN 0	of IN 0	patients NNS B-noun.person	. . 0	. . 0
a8996652.s4	Ototoxicity NNP 0	appeared VBD B-verb.change	closely RB B-adv.all	related VBN B-verb.cognition	to TO 0	a DT 0	prolonged JJ B-adj.all	administration NN B-noun.person	and CC 0	higher JJR B-adj.all	total JJ B-adj.all	dose NN B-noun.act	of IN 0	ototoxic JJ B-adj.all	drugs NNS B-noun.artifact	, , 0	particularly RB B-adj.all	aminoglycosides NNS B-noun.person	and CC 0	furosemide NN B-noun.artifact	. . 0	. . 0
a7988234.s5	She PRP 0	had VBD B-verb.perception	no DT 0	previous JJ B-adj.all	beta NNS B-noun.cognition	- : 0	blocking VBG B-verb.communication	drug NN B-noun.person	exposure NN B-noun.person	. . 0	. . 0
a11745184.s6	Early JJ B-adj.all	trials NNS B-noun.cognition	of IN 0	cisplatin NN B-noun.food	and CC 0	amifostine NN B-noun.person	also RB B-adv.all	suggested VBD B-verb.communication	that IN 0	the DT 0	incidence NN B-noun.communication	and CC 0	severity NN B-noun.attribute	of IN 0	cisplatin NN B-noun.act	- : 0	induced VBN B-verb.creation	nephrotoxicity NN B-noun.attribute	, , 0	ototoxicity NN 0	, , 0	and CC 0	neuropathy JJ B-adj.all	were VBD 0	reduced VBN B-verb.change	. . 0	. . 0
a10669626.s16	These DT 0	observations NNS B-noun.act	indicate VBP B-verb.cognition	that IN 0	although IN 0	the DT 0	gamma NN B-noun.act	- : 0	carboxyglutamate NN B-noun.communication	residues NNS B-noun.communication	of IN 0	matrix NNP B-noun.person	Gla NNP I-noun.person	protein NN I-noun.person	are VBP 0	apparently RB B-adv.all	required VBN B-verb.stative	for IN 0	its PRP$ 0	function NN B-noun.act	as IN 0	a DT 0	calcification NN B-noun.person	inhibitor NN B-noun.person	, , 0	they PRP 0	are VBP B-verb.stative	not RB B-adv.all	required VBN B-verb.stative	for IN 0	its PRP$ 0	accumulation NN B-noun.act	at IN 0	calcification NN B-noun.process	sites NNS B-noun.location	. . 0	. . 0
a12084448.s4	Cranial NNP B-adj.all	magnetic JJ B-adj.all	resonance NN B-noun.act	imaging NN I-noun.act	and CC 0	extensive JJ B-adj.all	laboratory NN B-noun.artifact	studies NNS I-noun.artifact	failed VBD B-verb.social	to TO 0	reveal VB B-verb.social	structural_lesions_of_the_brain JJ B-adj.all	and CC 0	metabolic_abnormalities NNS B-noun.object	. . 0	. . 0
a8386779.s5	phentolamine NN B-noun.artifact	and CC 0	10 CD B-adj.all	micrograms NNS B-noun.quantity	. . 0	. . 0
a18752389.s1	Abstract NNP B-noun.person	Serum NNP I-noun.person	aminotransferase IN 0	elevations NNS B-noun.artifact	are VBP B-verb.stative	a DT 0	commonly RB B-adj.all	known VBN I-adj.all	adverse JJ B-adj.all	effect NN B-noun.cognition	of IN 0	3-hydroxy-3-methylglutaryl JJ B-noun.phenomenon	coenzyme NN I-noun.phenomenon	A DT 0	reductase NN B-noun.process	inhibitor NN 0	( ( 0	statin NN 0	) ) 0	therapy NN 0	. . 0	. . 0
a11135224.s2	The DT 0	emergence NN B-noun.event	of IN 0	new JJ B-adj.all	active JJ B-adj.all	drugs NNS B-noun.artifact	might MD 0	translate VB B-verb.contact	into IN 0	more JJR B-adv.all	effective JJ B-adj.all	regimens NNS B-noun.person	for IN 0	the DT 0	treatment NN B-noun.communication	of IN 0	this DT 0	disease NN B-noun.communication	. . 0	. . 0
a18442015.s0	Protective JJ B-adj.all	effect NN B-noun.cognition	of IN 0	verapamil NN B-noun.artifact	on IN 0	gastric_hemorrhagic JJ B-adj.pert	ulcers NNS B-noun.person	in IN 0	severe JJ B-adj.all	atherosclerotic JJ B-adj.all	rats NNS B-noun.animal	. . 0	. . 0
a18951540.s0	Repetitive JJ B-adj.all	transcranial JJ B-adj.all	magnetic JJ B-adj.all	stimulation NN B-noun.act	for IN 0	levodopa NN B-noun.attribute	- : 0	induced VBN B-verb.creation	dyskinesias NNS B-noun.artifact	in IN 0	Parkinson's_disease NN 0	. . 0	. . 0
a17437408.s7	RESULTS NNS B-noun.artifact	, , 0	Immunofluorescence NNP B-noun.person	staining VBG B-verb.change	with IN 0	the DT 0	MRP2 NNP B-noun.other	antibody NN B-noun.object	was VBD 0	found VBN B-verb.cognition	to TO 0	label VB B-verb.communication	a DT 0	high JJ B-adj.all	number NN B-noun.attribute	of IN 0	microvessels NNS B-noun.person	throughout IN 0	the DT 0	brain NN B-noun.food	in IN 0	normal JJ B-adj.all	Wistar NNP B-noun.person	rats NNS I-noun.person	, , 0	whereas IN 0	such JJ B-adj.all	labeling NN B-noun.possession	was VBD B-verb.stative	absent JJ B-adj.all	in IN 0	TR(- NN 0	) ) 0	rats NNS B-noun.animal	. . 0	. . 0
a15145918.s5	In IN 0	sham NN B-noun.act	- : 0	operated VBD B-verb.contact	rats NNS B-noun.person	, , 0	rilmenidine NN B-noun.person	or CC 0	alpha NN B-noun.act	- : 0	methyldopa NN B-noun.person	elicited VBD B-verb.emotion	similar JJ B-adj.all	hypotension NN B-noun.communication	that WDT 0	lasted VBD B-verb.contact	at IN B-adv.all	least JJS I-adv.all	5 CD B-adj.all	h NN 0	and CC 0	was VBD 0	associated VBN B-verb.cognition	with IN 0	reductions NNS B-noun.group	in IN 0	standard JJ B-adj.all	deviation NN B-noun.event	of IN 0	mean JJ B-adj.all	arterial JJ B-adj.all	pressure NN B-noun.act	. . 0	. . 0
a2484011.s13	The DT 0	biochemical JJ B-adj.all	results NNS B-noun.event	of IN 0	brain NN B-noun.food	biogenic JJ B-adj.all	amines NNS B-noun.event	of IN 0	BALB NNP B-noun.group	/ ( 0	C NNP 0	mouse NN 0	strain NN B-noun.communication	suggest VBP B-verb.communication	a DT 0	probable JJ B-adj.all	decrease NN B-noun.state	of IN 0	catecholamine NN B-noun.phenomenon	turnover NN B-noun.event	rate NN B-noun.time	and/or CC 0	metabolism NN B-noun.attribute	by IN 0	monoamine NN B-noun.person	oxidase NN B-noun.person	and CC 0	a DT 0	resulting VBG B-verb.stative	increase NN B-noun.event	in IN 0	O NNP 0	- : 0	methylation NN B-noun.attribute	of IN 0	norepinephrine NN B-noun.shape	which WDT 0	may MD 0	account VB B-verb.communication	for IN 0	a DT 0	behavioral_depression NN 0	caused VBN B-verb.communication	by IN 0	amantadine NN B-noun.person	in IN 0	the DT 0	BALB NNP B-noun.group	/ ( 0	C NNP 0	mice NNS B-noun.animal	. . 0	. . 0
a7890216.s4	In IN 0	the DT 0	remaining VBG B-verb.stative	12 CD B-adj.all	patients NNS B-noun.person	, , 0	localised VBD 0	computed VBN B-verb.stative	tomography NN 0	of IN 0	the DT 0	gall NN B-noun.artifact	bladder NN B-noun.person	showed VBD B-verb.communication	that IN 0	eight CD 0	had VBD 0	stones NNS B-noun.object	with IN 0	maximum JJ B-adj.all	attenuation NN B-noun.act	scores NNS B-noun.cognition	of IN 0	< $ 0	100 CD 0	Hounsfield NNP 0	units NNS B-noun.relation	( ( 0	values NNS B-noun.attribute	of IN 0	< $ 0	100 CD 0	HU NNP 0	predict VBP B-verb.cognition	cholesterol NN B-noun.person	rich JJ I-noun.person	, , 0	dissolvable JJ B-adj.all	stones NNS B-noun.object	) ) 0	. . 0	. . 0
a14659530.s3	Sublingual JJ B-adj.all	nitroglycerin NN B-noun.person	( ( 0	0.5 CD 0	mg NN B-noun.quantity	) ) 0	was VBD 0	administered VBN B-verb.possession	. . 0	. . 0
a15145918.s3	Changes NNS B-noun.person	evoked VBN B-verb.emotion	by IN 0	a DT 0	single JJ B-adj.all	intraperitoneal JJ B-adj.all	injection NN B-noun.act	of IN 0	rilmenidine NN 0	( ( 0	600 CD 0	microg NN B-noun.quantity	/ : 0	kg LS 0	) ) 0	or CC 0	alpha NN B-noun.act	- : 0	methyldopa NN B-noun.attribute	( ( 0	100 CD 0	mg NN B-noun.quantity	/ : 0	kg LS 0	) ) 0	, , 0	selective JJ B-adj.all	I1- NN B-noun.person	and CC 0	alpha2-receptor NN B-noun.person	agonists NNS B-noun.person	, , 0	respectively RB B-adv.all	, , 0	in IN 0	blood NN B-adj.all	pressure NN B-noun.act	, , 0	hemodynamic JJ B-adj.all	variability NN B-noun.attribute	, , 0	and CC 0	locomotor NN B-noun.person	activity NN B-noun.person	were VBD 0	assessed VBN B-verb.communication	in IN 0	radiotelemetered VBN B-verb.consumption	sham NN I-verb.consumption	- : 0	operated VBN B-verb.contact	and CC 0	ovariectomized VBN B-verb.consumption	( ( 0	Ovx NNP 0	) ) 0	Sprague NNP B-noun.group	- : I-noun.group	Dawley NNP I-noun.group	female NN B-noun.person	rats NNS B-noun.person	with IN 0	or CC 0	without IN 0	12-wk JJ 0	estrogen NN B-adj.all	replacement NN B-noun.person	. . 0	. . 0
a2802551.s3	In IN 0	contrast NN 0	, , 0	in IN 0	normal JJ B-adj.all	- : 0	salt NN B-noun.food	rats NNS B-noun.phenomenon	creatinine JJ B-adj.all	clearance NN B-noun.person	was VBD 0	decreased VBN B-verb.change	but CC 0	to TO 0	a DT 0	lesser JJR B-adj.all	extent NN B-noun.person	at IN 0	week NN B-noun.communication	2 CD 0	and CC 0	3 CD B-adj.all	, , 0	and CC 0	in IN 0	salt NN B-noun.act	- : 0	loaded VBN B-verb.contact	rats NNS B-noun.animal	creatinine JJ B-adj.all	clearance NN B-noun.attribute	did VBD 0	not RB B-adv.all	change VB B-verb.change	for IN 0	2 CD B-adj.all	weeks NNS B-noun.time	and CC 0	was VBD 0	decreased VBN B-verb.change	by IN 0	43 CD 0	% NN 0	at IN 0	week NN B-noun.communication	3 CD 0	. . 0	. . 0
a18560792.s12	Pergolide NNP B-noun.person	was VBD 0	discontinued VBN B-verb.stative	in IN 0	10 CD B-adj.all	patients NNS B-noun.person	with IN 0	valvular_heart_disease NNP B-noun.person	, , 0	resulting VBG B-verb.stative	in IN 0	a DT 0	lower JJR B-adj.all	regurgitation NN B-noun.relation	grade NN B-noun.attribute	( ( 0	p=0.01 NNP 0	) ) 0	at IN 0	the DT 0	second JJ B-adj.all	transthoracic JJ B-adj.all	echocardiography NN B-noun.attribute	and CC 0	the DT 0	two CD 0	patients NNS B-noun.person	with IN 0	heart_failure NN B-noun.person	returned VBD B-verb.motion	to TO 0	nearly RB B-adj.all	normal JJ B-adj.all	clinical JJ B-noun.phenomenon	examination NN I-noun.phenomenon	. . 0	. . 0
a19356053.s10	In IN 0	7 CD 0	of IN 0	the DT 0	28 CD B-adj.all	patients NNS B-noun.person	there EX 0	was VBD B-verb.stative	a DT 0	striking JJ B-adj.all	temporal JJ B-adj.all	association NN B-noun.state	between IN 0	the DT 0	initiation NN B-noun.act	of IN 0	sirolimus NN B-noun.food	and CC 0	the DT 0	development NN B-noun.process	of IN 0	nephrotic JJ B-adj.all	- : 0	range NN B-noun.person	proteinuria NN B-noun.person	. . 0	. . 0
a9495837.s9	+ DT 0	/-)-PG-9 NNP B-noun.person	( ( 0	10 CD B-adj.all	- : 0	40 CD 0	mg RB B-adj.all	kg-1 JJ B-noun.person	i.p NNP I-noun.person	. . 0	) ) 0	. . 0
a17261653.s2	Activation NN B-noun.person	of IN 0	presynaptic JJ B-adj.all	alpha2-adrenoceptors NNS B-noun.person	is VBZ B-verb.stative	the DT 0	most RBS 0	widely RB B-adv.all	accepted VBN B-verb.possession	mechanism NN B-noun.attribute	of IN 0	action NN B-noun.process	of IN 0	the DT 0	antisympathetic JJ B-adj.all	drug NN B-noun.phenomenon	clonidine NN 0	, , 0	however RB 0	, , 0	other JJ 0	target NN B-noun.location	proteins NNS B-noun.person	have VBP 0	been VBN 0	postulated VBN B-verb.communication	to TO 0	contribute VB B-verb.social	to TO 0	the DT 0	in FW 0	vivo FW 0	actions NNS B-noun.act	of IN 0	clonidine NN B-noun.phenomenon	. . 0	. . 0
a8170551.s0	Acetazolamide SYM 0	- : 0	induced VBN B-verb.communication	nephrolithiasis NN B-noun.person	, , 0	implications NNS B-noun.motive	for IN 0	treatment NN B-noun.act	of IN 0	neuromuscular_disorders NNS B-noun.person	. . 0	. . 0
a9522143.s8	Long RB 0	- DT 0	term NN B-noun.time	follow VB B-verb.stative	- : 0	up IN 0	of IN 0	the DT 0	patients NNS B-noun.person	was VBD B-verb.stative	not RB B-adv.all	possible JJ B-adj.all	. . 0	. . 0
a19211690.s8	Radiotelemetric NNP B-noun.person	BP NNP I-noun.person	was VBD B-verb.stative	similar JJ B-adj.all	between IN 0	males NNS B-noun.person	and CC 0	castrated VBD B-verb.communication	rats NNS B-noun.person	on IN 0	LS NNP 0	diet NN 0	. . 0	. . 0
a9088814.s6	AKBR NNP B-noun.group	and CC 0	biological JJ B-adj.all	hepatic JJ B-adj.all	function NN B-noun.act	tests NNS B-noun.person	showed VBD B-verb.communication	no DT 0	change NN 0	throughout IN 0	the DT 0	time NN B-noun.time	course NN B-noun.object	in IN 0	groups NNS B-noun.group	A DT 0	and CC 0	B. NNP B-noun.person	In NNP I-noun.person	group NN 0	C NNP 0	, , 0	AKBR NNP B-noun.person	showed VBD B-verb.communication	a DT 0	significant JJ B-adj.all	decrease NN B-noun.state	at IN 0	120 CD 0	min NN 0	( ( 0	-40 CD 0	% NN 0	) ) 0	and CC 0	at IN 0	180 CD 0	min NN 0	( ( 0	-49 CD 0	% NN 0	) ) 0	after IN 0	the DT 0	start NN B-noun.attribute	of IN 0	hypotension NN B-noun.act	and CC 0	at IN 0	60 CD B-adj.all	min NN B-noun.quantity	( ( 0	-32 CD 0	% NN 0	) ) 0	after IN 0	recovery NN B-noun.process	of IN 0	normotension NN B-noun.person	, , 0	and CC 0	SGOT NNP B-noun.group	, , 0	SGPT NNP B-noun.group	, , 0	LDH NNP 0	and CC 0	total JJ B-adj.all	bilirubin NN B-noun.person	showed VBD B-verb.communication	significant JJ B-adj.all	increases NNS B-noun.event	after IN 0	operation NN B-noun.person	. . 0	. . 0
a1749407.s5	Although IN 0	certain JJ B-adj.all	clinical JJ B-adj.all	and CC 0	experimental JJ B-adj.all	findings NNS B-noun.act	support VBP B-verb.stative	the DT 0	hypothesis NN B-noun.communication	that WDT 0	spasm NN B-noun.attribute	involves VBZ B-verb.stative	the DT 0	epicardial NN B-noun.communication	, , 0	medium NN B-noun.person	- : 0	size NN B-noun.attribute	vessels NNS B-noun.artifact	, , 0	other JJ 0	data NNS B-noun.cognition	suggest VBP B-verb.communication	intramural JJ B-noun.phenomenon	vasoconstriction NN I-noun.phenomenon	. . 0	. . 0
a10737864.s0	A DT 0	developmental JJ B-adj.all	analysis NN B-noun.attribute	of IN 0	clonidine NN B-noun.person	's POS 0	effects NNS B-noun.phenomenon	on IN 0	cardiac JJ B-adj.all	rate NN B-noun.time	and CC 0	ultrasound JJ B-adj.all	production NN B-noun.artifact	in IN 0	infant NN 0	rats NNS 0	. . 0	. . 0
a2559236.s6	Groups NNS B-noun.group	3 CD 0	and CC 0	4 CD B-adj.all	were VBD 0	studied VBN B-verb.cognition	at IN 0	four CD 0	and CC 0	at IN 0	six CD B-adj.all	months NNS B-noun.person	to TO 0	assess VB B-verb.cognition	the DT 0	effect NN B-noun.cognition	of IN 0	enalapril NN B-noun.person	on IN 0	progression NN B-noun.act	of IN 0	renal_injury NN B-noun.food	in IN 0	adriamycin JJ B-adj.all	nephrosis NN B-noun.person	. . 0	. . 0
a17931375.s8	The DT 0	visual JJ B-adj.pert	analog NN 0	scale NN 0	( ( 0	VAS NNP 0	) ) 0	was VBD 0	used VBN B-verb.consumption	to TO 0	measure VB B-verb.change	pain NN B-noun.cognition	intensity NN B-noun.attribute	and CC 0	a DT 0	stop NN B-noun.person	- : 0	watch NN B-noun.time	was VBD 0	used VBN B-verb.consumption	to TO 0	time VB B-verb.change	the DT 0	pain NN B-noun.person	period NN B-noun.person	. . 0	. . 0
a18442015.s11	This DT 0	hemorrhagic JJ B-adj.pert	ulcer NN B-noun.state	and CC 0	various JJ B-adj.all	ulcerogenic JJ B-adj.pert	parameters NNS B-noun.person	were VBD B-verb.stative	dose JJ B-adj.all	- : 0	dependently RB B-adv.all	ameliorated VBN B-verb.communication	by IN 0	daily JJ B-adj.pert	intragastric JJ B-adj.all	verapamil NN B-noun.artifact	. . 0	. . 0
a16574712.s0	MDMA NNP B-noun.person	polydrug NN I-noun.person	users NNS B-noun.person	show VBP B-verb.communication	process NN B-noun.person	- : 0	specific JJ B-adj.all	central JJ B-noun.body	executive NN I-noun.body	impairments NNS B-noun.person	coupled VBN B-verb.contact	with IN 0	impaired_social_and_emotional_judgement_processes NNS B-noun.artifact	. . 0	. . 0
a10683478.s10	However RB 0	, , 0	apomorphine JJ B-noun.person	- : 0	induced VBN B-verb.creation	reductions NNS B-noun.process	in IN 0	striatal JJ B-adj.all	dopamine NN 0	turnover NN 0	were VBD 0	detected VBN B-verb.perception	in IN 0	both DT 0	novel NN B-noun.communication	and CC 0	home NN B-noun.artifact	cage NN B-noun.state	environments NNS B-noun.person	. . 0	. . 0
a10526274.s11	Two CD 0	patients NNS B-noun.person	attained VBD B-verb.social	a DT 0	complete JJ B-adj.all	response NN B-noun.communication	( ( 0	4 CD B-adj.all	% NN 0	) ) 0	and CC 0	11 CD B-adj.all	patients NNS B-noun.person	( ( 0	22 CD B-adj.all	% NN 0	) ) 0	achieved VBD B-verb.stative	a DT 0	partial JJ B-adj.all	response NN B-noun.communication	. . 0	. . 0
a137340.s9	The DT 0	study NN B-noun.artifact	suggests VBZ B-verb.communication	that IN 0	the DT 0	activity NN B-noun.process	- : 0	increasing VBG B-verb.change	effects NNS B-noun.phenomenon	of IN 0	morphine NN B-noun.person	are VBP 0	mediated VBN B-verb.cognition	by IN 0	the DT 0	release NN B-noun.state	of IN 0	catecholamines NNS B-noun.animal	from IN 0	adrenergic JJ B-adj.all	neurons NNS B-noun.person	in IN 0	the DT 0	brain NN B-noun.person	. . 0	. . 0
a18560792.s5	Thirty NNP 0	PD NNP 0	patients NNS B-noun.person	participated VBD B-verb.social	in IN 0	the DT 0	study NN B-noun.artifact	. . 0	. . 0
a12584269.s11	The DT 0	semi NN B-noun.group	- : 0	quantitative JJ B-adj.all	scoring NN B-noun.person	was VBD B-verb.stative	significantly RB B-adv.all	worst JJS B-adj.all	in IN 0	the DT 0	group NN 0	treated VBN B-verb.change	with IN 0	CsA NNP B-noun.person	plus CC 0	SRL NNP 0	( ( 0	P<0.001 NN 0	compared VBN B-verb.stative	with IN 0	controls NNS B-noun.artifact	) ) 0	and CC 0	the DT 0	analysis NN B-noun.communication	of IN 0	the DT 0	total JJ B-adj.all	grade NN B-noun.attribute	of IN 0	fibrosis NN 0	also RB B-adv.all	showed VBD B-verb.communication	the DT 0	highest JJS B-adj.all	proportion NN B-noun.person	in IN 0	the DT 0	same JJ B-adj.all	group NN B-noun.person	and CC 0	was VBD B-verb.stative	significantly RB B-adv.all	different JJ B-adv.all	from IN 0	controls NNS B-noun.cognition	( ( 0	P<0.02 NNP 0	) ) 0	. . 0	. . 0
a9284778.s11	Autoantibodies NNS B-noun.person	against IN 0	P450 JJ B-noun.group	2E1 CD I-noun.group	or CC 0	P58 NN 0	, , 0	previously RB B-adv.all	associated VBN B-verb.cognition	with IN 0	halothane_hepatitis NN B-noun.food	, , 0	were VBD 0	detected VBN B-verb.perception	in IN 0	the DT 0	serum NN B-noun.person	of IN 0	five CD 0	affected JJ B-adj.all	workers NNS B-noun.person	. . 0	. . 0
a2445283.s0	Tolerance NNP B-noun.person	and CC 0	antiviral JJ B-adj.all	effect NN B-noun.cognition	of IN 0	ribavirin NN B-noun.food	in IN 0	patients NNS B-noun.person	with IN 0	Argentine_hemorrhagic_fever NN B-noun.person	. . 0	. . 0
a150790.s3	After IN 0	discontinuing VBG B-verb.change	isoniazid JJ B-adj.all	therapy NN B-noun.person	a DT 0	similar JJ B-adj.all	pattern NN B-noun.act	of IN 0	behavior NN B-noun.attribute	was VBD 0	noted VBN B-verb.perception	that DT 0	was VBD 0	controlled VBN B-verb.social	by IN 0	pyridoxine NN B-noun.person	. . 0	. . 0
a8386779.s2	A DT 0	total NN B-noun.state	of IN 0	38 CD 0	consecutive JJ B-adj.all	patients NNS B-noun.person	who WP 0	presented VBD B-verb.communication	to TO 0	our PRP$ 0	clinic NN B-noun.person	with IN 0	impotence NN B-noun.person	received VBD B-verb.possession	0.2 CD 0	ml NN B-noun.quantity	. . 0	. . 0
a9727773.s0	High JJ B-adj.all	incidence NN B-noun.attribute	of IN 0	primary_pulmonary_hypertension NN B-noun.attribute	associated VBN B-verb.cognition	with IN 0	appetite_suppressants NNS B-noun.person	in IN 0	Belgium NNP B-noun.location	. . 0	. . 0
a11581460.s4	Here RB 0	, , 0	2 CD B-adj.all	cases NNS B-noun.quantity	of IN 0	urinary_bladder_retention NN 0	leading VBG B-verb.stative	to TO 0	renal VB B-verb.communication	pelvocalyceal JJ B-noun.person	dilatation NN B-noun.person	mimicking VBG B-verb.emotion	hydronephrosis NN I-verb.emotion	as IN 0	a DT 0	result NN B-noun.act	of IN 0	continuous JJ B-adj.all	infusion NN B-noun.cognition	of IN 0	fentanyl NN B-noun.animal	are VBP 0	reported VBN B-verb.communication	. . 0	. . 0
a11745184.s19	Neither CC 0	a DT 0	tumor NN B-noun.feeling	- : 0	protective JJ B-adj.all	effect NN B-noun.cognition	nor CC 0	reduced JJ B-verb.change	toxicity NN 0	to TO 0	normal JJ B-adj.all	tissues NNS B-noun.body	was VBD 0	observed VBN B-verb.perception	with IN 0	the DT 0	addition NN B-noun.act	of IN 0	amifostine NN 0	to TO 0	cisplatin VB B-verb.contact	in IN 0	this DT 0	trial NN B-noun.cognition	. . 0	. . 0
a2522601.s1	We PRP 0	report VBP B-verb.communication	a DT 0	patient NN B-noun.person	in IN 0	whom JJ 0	hypersensitivity NN 0	to TO 0	carbamazepine VB 0	presented VBN B-verb.perception	with IN 0	generalized JJ B-adj.all	erythroderma NN B-noun.person	, , 0	a DT 0	severe JJ B-adj.all	leukemoid_reaction NN B-noun.state	, , 0	eosinophilia NNS B-noun.person	, , 0	hyponatremia NN B-noun.person	, , 0	and CC 0	renal_failure NN B-noun.act	. . 0	. . 0
a11745184.s3	Although IN 0	a DT 0	dose NN B-noun.person	- : 0	response NN B-noun.communication	effect NN B-noun.cognition	has VBZ 0	been VBN 0	observed VBN B-verb.perception	with IN 0	cisplatin NN B-noun.food	, , 0	the DT 0	dose NN B-noun.person	- : 0	limiting VBG B-verb.social	toxicities NNS B-noun.person	associated VBN B-verb.cognition	with IN 0	cisplatin NN B-noun.substance	( ( 0	e.g. UH 0	, , 0	nephrotoxicity NN B-noun.person	, , 0	ototoxicity NN 0	, , 0	and CC 0	neurotoxicity NN B-noun.attribute	) ) 0	have VBP 0	limited VBN B-verb.change	its PRP$ 0	use NN 0	as IN 0	a DT 0	treatment NN B-noun.communication	for IN 0	breast_carcinoma NNP B-noun.person	. . 0	. . 0
a19308880.s5	RESULTS NNS B-noun.artifact	, , 0	272 CD 0	cases NNS B-noun.quantity	of IN 0	confusion NN B-noun.cognition	were VBD 0	reported VBN B-verb.communication	with IN 0	valproic_acid NNP B-noun.person	, , 0	153 CD 0	women NNS B-noun.person	and CC 0	119 CD 0	men NNS B-noun.person	. . 0	. . 0
a20067456.s11	In IN 0	linear JJ B-adj.all	regression NN B-noun.act	analyses VBZ B-verb.cognition	the DT 0	CGI NNP B-noun.group	- : 0	SF NNP 0	score NN 0	was VBD B-verb.stative	not RB B-adv.all	affected VBN B-verb.change	significantly RB B-adv.all	by IN 0	the DT 0	duration NN 0	of IN 0	SD NNP 0	, , 0	type NN B-noun.person	of IN 0	SSRI NNP B-noun.group	used VBD B-verb.consumption	and CC 0	age NN B-noun.person	. . 0	. . 0
a12536034.s4	Because IN 0	drug NN B-noun.person	- : 0	induced VBN B-verb.creation	de IN 0	novo RB B-adj.all	absence_seizure JJ B-noun.relation	is VBZ B-verb.stative	rare JJ B-adj.all	, , 0	pro FW 0	- : 0	absence NN B-noun.person	drugs NNS B-noun.person	can MD 0	only RB B-adv.all	be VB 0	considered VBN B-verb.cognition	a DT 0	promoting VBG B-verb.communication	factor NN B-noun.person	. . 0	. . 0
a424937.s9	In IN 0	this DT 0	latter JJ B-adj.all	patient NN B-noun.person	, , 0	and CC 0	in IN 0	2 CD B-adj.all	others NNS 0	, , 0	the DT 0	causal NN B-adj.all	relationship NN B-noun.state	between IN 0	methyldopa NN B-noun.person	and CC 0	hepatic_dysfunction NNP B-noun.person	was VBD 0	proved VBN B-verb.stative	with IN 0	the DT 0	recurrence NN B-noun.act	of IN 0	hepatitis NN B-noun.location	within IN 0	2 CD B-adj.all	weeks NNS B-noun.time	of IN 0	re SYM 0	- : 0	exposure NN B-noun.person	to TO 0	the DT 0	drug NN B-noun.artifact	. . 0	. . 0
a19843802.s0	When WRB 0	drugs NNS B-noun.animal	disappear VBP B-verb.possession	from IN 0	the DT 0	patient NN B-noun.person	, , 0	elimination NN B-noun.act	of IN 0	intravenous JJ B-adj.all	medication NN B-noun.act	by IN 0	hemodiafiltration NN B-noun.person	. . 0	. . 0
a18544179.s10	Fentanyl NNP B-noun.person	did VBD 0	reduce VB B-verb.change	minor JJ B-adj.all	intraoperative JJ B-adj.all	movement NN B-noun.person	but CC 0	had VBD 0	no DT 0	sevoflurane NN 0	- : 0	sparing JJ B-adj.all	effect NN B-noun.cognition	and CC 0	increased VBD B-verb.change	respiratory_depression NN B-noun.artifact	, , 0	hypotension NN B-noun.person	and CC 0	bradycardia NNS B-noun.person	. . 0	. . 0
a8558192.s16	Given VBN B-verb.possession	its PRP$ 0	excellent JJ B-adj.all	tolerance NN B-noun.act	profile NN I-noun.act	and CC 0	low JJ B-adj.all	toxicity NN B-noun.person	, , 0	further JJ B-adj.all	evaluation NN B-noun.act	of IN 0	VNB NNP B-noun.group	in IN 0	combination NN 0	therapy NN 0	is VBZ 0	warranted VBN B-verb.communication	. . 0	. . 0
a18329269.s2	SAR NNP 0	studies NNS B-noun.artifact	led VBD B-verb.motion	to TO 0	compound VB B-verb.possession	14 CD B-adj.all	with IN 0	excellent JJ B-adj.all	potency NN B-noun.person	( ( 0	K(i NNP 0	) ) 0	= SYM 0	0.4 CD 0	nM CD B-noun.quantity	) ) 0	, , 0	selectivity NN B-noun.person	( ( 0	A(1)/A(2A NNP 0	) ) 0	> $ 0	100 CD 0	) ) 0	, , 0	and CC 0	efficacy NN B-noun.person	( ( 0	MED VBN B-verb.stative	10 CD B-adj.all	mg FW B-noun.quantity	/ FW 0	kg FW 0	p.o FW 0	. . 0	) ) 0	. . 0
a10365197.s1	This DT 0	paper NN B-noun.communication	attempts NNS B-noun.communication	to TO 0	examine VB B-verb.communication	and CC 0	compare VB B-verb.emotion	prevalence NN I-verb.emotion	rates NNS B-noun.time	and CC 0	symptom NN B-noun.body	patterns NNS I-noun.body	of IN 0	DSM NNP 0	substance NN B-adv.all	- : 0	induced VBN B-verb.creation	and CC 0	other JJ B-adj.all	mood_disorders NNS B-noun.person	. . 0	. . 0
a19957053.s7	However RB 0	, , 0	a DT 0	14 CD B-adj.all	% NN 0	( ( 0	from IN 0	70 CD B-adj.all	+ SYM 0	/- $ 0	8 CD B-adj.all	% NN 0	to TO 0	60 CD B-adj.all	+ SYM 0	/- $ 0	7 CD B-adj.all	% NN 0	) ) 0	reduction NN B-noun.act	in IN 0	S(c)O(2 NNP B-noun.location	) ) 0	( ( 0	P NNP 0	< $ 0	0.05 CD 0	) ) 0	followed VBD B-verb.stative	with IN 0	no DT 0	change NN B-noun.act	in IN 0	CO NNP 0	( ( 0	3.7 CD 0	+ : 0	/- $ 0	1.1 CD 0	to TO 0	3.4 CD 0	+ CD B-noun.quantity	/- $ 0	0.9 CD 0	l DT 0	min(-1 NNP B-noun.location	) ) 0	) ) 0	. . 0	. . 0
a17261653.s7	Clonidine NNP B-noun.person	inhibited VBD B-verb.change	the DT 0	native JJ B-adj.all	pacemaker NN B-noun.person	current JJ B-noun.person	( ( 0	I(f NNP 0	) ) 0	) ) 0	in IN 0	isolated VBN B-verb.change	sinoatrial JJ B-adj.all	node NN B-noun.body	pacemaker NN B-noun.body	cells NNS B-noun.body	and CC 0	the DT 0	I(f)-generating VBG 0	hyperpolarization NN B-noun.act	- : 0	activated VBN B-verb.creation	cyclic_nucleotide JJ 0	- : 0	gated VBD B-verb.communication	( ( 0	HCN NNP 0	) ) 0	2 CD B-noun.quantity	and CC 0	HCN4 JJ B-noun.body	channels NNS I-noun.body	in IN 0	transfected VBN B-verb.change	HEK293 JJ B-noun.body	cells NNS I-noun.body	. . 0	. . 0
a18703024.s8	No DT 0	statistically RB B-adv.all	significant JJ B-adj.all	changes NNS B-noun.relation	in IN 0	behavior NN B-noun.attribute	or CC 0	receptor NN B-noun.substance	binding NN B-verb.contact	were VBD 0	found VBN B-verb.possession	in IN 0	PD NNP 0	males NNS 0	with IN 0	the DT 0	exception NN B-noun.act	of IN 0	increased VBN B-verb.change	( ( 0	3))H UH 0	- : 0	MK-801 NN B-noun.substance	binding NN B-verb.contact	in IN 0	cortex NN B-noun.location	. . 0	. . 0
a15863244.s11	Lack NN B-noun.person	of IN 0	teratogenicity NN B-noun.phenomenon	was VBD 0	found VBN B-verb.possession	in IN 0	piroxicam NN B-noun.animal	and CC 0	DFU NNP B-noun.group	- : 0	exposed VBN B-verb.communication	groups NNS B-noun.group	. . 0	. . 0
a18544179.s5	RESULTS NNS B-noun.artifact	, , 0	Omission NNP B-noun.person	of IN 0	fentanyl NN B-noun.artifact	did VBD 0	not RB B-adv.all	reduce VB B-verb.change	the DT 0	overall JJ B-adj.all	incidence NN B-noun.event	of IN 0	postoperative_nausea_and_vomiting VBG B-verb.stative	, , 0	but CC 0	did VBD 0	reduce VB B-verb.change	the DT 0	incidence NN B-noun.event	of IN 0	vomiting VBG B-verb.social	and/or CC 0	moderate JJ B-adj.all	to TO 0	severe JJ B-adj.all	nausea NN B-noun.state	prior RB 0	to TO 0	discharge VB B-verb.communication	from IN 0	20 CD B-adj.all	% NN 0	and CC 0	17 CD B-adj.all	% NN 0	with IN 0	fentanyl NN B-noun.food	and CC 0	fentanyl NN B-noun.person	- : 0	dexamethasone NN B-noun.person	, , 0	respectively RB B-adv.all	, , 0	to TO 0	5 CD B-adj.all	% NN 0	( ( 0	P UH 0	= SYM 0	0.013 CD 0	) ) 0	. . 0	. . 0
a17020434.s5	The DT 0	ACTIVE JJ B-noun.group	- : 0	W NNP 0	( ( 0	Atrial_Fibrillation NNP B-noun.other	Clopidogrel NNP I-noun.other	Trial NNP I-noun.other	with IN 0	Irbesartan NNP B-noun.person	for IN 0	Prevention NNP B-noun.person	of IN 0	Vascular NNP B-noun.other	Events NNP I-noun.other	) ) 0	study NN B-noun.group	has VBZ 0	demonstrated VBN B-verb.cognition	that IN 0	warfarin NN B-noun.act	is VBZ B-verb.stative	superior JJ B-adj.all	to TO 0	platelet VB B-verb.social	therapy NN I-verb.social	( ( 0	clopidogrel NN B-noun.cognition	plus CC 0	aspirin NN B-noun.location	) ) 0	in IN 0	the DT 0	prevention NN B-noun.person	af IN 0	embolic_events NNS B-noun.person	. . 0	. . 0
a2950248.s1	Angina NNP B-noun.person	and CC 0	ischemic JJ B-adj.all	electrocardiographic JJ B-adj.all	changes NNS B-noun.relation	occurred VBD B-verb.cognition	after IN 0	administration NN B-noun.time	of IN 0	oral JJ B-adj.all	dipyridamole NN B-noun.person	in IN 0	four CD 0	patients NNS B-noun.person	awaiting VBG B-verb.cognition	urgent JJ B-adj.all	myocardial JJ B-adj.all	revascularization NN B-noun.act	procedures NNS B-noun.person	. . 0	. . 0
a12464714.s6	Forty NNP B-noun.person	- : 0	nine CD B-adj.all	percent NN B-noun.person	of IN 0	patients NNS B-noun.person	were VBD B-verb.stative	pain JJ B-adj.all	free JJ B-noun.relation	2 CD B-adj.all	h NN 0	after IN 0	rizatriptan JJ B-noun.animal	, , 0	compared VBN B-verb.cognition	with IN 0	24.3 CD 0	% NN 0	treated VBN B-verb.communication	with IN 0	ergotamine NN 0	/ : 0	caffeine NN B-noun.substance	( ( 0	p UH 0	< : 0	or CC 0	= $ 0	0.001 CD 0	) ) 0	, , 0	rizatriptan NN 0	being VBG B-verb.stative	superior JJ B-adj.all	within IN 0	1 CD B-adj.all	h NN 0	of IN 0	treatment NN B-noun.plant	. . 0	. . 0
a19037603.s13	Prophylactic JJ B-adj.all	administration NN B-noun.time	of IN 0	lamivudine NN B-noun.act	in IN 0	patients NNS B-noun.person	who WP 0	required VBD B-verb.stative	immunosuppressive JJ B-adj.all	therapy NN B-noun.person	seems VBZ B-verb.perception	to TO 0	be VB B-verb.stative	safe JJ B-adj.all	, , 0	well RB 0	tolerated VBN 0	and CC 0	effective JJ B-adj.all	in IN 0	preventing VBG B-verb.creation	HBV NNP 0	reactivation NN B-noun.process	. . 0	. . 0
a8387218.s9	The DT 0	most RBS 0	common JJ B-adj.all	side NN B-noun.attribute	- : 0	effect NN B-noun.cognition	was VBD B-verb.stative	diarrhoea NN B-noun.person	, , 0	which WDT 0	resulted VBD B-verb.stative	in IN 0	cessation NN 0	of IN 0	therapy NN B-noun.act	in IN 0	19 CD B-adj.all	individuals NNS B-noun.person	. . 0	. . 0
a10669626.s3	Treatment NN B-noun.person	for IN 0	2 CD B-adj.all	weeks NNS B-noun.time	with IN 0	Warfarin NNP B-noun.person	caused VBD B-verb.creation	massive JJ B-adj.all	focal JJ B-adj.all	calcification_of_the_artery JJ B-adj.all	media NNS B-noun.person	in IN 0	20-day JJ B-noun.time	- : 0	old JJ B-adj.all	rats NNS B-noun.person	and CC 0	less RBR B-adv.all	extensive JJ B-adj.all	focal JJ B-adj.all	calcification NN B-noun.act	in IN 0	42-day JJ B-noun.time	- : 0	old JJ B-adj.all	rats NNS B-noun.person	. . 0	. . 0
a12589964.s5	Ten CD 0	rats NNS B-noun.person	received VBD B-verb.possession	saline NN 0	as IN 0	a DT 0	control NN B-noun.act	group NN I-noun.act	. . 0	. . 0
a809711.s2	Our PRP$ 0	study NN B-noun.artifact	was VBD 0	designed VBN B-verb.creation	to TO 0	determine VB B-verb.communication	the DT 0	effects NNS B-noun.phenomenon	of IN 0	combined JJ B-adj.all	nitroglycerin NN B-noun.person	and CC 0	phenylephrine NN B-noun.person	therapy NN B-noun.person	. . 0	. . 0
a7582165.s10	The DT 0	basic JJ B-adj.all	mechanisms NNS B-noun.act	of IN 0	those DT 0	reactions NNS B-noun.cognition	are VBP 0	not RB 0	yet RB 0	fully RB B-adv.all	understood VBN B-verb.cognition	. . 0	. . 0
a7504976.s9	CONCLUSION NN B-noun.group	, , 0	Toxic_hepatitis NN B-noun.location	is VBZ B-verb.stative	a DT 0	potential JJ B-adj.all	adverse JJ B-adj.all	effect NN B-noun.cognition	of IN 0	antithyroid JJ B-adj.all	drugs NNS B-noun.artifact	which WDT 0	warrants NNS B-noun.location	, , 0	as IN 0	for IN 0	haematological JJ B-adj.all	disturbances NNS B-noun.person	, , 0	a DT 0	pre NN B-noun.person	- : 0	therapeutic JJ B-adj.all	determination NN B-noun.attribute	and CC 0	a DT 0	careful JJ B-adj.all	follow NN B-noun.act	- : 0	up IN 0	of IN 0	relevant JJ B-adj.all	biological JJ B-adj.all	markers NNS B-noun.person	. . 0	. . 0
a347884.s5	These DT 0	results NNS B-noun.communication	were VBD 0	confirmed VBN B-verb.change	by IN 0	statistical JJ B-adj.all	analysis NN B-noun.communication	. . 0	. . 0
a18186898.s0	Renal_Fanconi_syndrome VB 0	and CC 0	myopathy JJ B-adj.all	after IN 0	liver NN B-noun.relation	transplantation NN I-noun.relation	, , 0	drug NN B-noun.person	- : 0	related VBN B-verb.cognition	mitochondrial_cytopathy JJ 0	? . 0	. . 0
a15572383.s7	n LS 0	= $ 0	9 CD B-adj.all	] CD 0	. . 0	. . 0
a3496378.s4	Finally RB B-adv.all	, , 0	pruritus NN B-noun.person	disappeared VBD B-verb.stative	within IN 0	19 CD B-adj.all	months NNS B-noun.person	, , 0	and CC 0	liver NN B-noun.person	tests NNS B-noun.person	returned VBD B-verb.communication	to TO 0	normal JJ B-adj.all	27 CD B-adj.all	months NNS B-noun.person	after IN 0	the DT 0	onset NN B-noun.event	of IN 0	hepatitis NN B-noun.location	. . 0	. . 0
a9522152.s3	Sensation NN B-noun.person	in IN 0	this DT 0	area NN B-noun.cognition	returned VBD B-verb.change	to TO 0	normal JJ B-adj.all	over IN 0	the DT 0	following VBG 0	2 CD B-adj.all	weeks NNS B-noun.time	. . 0	. . 0
a17437408.s5	This DT 0	prompted VBD B-verb.creation	us PRP 0	to TO 0	study VB B-verb.cognition	the DT 0	brain NN B-adj.all	expression NN B-noun.communication	of IN 0	P NNP 0	- : 0	glycoprotein NN B-noun.person	( ( 0	Pgp NNP 0	) ) 0	, , 0	a DT 0	major JJ B-adj.all	drug NN B-noun.phenomenon	efflux NN B-noun.phenomenon	transporter NN I-noun.phenomenon	in IN 0	many JJ 0	tissues NNS B-noun.event	, , 0	including VBG B-verb.change	the DT 0	BBB NNP B-noun.group	, , 0	in IN 0	TR(- NN 0	) ) 0	rats NNS 0	compared VBN B-verb.stative	with IN 0	nonmutant JJ B-adj.all	( ( 0	wild JJ B-noun.person	- : 0	type NN B-noun.person	) ) 0	Wistar NNP B-noun.person	rats NNS I-noun.person	. . 0	. . 0
a2476560.s4	Preparations NNS B-noun.person	containing VBG B-verb.creation	lindane NN B-noun.shape	continue VBP B-verb.stative	to TO 0	be VB 0	sold VBN B-verb.possession	over IN 0	the DT 0	counter NN B-noun.person	and CC 0	may MD 0	represent VB B-verb.social	a DT 0	hazard NN B-noun.person	to TO 0	poorly RB B-adv.all	informed VBN B-verb.communication	patients NNS B-noun.person	. . 0	. . 0
a2385256.s5	After IN 0	her PRP$ 0	strength NN B-noun.attribute	returned VBD B-verb.change	, , 0	repetitive JJ B-adj.all	stimulation NN B-noun.artifact	was VBD B-verb.stative	normal JJ B-adj.all	, , 0	but CC 0	single JJ B-adj.all	fiber NN B-noun.person	EMG NNP B-noun.person	revealed VBD B-verb.communication	increased VBN B-verb.change	jitter NN B-noun.person	and CC 0	blocking VBG B-verb.change	. . 0	. . 0
a3780846.s8	was VBD 0	used VBN B-verb.consumption	in IN 0	order NN 0	to TO 0	block VB B-verb.change	the DT 0	dopaminergic JJ B-adj.all	activation NN B-noun.act	and CC 0	to TO 0	estimate VB B-verb.cognition	the DT 0	real JJ B-adj.all	degree NN B-noun.state	of IN 0	the DT 0	tolerance NN B-noun.act	to TO 0	the DT 0	rigidity NN B-noun.attribute	without IN 0	any DT 0	dopaminergic JJ B-adj.all	interference NN B-noun.event	. . 0	. . 0
a603022.s1	Galanthamine_hydrobromide NN B-noun.artifact	, , 0	an DT 0	anticholinesterase JJ B-adj.all	drug NN B-noun.person	capable JJ 0	of IN 0	penetrating VBG B-verb.cognition	the DT 0	blood NN B-noun.act	- : 0	brain NN B-noun.person	barrier NN I-noun.person	, , 0	was VBD 0	used VBN B-verb.consumption	in IN 0	a DT 0	patient NN B-noun.person	demonstrating VBG B-verb.body	central JJ B-adj.pert	effects NNS B-noun.phenomenon	of IN 0	scopolamine NN B-noun.person	( ( 0	hyoscine NN 0	) ) 0	overdosage NN B-noun.state	. . 0	. . 0
a1378968.s11	In IN 0	this DT 0	model NN B-noun.person	of IN 0	chronic_renal_failure NNP B-noun.group	the DT 0	decline NN B-noun.state	in IN 0	GFR NNP 0	is VBZ B-verb.stative	not RB B-adv.all	accompanied VBN B-verb.stative	by IN 0	a DT 0	corresponding JJ B-adj.all	fall NN B-noun.person	in IN 0	effective JJ B-adj.all	renal JJ B-adj.all	plasma NN B-noun.attribute	flow NN B-noun.process	, , 0	which WDT 0	may MD 0	be VB B-verb.stative	the DT 0	functional JJ B-adj.all	expression NN B-noun.communication	of IN 0	the DT 0	formation NN B-noun.act	of IN 0	nonfiltrating VBG B-verb.perception	atubular JJ B-adj.all	glomeruli NN B-noun.person	. . 0	. . 0
a88336.s6	The DT 0	similarities NNS B-noun.attribute	between IN 0	the DT 0	effects NNS B-noun.phenomenon	of IN 0	structural JJ B-adj.all	lesions NNS B-noun.person	and CC 0	pharmacological JJ B-adj.all	depression NN B-noun.state	of IN 0	the DT 0	brain NN B-noun.plant	stem NN B-noun.plant	reticular JJ B-adj.all	formation NN B-noun.act	are VBP 0	discussed VBN B-verb.communication	. . 0	. . 0
a20528871.s2	The DT 0	most RBS 0	common JJ 0	side NN 0	effects NNS B-noun.phenomenon	attributable JJ B-adj.all	to TO 0	the DT 0	AraG NN B-noun.communication	included VBD B-verb.stative	Grade NNP 0	2 CD 0	and CC 0	3 CD B-adj.all	sensory NN B-noun.person	and CC 0	motor NN B-verb.creation	neuropathy JJ B-adj.all	and CC 0	musculoskeletal_pain NN B-noun.person	. . 0	. . 0
a11807648.s12	INTERPRETATION NN B-noun.artifact	, , 0	Tranexamic_acid NN B-noun.person	retains VBZ B-verb.possession	its PRP$ 0	convulsive JJ B-adj.all	action NN B-noun.process	within IN 0	FS NNP 0	. . 0	. . 0
a2334618.s3	Monitoring NN B-noun.person	consisted VBD B-verb.communication	of IN 0	airflow NN B-noun.phenomenon	detection NN B-noun.process	by IN 0	a DT 0	carbon_dioxide JJ 0	analyser NN B-noun.animal	, , 0	chest JJS B-adj.all	wall NN 0	movement NN 0	detected VBN B-verb.perception	by IN 0	pneumatic JJ B-adj.all	capsules NNS B-noun.artifact	, , 0	and CC 0	continuous JJ B-adj.all	electrocardiograph NN B-noun.person	recorded VBN B-verb.communication	with IN 0	a DT 0	Holter NNP B-noun.person	ambulatory NN B-noun.person	monitor NN B-noun.person	. . 0	. . 0
a9351491.s1	Risperidone NN 0	is VBZ B-verb.stative	an DT 0	antipsychotic JJ B-adj.all	drug NN B-noun.person	with IN 0	high JJ B-adj.all	affinity NN B-noun.phenomenon	at IN 0	dopamine NN B-noun.act	D2 : 0	and CC 0	serotonin_5-HT2 JJ B-noun.body	receptors NNS I-noun.body	. . 0	. . 0
a10669626.s4	In IN 0	contrast NN 0	, , 0	no DT 0	artery_calcification NN 0	could MD 0	be VB 0	detected VBN B-verb.perception	in IN 0	10-month JJ 0	- : 0	old JJ B-adj.all	adult NN B-noun.person	rats NNS B-noun.person	even RB B-adv.all	after IN 0	4 CD B-adj.all	weeks NNS B-noun.time	of IN 0	Warfarin NNP B-noun.location	treatment NN B-noun.feeling	. . 0	. . 0
a11745184.s2	Older JJR B-adj.all	reports NNS B-noun.person	suggest VBP B-verb.communication	an DT 0	objective JJ B-adj.all	response NN B-noun.communication	rate NN B-noun.time	of IN 0	8 CD B-adj.all	% NN 0	when WRB 0	60 SYM 0	- : 0	120 CD 0	mg NN B-noun.quantity	/ $ 0	m2 CD 0	of IN 0	cisplatin NN B-noun.food	is VBZ 0	administered VBN B-verb.possession	every DT 0	3 CD B-adj.all	- : 0	4 CD B-adj.all	weeks NNS B-noun.time	. . 0	. . 0
a16938416.s5	RESULTS NNS B-noun.artifact	, , 0	Intramuscular NNP 0	hormone NN 0	therapy NN 0	use NN 0	for IN 0	1 CD B-adj.all	year NN B-noun.time	or CC 0	longer JJR B-adj.all	was VBD 0	reported VBN B-verb.communication	by IN 0	25 CD B-adj.all	women NNS B-noun.person	. . 0	. . 0
a19759529.s2	However RB 0	, , 0	the DT 0	observation NN B-noun.communication	that IN 0	antagonists NNS B-noun.person	of IN 0	the DT 0	glutamate NN B-noun.group	N NNP 0	- : 0	methyl NN B-noun.attribute	- : 0	D SYM 0	- : 0	aspartate NN B-noun.person	( ( 0	NMDA NNP 0	) ) 0	receptor NN B-noun.person	produce VBP B-verb.emotion	schizophrenic JJ B-noun.person	- : 0	like IN 0	symptoms NNS B-noun.body	in IN 0	humans NNS B-noun.animal	has VBZ 0	led VBN B-verb.stative	to TO 0	the DT 0	idea NN B-noun.cognition	of IN 0	a DT 0	dysfunctioning NN B-noun.act	of IN 0	the DT 0	glutamatergic JJ B-adj.all	system NN B-noun.body	via IN 0	its PRP$ 0	NMDA NNP B-noun.group	receptor NN B-noun.artifact	. . 0	. . 0
a20619828.s4	RESULTS NNS B-noun.artifact	, , 0	Clomipramine NNP B-noun.person	exposure NN I-noun.person	in IN 0	immature JJ B-adj.all	rats NNS B-noun.person	produced VBD B-verb.creation	significant JJ B-adj.all	behavioral JJ B-noun.attribute	and CC 0	biochemical JJ B-adj.pert	changes NNS B-noun.phenomenon	that WDT 0	include VBP 0	enhanced VBN B-verb.change	anxiety NN 0	( ( 0	elevated JJ B-noun.person	plus CC 0	maze VB B-verb.change	and CC 0	marble NN 0	burying VBG B-verb.perception	) ) 0	, , 0	behavioral_inflexibility NN B-noun.attribute	( ( 0	perseveration NN B-noun.person	in IN 0	the DT 0	spontaneous JJ B-adj.all	alternation NN B-noun.act	task NN 0	and CC 0	impaired VBN B-verb.change	reversal NN B-noun.person	learning VBG B-verb.cognition	) ) 0	, , 0	working VBG B-verb.social	memory_impairment NN B-noun.relation	( ( 0	e.g. UH 0	, , 0	win VBP B-verb.possession	- : 0	shift NN B-noun.act	paradigm NN B-noun.act	) ) 0	, , 0	hoarding NN B-noun.person	, , 0	and CC 0	corticostriatal_dysfunction NN B-noun.artifact	. . 0	. . 0
a18023325.s8	A DT 0	nerve NN B-noun.attribute	conduction NN I-noun.attribute	study NN B-noun.artifact	was VBD B-verb.stative	consistent JJ B-adj.all	with IN 0	severe JJ B-adj.all	sensorimotor NN B-noun.feeling	axonal JJ B-adj.all	polyneuropathy NN B-noun.state	. . 0	. . 0
a3015567.s3	Application NN B-noun.act	of IN 0	a DT 0	delayed JJ B-adj.all	feedback NN B-noun.artifact	signal NN I-noun.artifact	, , 0	in IN 0	the DT 0	form NN B-noun.attribute	of IN 0	a DT 0	2-h JJ 0	systemic JJ B-adj.all	corticosterone NN 0	infusion NN 0	in IN 0	urethane NN 0	- : 0	anesthetized JJ B-adj.all	rats NNS B-noun.person	with IN 0	pharmacological JJ B-adj.all	blockade NN B-noun.attribute	of IN 0	glucocorticoid JJ B-adj.all	synthesis NN B-noun.body	, , 0	is VBZ B-verb.stative	without IN 0	effect NN B-noun.cognition	on IN 0	the DT 0	resting VBG B-verb.change	secretion NN B-noun.act	of IN 0	arginine_vasopressin NN B-noun.food	and CC 0	oxytocin NN B-noun.person	at IN 0	any DT 0	corticosterone NN B-noun.artifact	feedback NN B-noun.artifact	dose NN I-noun.artifact	tested VBN B-verb.social	. . 0	. . 0
a16330293.s14	The DT 0	most RBS 0	common JJ B-noun.person	adverse JJ B-adj.all	events NNS B-noun.person	were VBD B-verb.stative	nausea NN B-noun.quantity	( ( 0	17.2 CD 0	% NN 0	and CC 0	16.1 CD 0	% NN 0	, , 0	95 CD 0	% NN 0	CI NNP 0	, , 0	-3.7 UH 0	to TO 0	6.0 CD 0	) ) 0	, , 0	hiccups NNS 0	( ( 0	10.7 CD 0	% NN 0	and CC 0	6.6 CD 0	% NN 0	, , 0	95 CD 0	% NN 0	CI NNP 0	, , 0	0.5 CD 0	to TO 0	7.8 CD 0	) ) 0	, , 0	and CC 0	headache NN B-noun.state	( ( 0	8.7 CD 0	% NN 0	and CC 0	9.9 CD 0	% NN 0	, , 0	95 CD 0	% NN 0	Cl NNP 0	, , 0	-5.0 UH 0	to TO 0	2.6 CD 0	) ) 0	. . 0	. . 0
a18619688.s2	The DT 0	aim NN 0	of IN 0	this DT 0	study NN B-noun.artifact	was VBD 0	to TO 0	investigate VB B-verb.communication	whether IN 0	autophagy NN B-noun.person	was VBD 0	involved VBN B-verb.stative	in IN 0	the DT 0	progression NN B-noun.act	of IN 0	heart_failure NN B-noun.phenomenon	induced VBN B-verb.creation	by IN 0	adriamycin NN B-noun.person	, , 0	so RB B-adv.all	that IN 0	we PRP 0	can MD 0	develop VB B-verb.change	a DT 0	novel NN B-noun.communication	treatment NN B-noun.communication	strategy NN B-noun.communication	for IN 0	heart_failure NN B-noun.state	. . 0	. . 0
a17615423.s9	Amiodarone NNP B-noun.person	and CC 0	atazanavir NN B-noun.person	are VBP 0	recognized VBN B-verb.cognition	CYP3A4 JJ B-adj.all	inhibitors NNS B-noun.person	. . 0	. . 0
a15649445.s2	In IN 0	the DT 0	present JJ B-adj.all	study NN B-noun.artifact	, , 0	the DT 0	authors NNS B-noun.person	induced VBN B-verb.creation	orofacial_dyskinesia NNP 0	by IN 0	acute JJ B-adj.all	reserpine NN B-noun.person	and CC 0	subchronic JJ B-adj.all	haloperidol NN B-noun.person	administration NN B-noun.person	to TO 0	rats NNS B-noun.animal	. . 0	. . 0
a15572383.s14	CONCLUSION NN B-noun.group	, , 0	Individual JJ B-adj.all	differences NNS B-noun.attribute	in IN 0	renal JJ B-adj.all	ACE NNP B-noun.group	activity NN B-noun.process	predict VBP B-verb.change	the DT 0	severity NN B-noun.attribute	of IN 0	adriamycin NN B-noun.person	- : 0	induced VBN B-verb.creation	renal_damage NN B-noun.act	in IN 0	this DT 0	outbred JJ B-adj.all	rat NN B-noun.body	strain NN I-noun.body	. . 0	. . 0
a17931375.s6	Injections NNS B-noun.animal	areas NNS B-noun.body	were VBD 0	assessed VBN B-verb.social	for IN 0	the DT 0	presence NN B-noun.person	of IN 0	bruising VBG B-verb.contact	at IN 0	48 CD 0	and CC 0	72 CD 0	hours NNS B-noun.person	after IN 0	each DT 0	injection NN B-noun.event	. . 0	. . 0
a19820426.s2	One CD 0	of IN 0	the DT 0	twins NNS B-noun.person	developed VBD B-verb.creation	complete JJ B-adj.all	heart_block NN B-noun.person	and CC 0	dilated_cardiomyopathy JJ 0	related VBN B-verb.communication	to TO 0	lopinavir VB B-verb.change	/ : 0	ritonavir NN B-noun.person	therapy NN 0	, , 0	a DT 0	boosted JJ B-adj.all	protease NN B-noun.person	- : 0	inhibitor NN B-noun.person	agent NN B-noun.person	, , 0	while IN 0	the DT 0	other JJ 0	twin NN B-noun.person	developed VBD B-verb.change	mild JJ B-adj.all	bradycardia NNS B-noun.person	. . 0	. . 0
a9495837.s12	in IN 0	the DT 0	mouse NN B-noun.communication	passive NN B-noun.communication	- : 0	avoidance NN B-noun.act	test NN 0	. . 0	. . 0
a10901305.s0	Ketamine NNP B-noun.person	sedation NN B-noun.act	for IN 0	the DT 0	reduction NN B-noun.act	of IN 0	children NNS B-noun.person	's POS 0	fractures NNS B-noun.body	in IN 0	the DT 0	emergency NN B-noun.person	department NN B-noun.person	. . 0	. . 0
a18308784.s9	We PRP 0	conclude VBP B-verb.cognition	that IN 0	Rg1 JJ 0	may MD 0	significantly RB 0	improve VB B-verb.communication	the DT 0	spatial JJ B-adj.all	learning VBG B-verb.cognition	capacity NN B-noun.act	impaired VBN B-verb.change	by IN 0	chonic JJ B-adj.pert	morphine NN B-noun.substance	administration NN B-noun.artifact	and CC 0	restore VB B-verb.contact	the DT 0	morphine NN B-noun.person	- : 0	inhibited JJ B-adj.all	LTP NNP B-noun.group	. . 0	. . 0
a7234705.s5	In IN 0	four CD 0	patients NNS B-noun.person	, , 0	the DT 0	arrhythmia NN B-noun.person	was VBD 0	rapidly RB B-adv.all	diagnosed VBD B-verb.communication	and CC 0	treated VBN B-verb.change	with IN 0	disappearance NN B-noun.act	of IN 0	further JJ B-adj.all	episodes NNS B-noun.communication	of IN 0	the DT 0	arrhythmia NN B-noun.person	. . 0	. . 0
a10526274.s15	Six CD 0	patients NNS B-noun.person	( ( 0	12 CD B-adj.all	% NN 0	) ) 0	had VBD 0	World NNP B-noun.group	Health NNP I-noun.group	Organization NNP I-noun.group	Grade NNP I-noun.group	3 SYM 0	- : 0	4 CD B-adj.all	neutropenia NN B-noun.person	, , 0	2 CD B-adj.all	patients NNS B-noun.person	( ( 0	4 CD B-adj.all	% NN 0	) ) 0	had VBD 0	Grade NNP B-noun.other	3 SYM 0	- : 0	4 CD B-adj.all	thrombocytopenia NN B-noun.communication	, , 0	and CC 0	2 CD B-adj.all	patients NNS B-noun.person	( ( 0	4 CD B-adj.all	% NN 0	) ) 0	had VBD 0	Grade NNP B-noun.other	3 CD 0	neurotoxicity NN B-noun.quantity	. . 0	. . 0
a3425586.s5	The DT 0	pentose_phosphate JJ B-adj.all	shunt NN B-noun.phenomenon	activity NN B-noun.process	of IN 0	the DT 0	non NN B-noun.person	- : 0	dapsone NN B-noun.person	- : 0	exposed VBN B-verb.communication	AE NNP B-noun.person	RBCs NNP I-noun.person	was VBD 0	decreased VBN B-verb.change	compared VBN I-verb.change	to TO 0	normal JJ B-adj.all	RBCs NNP B-noun.person	. . 0	. . 0
a137340.s0	Effect NN 0	of IN 0	humoral JJ B-adj.all	modulators NNS B-noun.person	of IN 0	morphine NN B-noun.person	- : 0	induced VBN B-verb.creation	increase_in_locomotor_activity NN B-noun.quantity	of IN 0	mice NNS B-noun.animal	. . 0	. . 0
a2578334.s7	Perhaps RB 0	two CD 0	events NNS 0	might MD 0	be VB B-verb.stative	necessary JJ B-adj.all	for IN 0	initiation NN B-noun.act	, , 0	the DT 0	first JJ B-noun.person	caused VBN B-verb.communication	by IN 0	the DT 0	carcinogen NN B-noun.artifact	and CC 0	a DT 0	second JJ B-adj.all	involving VBG B-verb.stative	hypomethylation NN 0	of IN 0	DNA NNP B-noun.group	. . 0	. . 0
a2224762.s13	Activity NN B-noun.person	was VBD 0	noted VBN B-verb.perception	in IN 0	mesothelioma NN B-noun.food	, , 0	leiomyosarcoma NN B-noun.person	, , 0	and CC 0	basal_cell_carcinoma NNP B-noun.person	. . 0	. . 0
a16330293.s5	Patients NNS B-noun.person	were VBD 0	randomized VBN B-verb.perception	in IN 0	a DT 0	1,1 CD 0	ratio NN B-noun.time	to TO 0	receive VB B-verb.communication	the DT 0	4-mg JJ B-adj.all	nicotine NN B-noun.artifact	lozenge NN B-noun.artifact	or CC 0	4-mg JJ B-adj.all	nicotine NN B-noun.person	gum NN B-noun.person	. . 0	. . 0
a20588063.s14	The DT 0	novel JJ B-adj.all	proteins NNS B-noun.act	dendrin VBP B-verb.possession	and CC 0	plekhh2 NNP B-noun.person	were VBD B-verb.stative	both DT 0	reduced VBD B-verb.change	, , 0	suggesting VBG B-verb.communication	roles NNS B-noun.act	in IN 0	PAN NNP 0	, , 0	whereas IN 0	a SYM 0	- : 0	actinin NN B-noun.person	was VBD B-verb.stative	unchanged JJ B-adj.all	. . 0	. . 0
a16337777.s1	Mitochondrial_abnormalities NNS B-noun.artifact	have VBP 0	been VBN 0	associated VBN B-verb.cognition	with IN 0	several JJ B-adj.all	aspects NNS B-noun.location	of IN 0	epileptogenesis NN B-noun.food	, , 0	such JJ 0	as IN 0	energy NN B-noun.phenomenon	generation NN I-noun.phenomenon	, , 0	control NN B-noun.act	of IN 0	cell NN B-noun.body	death NN 0	, , 0	neurotransmitter NN B-noun.person	synthesis NN B-noun.person	, , 0	and CC 0	free JJ B-adj.all	radical NN B-noun.substance	( ( 0	FR NNP 0	) ) 0	production NN B-noun.communication	. . 0	. . 0
a8682684.s1	Through IN 0	30 CD B-adj.all	years NNS B-noun.time	of IN 0	widespread JJ B-adj.all	use NN 0	, , 0	acetaminophen NN B-noun.person	has VBZ 0	been VBN 0	shown VBN B-verb.perception	to TO 0	be VB B-verb.stative	a DT 0	remarkably RB B-adv.all	safe JJ B-adj.all	medication NN B-noun.act	in IN 0	therapeutic JJ B-adj.all	dosages NNS B-noun.person	. . 0	. . 0
a2224762.s2	Twenty CD 0	- : 0	six CD 0	had VBD 0	minimal JJ B-adj.all	prior JJ B-adj.all	therapy NN B-noun.act	( ( 0	good JJ 0	risk NN 0	) ) 0	, , 0	23 CD 0	had VBD 0	extensive JJ B-verb.communication	prior RB B-adj.all	therapy NN B-noun.act	( ( 0	poor JJ B-adj.all	risk NN 0	) ) 0	, , 0	and CC 0	six CD 0	had VBD 0	renal_and NNP B-noun.location	/ POS I-noun.location	or_hepatic_dysfunction NN I-noun.location	. . 0	. . 0
a2445283.s6	The DT 0	possible JJ B-adj.all	beneficial JJ B-adj.all	effect NN B-noun.cognition	of IN 0	ribavirin NN 0	during IN 0	the DT 0	initial JJ B-adj.all	days NNS B-noun.phenomenon	of IN 0	AHF NNP 0	is VBZ 0	discussed VBN B-verb.communication	. . 0	. . 0
a11807648.s2	In IN 0	order NN 0	to TO 0	increase VB B-verb.body	clot NN B-noun.phenomenon	stability NN B-noun.attribute	, , 0	FS NNP 0	typically RB B-adv.all	contain VBP B-verb.stative	aprotinin NN I-verb.stative	, , 0	a DT 0	natural JJ B-adj.all	fibrinolysis NN 0	inhibitor NN 0	. . 0	. . 0
a15275829.s4	We PRP 0	examined VBD B-verb.perception	the DT 0	role NN B-noun.attribute	of IN 0	the DT 0	beta4 JJ B-adj.all	subunits NNS B-noun.person	in IN 0	nicotine NN B-noun.person	- : 0	induced VBN B-verb.creation	seizures NNS B-noun.artifact	and CC 0	hypolocomotion NN B-noun.person	in IN 0	beta4 RBR 0	homozygous JJ B-adj.all	null NN B-noun.attribute	( ( 0	beta4 IN 0	-/- LS 0	) ) 0	and CC 0	alpha3 RB 0	heterozygous JJ 0	( ( 0	+ : 0	/- LS 0	) ) 0	mice NNS B-noun.animal	. . 0	. . 0
a7582165.s2	A DT B-adj.all	few JJ I-adj.all	minutes NNS B-noun.time	after IN 0	administration NN B-noun.time	of IN 0	the DT 0	drugs NNS B-noun.artifact	, , 0	they PRP 0	presented VBD B-verb.communication	urticaria NNS B-noun.person	( ( 0	patients NNS B-noun.communication	1 CD B-adj.all	and CC 0	2 CD B-adj.all	) ) 0	and CC 0	conjunctivitis NN B-noun.person	( ( 0	patient JJ B-verb.contact	1 CD 0	) ) 0	. . 0	. . 0
a20520283.s2	In IN 0	a DT 0	double JJ B-adj.all	- : 0	blind JJ B-adj.all	6-week JJ B-adj.all	trial NN B-noun.communication	, , 0	458 CD 0	patients NNS B-noun.person	with IN 0	acute JJ B-adj.all	schizophrenia NN B-noun.person	were VBD 0	randomly RB B-adv.all	assigned VBN B-verb.social	to TO 0	fixed VBN B-verb.consumption	- : 0	dose NN B-noun.communication	treatment NN B-noun.communication	with IN 0	asenapine NN B-noun.person	at IN 0	5 CD B-adj.all	mg NN B-noun.quantity	twice RB B-adv.all	daily RB B-adv.all	( ( 0	BID NNP 0	) ) 0	, , 0	asenapine NN B-noun.person	at IN 0	10 CD B-adj.all	mg IN 0	BID NNP B-noun.group	, , 0	placebo NN 0	, , 0	or CC 0	haloperidol NN B-noun.person	at IN 0	4 CD 0	mg IN 0	BID NNP 0	( ( 0	to TO 0	verify VB B-verb.social	assay JJ B-adj.all	sensitivity NN B-noun.feeling	) ) 0	. . 0	. . 0
a18703024.s3	We PRP 0	report VBP B-verb.communication	that IN 0	prenatally RB B-adv.all	protein VBP 0	deprived VBN B-verb.creation	( ( 0	PD NNP 0	) ) 0	female NN B-noun.person	rats NNS B-noun.person	showed VBD B-verb.communication	an DT 0	increased VBN B-verb.change	stereotypic JJ B-adj.all	response NN B-noun.communication	to TO 0	apomorphine VB B-verb.social	and CC 0	an DT 0	increased VBN B-adj.all	locomotor NN B-noun.artifact	response NN B-noun.communication	to TO 0	amphetamine VB B-verb.social	in IN 0	adulthood NN B-noun.act	. . 0	. . 0
a15130900.s3	Through IN 0	linkage NN B-noun.act	with IN 0	the DT 0	Swedish NNP B-noun.other	Cancer NNP I-noun.other	Register NNP I-noun.other	, , 0	all DT 0	subjects NNS B-noun.person	in IN 0	this DT 0	cohort NN B-noun.person	diagnosed VBD B-verb.communication	with IN 0	bladder_cancer NNP B-noun.person	were VBD 0	identified VBN B-verb.cognition	. . 0	. . 0
a15233872.s0	Cardioprotective JJ B-adj.all	effect NN B-noun.cognition	of IN 0	tincture_of_Crataegus JJ 0	on IN 0	isoproterenol NN B-noun.act	- : 0	induced VBN B-verb.creation	myocardial_infarction NN B-noun.process	in IN 0	rats NNS B-noun.animal	. . 0	. . 0
a20619828.s7	Moreover RB B-adv.all	, , 0	these DT 0	behaviors NNS B-noun.person	are VBP 0	accompanied VBN B-verb.stative	by IN 0	biochemical JJ B-adj.pert	changes NNS B-noun.communication	in IN 0	brain NN B-noun.animal	regions NNS I-noun.animal	previously RB B-adv.all	identified VBN B-verb.cognition	as IN 0	relevant JJ B-adj.all	to TO 0	OCD NNP 0	. . 0	. . 0
a12041669.s3	Use NNP B-noun.person	of IN 0	antithymocyte_globulin NNP B-noun.location	may MD 0	be VB B-verb.stative	the DT 0	optimal JJ B-adj.all	treatment NN B-noun.act	of IN 0	D NNP 0	- : 0	penicillamine NN B-noun.person	- : 0	induced VBN B-verb.creation	aplastic_anemia NNP B-noun.person	. . 0	. . 0
a9284778.s14	In IN 0	view NN 0	of IN 0	the DT 0	potentially RB B-adj.all	widespread JJ B-adj.all	use NN 0	of IN 0	these DT 0	compounds NNS B-noun.person	, , 0	there EX 0	is VBZ B-verb.stative	an DT 0	urgent JJ B-adj.all	need NN B-noun.motive	to TO 0	develop VB B-verb.change	safer JJR B-adj.all	alternatives NNS B-noun.person	. . 0	. . 0
